tsawon lokacin da waɗannan cututtukan ke ci gaba?
Kuma duk wani ciwo a kirji ya kamata a bi da shi ta wannan hanyar, musamman idan aka yi la'akari da shekarunka.
kuma tare da zafin jiki mai zafi
kuma ana bukatar a duba matakin cholesterol da kuma karfin jini
kuma kuna da zazzabi a yanzu?
kuma kuna jin wannan ciwon kirji a yanzu?
kuma idan kana da wahalar numfashi
kuma za ku iya gaya mani, waɗanne alamun da kuke da su ban da waɗannan?
da kuma yawan zafin jikinka
Kuma ina da tari.
kuma ina da ɗan sanyi tare da tari
kuma ina da ciwo mai tsanani a kirji a yau
kuma ko wannan lokaci ya dace da bayyanar hay fever da kake fama da ita
kuma akwai ciwon kirji
kuma ina tsammanin ina da zazzabi kadan
kuma ina son ku bayyana inda kuke jin zafi a kirji
kuma suna da zazzabi kadan.
da kuma tarihin ciwon sukari
Kuma kun san, yana jin kamar an murƙushe kirjina.
Kuma, ka sani, mutane suna yawan yin tari a kaina.
kuma kuna jin ciwon kirji
kuma ka ce wannan shi ne chest pressure
wani a cikin iyalinka yana da ciwon zuciya, rashin lafiya na zuciya, ciwon zuciya, yawan cholesterol, hawan jini
Shin akwai wasu alamun ko matsalolin da kuka lura da su da suka shafi ciwon tsoka?
Shin akwai wasu marasa lafiya a gidanku da ke nuna alamun cutar?
Shin kana da wasu alamun cutar?
Shin kuna jin numfashi a yanzu?
shin har yanzu kuna jin ciwon kirji
saboda wannan shine lokacin mura
Amma kuma bai kamata mu manta da cewa akwai ciwon kirji wanda yake da ciwon zuciya ba.
Amma yanzu matsalar da ta fi muhimmanci ita ce wannan ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa suna tari a kaina.
Amma dole ne muyi amfani da maganin ciwon kirji da tsanani.
Amma yanzu kana numfashi sosai, ko ba haka ba?
"Tun da ba zan iya tuna wannan ciwon kirji ba".
Shin yana kama da wani yana matsawa kirjinka?
har yanzu kuna jin numfashi
Shin suna gunaguni cewa suna da alamun rashin lafiya?
kuna da wata cuta mai tsanani kamar hawan jini ko wani abu makamancin haka?
kuna da wata cuta ko kuma wata cuta kamar ciwon sukari?
Shin kuna jin numfashi a cikin wannan ciwon kirji?
Shin kana da hawan jini?
Shin wannan yana tare da numfashi?
Shin kun san irin alamun da ta nuna?
Kuna ganin wannan hoton?
Ku sha ruwa mai yawa yau
Amma ina yin gwajin ciwon sukari.
Amma ta nuna alamun cutar kamar yadda na nuna.
Yaya zafin jikinka yake?
Yaya yawan hawan jini naka yake?
idan har yanzu kuna da zazzabi
idan kana da zazzabi talatin da takwas da tara ko sama
idan kuna ganin alamunku ko matsalolinku sun ba da tabbacin inganta yanayinku
Na yi zazzabi a jiya.
Ni ma na samu zazzabi kadan jiya.
Na yi zazzabi a jiya
Ina jin zafi sosai a cikin kirji.
Ina kuma da wahalar numfashi.
Zan aiko muku da hoto.
Ina jin wani ciwo a kirji yau
Ina da ciwon kai da zazzabi a yau.
Ina tsammanin mura ce.
Ina tsammanin mura ce mai laushi.
Shin yana sa ka ji kamar kana da mutum mai nauyi a wuyanka?
Dukkanin sun fara ne kusan lokaci guda da ciwon kai da zazzabi
Ina jin ciwo a tsakiyar kirji
Yana kama da ciwon kirji.
Wannan shine a cikin kirji na
Wannan shine tsakiyar kirji na
Wannan shine tsakiyar kirji
Na sami ciwo a kirji
Ina matukar damuwa da wannan ciwon kirji.
Ina so ku bayyana min wannan ciwon kirji.
kamar hawan jini ko ciwon sukari
kamar yadda daidai a tsakiyar kirji
don zazzabi mai zafi za ku iya ɗaukar takirin takirin a yanzu a cikin nau'i na candies
Yanzu, Mary, ka gaya mini tsawon lokacin da ka kasance kana da waɗannan cututtuka.
Yanzu kun ce kuna jin ciwon kirji
Wani lokaci ina jin kadan zafi a kirji
To, shin kana da wasu alamun ciwo da ke tattare da wannan?
Ko kuwa akwai wani a kan kirjinka?
Da yawan zazzabi da tari, ciwon kai da ciwon tsoka.
ciwo a tsakiyar kirji na
Ka nuna mini inda kake jin zafi a wannan hoton.
saboda kuna da zazzabi
Shin kuna ganin wasu daga cikin waɗannan alamun na iya kasancewa cikin ciki?
Shin yaranku suna da wasu daga cikin waɗannan alamun?
Ka gaya mani game da ciwon kirjinka.
zafin jiki yana ƙaruwa da dare
zazzabi da na yi a cikin kwanaki biyu da suka gabata
Zafin jiki ya fara tashi a daren jiya.
Wannan shi ne Dr. Porter a dakin karbar marasa lafiya.
To, za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a gaban jikina, a cikin kirji.
Ina jin zafi sosai a kirji.
Don haka idan na ji ciwon kirji
Abin da irin ciwo kuke ji a kirji?
Yaushe kuka fara jin wannan ciwon kirji?
A ina ne za ka iya samun ciwon kirji?
inda za ka ji wannan ciwon kirji
kuna jin wani abu mai kama da ƙuntatawa a cikin kirjin ku
Na san ina da ciwon sukari da sauransu.
Ka ce kana jin wannan ciwon kirji.
Yawan masu kamuwa da cutar coronavirus (COVID-19) da ke karuwa cikin sauri a Tarayyar Turai da Burtaniya a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Yawan kamuwa da cutar coronavirus (COVID-19) yana da irin wannan yanayin a cikin ƙasashen Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya, don haka yana tabbatar da cewa duk da cewa akwai matakai daban-daban na ci gabanta a cikin ƙasashe daban-daban, annobar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe.
Bisa ga abin da Italiya ta yi, ƙasashe, asibitoci da dakunan jinya na musamman suna bukatar su kasance a shirye don karɓar masu cutar COVID-19 da ke buƙatar magani da kuma jinya mai tsanani.
A ranar 31 ga Disamba, 2019, an sami wasu mutane da suka kamu da cutar sankarar bargo a birnin Wuhan na lardin Hubei na kasar Sin.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta sanar da cewa sabon nau'in coronavirus ne ya haifar da kamuwa da cutar, wanda yanzu aka sani da coronavirus mai fama da cutar cututtukan numfashi mai tsanani na 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da SARS-CoV-2 ke haifarwa an kira ta cutar coronavirus (COVID-19).
A cewar bayanan da ake da su a yau, kusan kashi 80 cikin ɗari na mutanen da ke da COVID-19 suna da cutar mai sauƙi, wato, cutar numfashi tare da ciwon huhu ko a'a, kuma yawancin mutanen da ke fama da cutar suna murmurewa.
Kimanin kashi 14 cikin ɗari na masu kamuwa da COVID-19 suna ci gaba zuwa wani yanayi mai tsanani da ke buƙatar asibiti, sauran kashi 6 cikin ɗari suna cikin mawuyacin hali, inda ake buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke cikin asibiti da COVID-19 ya kai kusan kashi 4%.
Wannan binciken ya yi nazarin yanayin cutar COVID-19 a kowace ƙasa ta Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya kuma ya kwatanta su da yanayin lardin Hubei na China.
Mun kuma kwatanta adadin masu kamuwa da COVID-19 a EU/EEA da Birtaniya da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a EU/EEA da Birtaniya
Bayan barkewar cutar a China, COVID-19 ta yadu zuwa wasu ƙasashe, kuma a halin yanzu a sauran duniya annobar COVID-19 tana ci gaba daidai da yadda ta faru a China.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana cutar COVID-19 a matsayin annoba.
A cikin mujallar Eurosurveillance ta 5 ga Maris, 2020, Mista Spiteri da abokan aikinsa sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai waɗanda suka cika ƙa'idodin WHO don gano cutar.
An samu mutum uku da suka kamu da cutar a Faransa a ranar 24 ga watan Janairun 2020  dukansu sun dawo daga birnin Wuhan na lardin Hubei na kasar Sin.
A ranar 15 ga Maris, 2020, an gano cututtukan COVID-19 a cikin dukkan ƙasashe 30 na EU/EEA da Burtaniya, tare da a cikin lokacin daga 31 ga Disamba, 2019 zuwa wannan ranar an sami kamuwa da cutar 39,768 da mutuwar 1,727, daga cikinsu akwai 17,750 daga cikinsu 1,441 da suka mutu a Italiya kadai.
Tabbatar da yawan adadin COVID-19 da yawan kamuwa da cutar
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana sabunta bayanai game da adadin masu cutar COVID-19 a kowace ƙasa a duniya a kowace rana da ƙarfe 8:00 na safe, daga kafofin hukuma kamar ma'aikatun kiwon lafiya na waɗannan ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO.
Ana amfani da wannan bayanan don nazarin yanayin yaduwar COVID-19 a cikin EU/EEA da UK da kuma kwatanta su da bayanan Italiya.
An ƙididdige yawan adadin masu cutar COVID-19 a cikin kwanaki 14 tare da la'akari da yanayin COVID-19 na yau da kullun a kowace ƙasa ta EU / EEA da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma nuna adadin adadin masu kamuwa da cutar a kowace ƙasa da karfe 8:00 na ranar 15 ga Maris, 2020, idan aka kwatanta da adadin da aka samu a Italiya daga ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da Burtaniya
Hanyoyin ci gaban cututtukan COVID-19 a cikin kwanaki 14 a cikin EU / EEA da Burtaniya gabaɗaya sun yi daidai da abubuwan da aka lura a lardin Hubei na China (Fig. 1).
Yawan kamuwa da COVID-19 a cikin EU/EEA da Birtaniya gabaɗaya ya fara ƙaruwa a kusan 21 ga Fabrairu, kuma a ranar 28 ga Fabrairu, 2020 an sami tsalle-tsalle a cikin wannan adadin (ƙarin bayani).
Wannan ya kasance saboda yawan karuwar adadin masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun lura da irin wannan yanayin karuwar yawan kamuwa da COVID-19 (ƙarin bayani).
Hoto na 2 ya nuna adadin mutanen da suka kamu da COVID-19 a cikin EU/EEA da Birtaniya idan aka kwatanta da adadin da aka samu a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Bisa ga wannan, yawan adadin da aka riga aka samu a ranar 15 ga Maris da karfe 8:00 na dare a wasu ƙasashe 15 na EU/EEA da kuma Burtaniya, ya yi daidai da adadin da aka samu a Italiya makonni uku da suka gabata.
Sakamakon bincikenmu ya nuna cewa an samu karuwar masu kamuwa da cutar COVID-19 a EU/EEA da Birtaniya.
Hanyoyin da ake lura da su na yawan kamuwa da cutar COVID-19 sun nuna cewa annobar tana ci gaba da sauri a duk ƙasashe.
Kuma wannan duk da cewa akwai matakai daban-daban a ƙasashe daban-daban, da bambance-bambance a matakan da hukumomin kiwon lafiyar jama'a na ƙasa ke ɗauka, kuma wataƙila akwai ma'auni daban-daban na ganewar cutar da kuma ƙa'idodin zaɓin marasa lafiya don gwajin COVID-19, gami da gwajin "sakewa".
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun ba da rahoton cewa kusan kashi 10 cikin ɗari na marasa lafiya da ke fama da COVID-19 suna buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ce asibitoci da sassan kulawa mai tsanani a waɗannan yankuna sun cika sosai.
A halin yanzu, ana samun bayanai game da shigar da marasa lafiya da COVID-19 asibitoci da (ko) sassan kulawa mai tsanani a cikin EU / EEA kawai game da kashi 6 cikin ɗari da kashi 1 cikin ɗari na shari'o'in daidai (ba a ba da bayanai ba).
Amma, ana bukatar a riƙa tattara irin wannan bayanan a kai a kai don a ci gaba da lura da yawan masu cutar da kuma yawan mutanen da suka mutu.
A cewar wani bincike da aka gudanar a shekara ta 2010 zuwa 2011, an samu raguwar gadaje a dakunan jinya da kuma dakunan kula da marasa lafiya a Turai: daga gado 29.2 a Jamus zuwa gadaje 4.2 a kowace mutum 100,000 a Portugal.
Wannan yana nufin cewa wasu ƙasashe suna da ƙarin ko ƙasa da albarkatu fiye da Italiya (gado 12.5 a cikin ICU da ICU a kowace mazauna 100,000 a 2010-2011).
Rahoton ECDC na shida da aka sabunta game da sakamakon kimanta haɗarin COVID-19 ya ba da yanayin samfurin tsarin kiwon lafiya tare da kimantawa game da asibiti na COVID-19 a kowace EU / EEA da Burtaniya, lokacin da haɗarin rashin gadaje a cikin sassan kulawa mai tsanani ya wuce 90%.
Tun da yake a halin yanzu an rarraba masu kamuwa da cutar zuwa wasu yankuna na EU/EEA da UK, kuma asibitoci da dakunan jinya na musamman suna kula da yawan jama'a a cikin wani yanki, ana ba da shawarar bayar da bayanai game da cututtuka da adadin gadaje a dakunan jinya a matakin 2 na Ƙididdigar Ƙasa don dalilai na kididdiga (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da Burtaniya.
Saboda haka, ƙasashe, asibitoci da dakunan jinya na musamman dole ne su kasance a shirye don yanayin kamuwa da SARS-CoV-2 na tuntuɓar wanda ba ya raguwa na dogon lokaci, da kuma ƙaruwar yawan marasa lafiya da COVID-19 da ke buƙatar kulawa ta likita, musamman kulawa mai tsanani, kamar yadda ake gani a yankunan da ke fama da cutar a Italiya.
Kamar yadda rahoton ECDC na baya-bayan nan ya nuna, gaggawa, tsinkaye da kuma daidaitawa yana da mahimmanci don hana yaduwar SARS-COV-2 tare da sauyawa daga hanawa zuwa rage tasirin, saboda yawan ƙwayoyin cuta da aka yi hasashen zai iya haifar da ƙarancin lokaci ga masu yanke shawara da asibitoci don tsarawa, ɗauka da daidaitawa idan ba a ɗauki irin waɗannan matakan ba.
Rahoton da aka bayar ya kuma nuna matakan da za a dauka don rage radadin annobar.
Kasashe suna da ɗan gajeren lokaci don ƙara ƙarfin ƙoƙarce-ƙoƙarcen su don rage yaduwar SARS-CoV-2 da rage nauyin da ke kan tsarin kiwon lafiyarsu.
Idan ba a yi hakan ba, a cikin kwanaki ko makonni masu zuwa, za a sami ƙarin marasa lafiya da ke bukatar jinya a wasu ƙasashen Tarayyar Turai da kuma yankin da ake kira EEA.
Cutar coronavirus ta 2019 (COVID-19), wadda cutar coronavirus ta haifar da mummunan cututtukan numfashi (SARS) nau'in 2 (SARS-CoV-2), ta zama bala'i ga ɗan adam: a halin yanzu mutane sama da 3 000 sun mutu a China da sauran ƙasashen duniya, kuma adadin masu kamuwa da cutar ya wuce 80,000.
Kamar kwayar cutar SARS-CoV da ta haifar da ciwon numfashi mai tsanani a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama daga bera kuma yana haifar da alamun bayyanar cututtuka iri ɗaya ta amfani da irin wannan hanyar.
Ko da yake COVID-19 ba ta da tsanani sosai kuma ba ta mutuwa sosai kamar SARS, amma tana da saurin kamuwa da cuta kuma tana shafar tsofaffi fiye da matasa, da maza fiye da mata.
Domin yawan littattafai da ake wallafawa game da wata sabuwar cuta, wannan talifin ya ba da cikakken bayani game da wannan sabon yanayin.
Za mu tattauna game da cututtuka da kuma yadda za a magance su.
Ko da yake ba a amsa tambayoyi da yawa ba, muna fatan wannan binciken zai taimaka mana mu fahimci wannan muguwar cuta kuma mu kawar da ita.
Bikin bazara (Sabuwar Shekarar kasar Sin), wanda ya zo ranar 25 ga Janairu, ya zama abin da ba a taɓa mantawa da shi ba ga duk Sinawa, waɗanda saboda barkewar sabon kamuwa da cutar kwayar cutar, an bukaci su zauna a gida a duk lokacin bikin da kuma makonni da yawa bayan haka.
Ganin irin kamanceceniyar da ke tsakanin cutar coronavirus (CoV) da ta haifar da cutar SARS a 2003, Hukumar Lafiya ta Duniya (WHO) ta sanya wa wannan kwayar cutar sunan SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke tattare da ita  cutar coronavirus 19 (COVID-19).
An fara annobar ne a birnin Wuhan na kasar Sin kuma ta bazu cikin sauri a fadin kasar, daga nan kuma zuwa kusan wasu kasashe 50 na duniya.
A ranar 2 ga Maris, 2020, an tabbatar da sama da mutane 80,000 da suka kamu da cutar COVID-19, sama da mutane 40,000 sun warke, sama da mutane 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 "maƙiyi na farko ga al'umma" ne kuma yana iya zama mafi haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga labarai sama da 200 game da COVID-19, gami da labarai game da ilimin ƙwayoyin cuta, cututtukan cututtuka, ilimin cututtuka, ganewar asali da magani, tun daga rahoton farko na 7 ga Janairu, 2020, wanda ya gano jerin ƙwayoyin cuta da aka ware daga yawancin marasa lafiya.
Wannan bita yana ƙoƙari ne na taƙaita sakamakon bincike a cikin sabon yanki mai tasowa.
Idan za mu iya, za mu gwada COVID-19 da SARS da kuma wata cutar da ke haifar da cutar coronavirus  cutar sankarar numfashi ta Gabas ta Tsakiya (MERS) wanda ya ɓarke a 2012.
Za mu kuma tattauna abubuwan da muka sani game da yadda za a hana cutar da kuma yadda za a yi hasashen yadda za ta ci gaba da ci gaba da kuma wasu batutuwa masu muhimmanci.
Coronavirus an saba da shi a cikin ƙwayoyin cuta waɗanda ba su da haɗari ga ɗan adam kuma galibi suna haifar da kusan kashi 15 cikin ɗari na cututtukan numfashi 4.
Duk da haka, a wannan karni, mun sami cututtukan mutum sau biyu, wato, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Saboda haka, cutar COVID-19 ta yanzu ita ce kamuwa da cutar coronavirus ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, rahoton farko game da tarin fuka-fukan cutar sankarar bargo ya fara zuwa Hukumar Lafiya ta Kasa ta kasar Sin daga Wuhan a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an saki tsarin kwayoyin cutar.
A ranar 15 ga Janairun 2020, an sami mutuwar mutum na farko a Wuhan.
A wannan lokacin, annobar ta bazu cikin sauri zuwa garuruwa da larduna da ƙasashe makwabta.
A ranar 20 ga Janairu, an gano cewa ma'aikatan kiwon lafiya sun kamu da cutar, wanda ya ba da damar yin tunanin yiwuwar yaduwar cutar daga mutum zuwa mutum.
A ranar 23 ga Janairu, an kafa dokar hana fita a birnin Wuhan, kuma an dakatar da zirga-zirgar jama'a.
A ranar 24 ga watan Janairu, binciken farko na cutar ya nuna cewa 21 daga cikin marasa lafiya 41 da ke da cutar coronavirus sun kasance suna da alaƙa kai tsaye da kasuwar abincin teku a Wuhan, wanda aka ɗauka cewa asalin cutar daga dabba da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta bayyana cewa annobar korona ta zama gaggawa a fannin kiwon lafiyar jama'a.
A lokacin da aka shirya wannan rahoto, cutar ta yadu a duk faɗin Sin kuma ta riga ta shiga wasu ƙasashe 50 a duniya (hoto (hoto 2).2).
Idan aka yi la'akari da yadda lamarin ke ci gaba, har yanzu ba a san iyakar yadda cutar za ta kai ga barkewa ba.
A ranar 11 ga Fabrairun 2020, sakamakon binciken asibiti na cibiyoyi da yawa wanda ya shafi marasa lafiya 8,866, gami da marasa lafiya 4,021 da aka tabbatar da COVID-19, ya gabatar da sabon yanayin cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Ko da yake mutane masu shekaru daban-daban suna da saurin kamuwa da cutar SARS-CoV-2, amma yawanci mutane masu shekaru 30 zuwa 65 ne ke kamuwa da cutar.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne  ƙasa da 20, kuma 14 ne kawai ke da shekaru 10 da haihuwa.
Cutar SARS-CoV-2 ta fi yawa a tsakanin maza (0,31/100 000) fiye da mata (0,27/100 000).
COVID-19 ya bazu a cikin rukuni-rukuni, galibi a lardin Hubei da yankuna masu kusa.
A matsakaita, kwanaki 5 (29) sun wuce daga lokacin bayyanar alamun COVID-19 zuwa lokacin da aka gano cutar.
Lokacin da aka yi amfani da shi ya kasance a matsakaici na kwanaki 4.8 (3.07.2).
Daga lokacin bayyanar cututtuka har zuwa lokacin mutuwa, an yi kwanaki 9.5 (4.813).
Ƙididdigar ƙididdigar ƙididdiga (R0) ya kasance 3.77 (95 % CI: 3,514,05), kuma R0 da aka gyara ya kasance 2.234,82.
A ranar 23 ga Janairun 2020, an sami karuwar yawan masu kamuwa da cutar, wanda ya yi daidai da lokacin da aka yi manyan zirga-zirgar ababen hawa a ranar bikin Sabuwar Shekarar China.
Mutuwa tsakanin marasa lafiya tare da tabbacin ganewar asali ya kai kashi 1.44% (95 % CI: 1.101.86 %), kuma daidaitaccen ma'aunin mutuwa tsakanin marasa lafiya  3.06 % (95 % CI: 2.024.59 %).
Abubuwa uku da ke haifar da haɗarin kamuwa da COVID-19 sune jinsi (maza), shekaru (≥60) da kuma cutar huhu mai tsanani.
Kwayoyin cutar korona suna cikin ƙananan ƙwayoyin cuta masu girma da ke ɗauke da RNA guda ɗaya.
Ana iya raba su zuwa nau'i huɗu, wato alpha, beta, gamma, da delta, kuma an san cewa cutar alpha da beta suna shafar mutane.
A lokacin da cutar SARS da MERS suka kamu da cutar coronavirus, glycoprotein na ƙwayoyin cuta na ƙwayoyin cuta (S) yana haɗuwa da ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta na 2 (ACE2) da dipeptidylpeptidaze-4 (DPP4), sa'an nan kuma an haɗa su da membrane.
Ana sakin kwayoyin RNA na kwayar cutar a cikin cytoplasm; bayan kwayar cutar ta kwayar cutar ta kwayar halitta tare da glycoproteins na membrane da kuma nucleocapsid sunadaran samar da virion-containing vesicles, wanda daga bisani ya haɗu da membrane na tantanin halitta, yana saki kwayar cutar.
Rahotanni na farko game da tsarin tsarin SARS-CoV-2 sun bayyana a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 wani sabon nau'in betacoronavirus ne wanda kwayoyin halittar sa ya yi daidai da kashi 99.98 cikin 100 da samfuran guda 10 da aka tattara a farkon cutar a kasuwar abincin teku ta Huanan da ke Wuhan.
A cikin kwayoyin halitta, SARS-CoV-2 ya fi kusa da SARS-CoV fiye da MERS-CoV.
An gano ƙwayoyin SARS-CoV-2 a cikin ƙananan ƙananan ƙwayoyin cuta na numfashi na mutum ta hanyar amfani da microscopy na lantarki.
An gano cewa enzyme na mutum ACE2 shine mai karɓar SARS-CoV-2, kamar yadda yake ga SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure da enzyme na ACE2 na ɗan adam da rauni fiye da SARS-CoV, wanda ke bayyana gaskiyar cewa SARS-CoV-2 yana haifar da rashin lafiya mai ƙarancin tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da furotin mai ɗan gajeren lokaci wanda ba a san shi ba a baya, wanda aka tsara shi da orf3b, da furotin mai ɓoyewa wanda aka tsara shi da orf8.
Furotin orf3b na SARS-CoV-2 na iya taka rawa a cikin yanayin cutar da cutar ta haifar da kuma hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani yanki ko dalili na aiki da aka sani.
A ranar 18 ga Fabrairun 2020, ƙungiyar marubuta da Zhou ke jagoranta sun gabatar da rahotanni game da tsarin tomography na cikakken girman enzymes na mutum ACE2 tare da ƙuduri na 2,9 Å a cikin hadaddun tare da jigilar amino acid B0AT1.
Sun gano cewa wannan hadaddun, wanda ya ƙunshi fasalin da aka rufe da wanda aka buɗe, an haɗa shi a matsayin dimer kuma cewa hadaddun ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da shaida wajen gane coronavirus da kuma kamuwa da shi.
B0AT1 na iya zama maƙasudin magani a cikin gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Asalinsa da kuma mai mallakar lokaci
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga bera, wanda cutar ta yadu zuwa mutum ta hanyar ciwon daji da raƙuma.
Ta hanyar kwatanta kwayoyin halitta na SARS-CoV-2 da sauran coronavirus, an gano cewa SARS-CoV-2 shine farkon masu watsawa na bat, saboda sabon kwayar cutar ya kasance daidai da kashi 96 cikin ɗari tare da coronaviruses biyu masu kama da SARS, wato, bat coronaviruses SL-CoVZX45 da SL-CoVZX21.
Amma ba a san irin kwayar cutar da ta kai ga cutar da kuma hanyar da ta kai ga mutum ba.
Shi da abokan aikinsa sun yi tunanin cewa macizai ne suka kawo cutar daga kura zuwa mutum, kuma hakan ya faru ne ta hanyar sake haɗuwa a cikin S-protein.
A sakamakon binciken da suka yi, masana kimiyya na kasar Sin daga Guangzhou sun yi hasashen cewa, pangolins  dabbobi masu shayarwa masu dogon ido da suke cin tururuwa kuma ana amfani da su a cikin maganin gargajiya na kasar Sin,  masu yuwuwar daukar SARS-CoV-2 ne; wannan hasashen ya dogara ne da kamanceceniya ta kashi 99 cikin 100 tsakanin kwayar cutar coronavirus ta pangolin da SARS-CoV-2.
Duk da haka, bambanci na 1%, wanda aka rarraba tsakanin kwayoyin halitta biyu, yana da girma sosai, saboda haka an yi la'akari da cewa ba a samu sakamakon ƙarshe ba tare da tabbaci na musamman (hoto (hoto 33).
Har yanzu ba a san yawancin abubuwan da ke tattare da SARS-CoV-2 ba.
A cikin yanayin dakin gwaje-gwaje, SARS-CoV da MERS-CoV na iya rayuwa na tsawon awanni 48 a cikin bushewa da har zuwa kwanaki 5 a yanayin zafi da ke ƙasa da 20 °C da zafi 4050%.
SARS-CoV-2 na iya samun irin wannan halaye.
An san cewa SARS-CoV-2 yana da ƙarancin haske da zafi har zuwa 56 °C na minti 30; ether, 75% ethyl alcohol, chlorine disinfectants, peroxide, chloroform da sauran masu narkewa masu ƙoshin mai suna iya toshe tasirin kwayar cutar amma ba chlorhexidine ba.
Yawancin mutane ba su da rigakafi ga SARS-CoV-2, saboda haka mutane suna da saurin kamuwa da sabon kwayar cutar.
A halin yanzu babu bayanai game da cikakken binciken da aka yi game da amsar rigakafi ga SARS-CoV-2.
Don haka, zamu iya komawa ne kawai ga binciken da aka yi a baya game da wasu cututtukan coronavirus, musamman SARS-CoV da MERS-CoV (hoto (hoto 4).4).
Yawancin lokaci, ƙwayar cuta da ta shiga cikin jikin mai shi ta fara ganewa ta hanyar tsarin rigakafi ta hanyar masu karɓar hoto (ORR), ciki har da masu karɓar lectin na C-type, masu karɓar Toll, masu karɓar NOD da masu karɓar RIG-I.
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtuka, da haɓaka kwayoyin dendritic da kuma haɗuwa da interferons na nau'in I, wanda ke hana yaduwar kwayar cutar da kuma hanzarta phagocytosis na macrophages game da antigen na kwayar cutar.
Amma, saboda furotin N, SARS-CoV na iya guje wa amsawar rigakafi.
Ba da daɗewa ba, jikinmu zai soma aiki da ƙwayar cuta.
Kwayoyin T, ciki har da CD4+ da CD8+ T-cell, suna taka muhimmiyar rawa wajen kare jiki.
Kwayoyin T na CD4+ suna motsa samar da ƙwayoyin cuta na musamman a cikin ƙwayoyin B, kuma ƙwayoyin T na CD8+ suna kashe ƙwayoyin cuta kai tsaye.
T-helpers suna samar da sinadarin ƙwayoyin cuta da ke taimakawa ƙwayoyinmu su kāre jikinmu.
Amma, cutar korona tana iya hana ƙwayoyin T yin aiki, ta sa su mutu.
Ƙwayar cuta mai ƙuntatawa, wadda ta ƙunshi abubuwa kamar C3a da C5a da kuma ƙwayoyin cuta, tana da muhimmanci wajen hana kamuwa da ƙwayoyin cuta.
Alal misali, ƙwayoyin cuta da aka samu daga mai ciwon sun kawar da MERS-CoV.
A wani ɓangare kuma, yawan aiki da tsarin garkuwar jiki yake yi yana sa a samu ƙwayoyin cuta da yawa a cikin jiki, kuma hakan zai iya lalata huhu da sauran gabobin jiki, kuma a mafi munin yanayin, zai iya kai ga rashin aiki da gabobin jiki da kuma mutuwa.
Cutar SARS-CoV-2, wacce ke nuna bayyanar tarin yawa, tana iya shafar tsofaffi da ke da cututtuka da yawa da kuma mata masu ciki.
Mutane da ke fama da ƙwayoyin cuta da yawa ko kuma waɗanda suke da lahani a cikin tsarin garkuwar jiki suna iya kamuwa da cutar.
Dangane da binciken da aka yi kan mutane 425 da suka kamu da cutar a Wuhan, an kiyasta matsakaicin lokacin kamuwa da cutar SARS-CoV-2 daga kwanaki 1 zuwa 14, galibi kwanaki 3.7.
Amma, binciken da aka yi a kan mutane 1,099 ya nuna cewa a matsakaita, lokacin da ake yin ciki yana da kwanaki uku, kuma ya kai kwanaki 0 zuwa 24.
Bayan haka, binciken da aka bayyana a sama, bisa ga bayanan alƙaluma na mutane 8,866, ya nuna cewa lokacin incubation ya kasance kwanaki 4.8 (3.07.2).
Yana da muhimmanci ga hukumomin kiwon lafiya su daidaita lokacin da za a yi keɓewa don yin la'akari da ƙididdigar tsawon lokacin ɓoyewa, don hana yaduwar cutar ga waɗanda ke da cutar ba tare da alamun cutar ba.
An saba yin keɓewar kwanaki 14 ga mutanen da suka taɓa yin cuta ko kuma waɗanda suka kamu da ita.
Shin ya kamata a tsawaita lokacin keɓewa zuwa kwanaki 24?
Babban alamun COVID-19 shine yawan zazzabi, wanda zai iya zama guda ɗaya ko kuma ya kasance tare da wasu alamun, kamar bushewar tari, wahalar numfashi, ciwon tsoka, zafin kai, ciwon kai, ciwon makogwaro, sanyi, ciwon kirji, zawo, tashin zuciya da amai.
Wasu marasa lafiya suna fama da rashin numfashi da kuma (ko) hypoxia mako guda bayan cutar ta fara.
A cikin mawuyacin hali, cutar ta ci gaba da sauri, kuma marasa lafiya suna fama da ciwon numfashi mai tsanani, damuwa, acidosis da kuma coagulopathy.
Masu fama da zazzabi da (ko) alamun cututtukan numfashi da zazzabi mai tsanani ya kamata a bincika su don cutar don saita ganewar asali da wuri ko da ba su da cututtuka a hotunan ƙirjin.
Binciken alƙaluma da aka gudanar a ƙarshen Disamba 2019 ya nuna alamun bayyanar cututtuka masu zuwa: 98  zazzabi mai zafi, 76  tari mai bushewa, 55  numfashi mai sauƙi da 3  zawo; 8  yawan marasa lafiya suna buƙatar iska mai iska.
An samu irin wannan sakamakon a cikin binciken biyu na baya-bayan nan game da kamuwa da cutar a cikin iyali da kuma kamuwa da cutar daga mutanen da ba su da alamun cutar.
An sami sakamako mai kama da haka a cikin binciken marasa lafiya da ke da MERS-CoV a cikin 2012, waɗanda alamun su na farko sun kasance zazzabi (98%), tari mai bushe (47%) da numfashi mai wuya (55%).
Amma kashi 80 cikin ɗari na waɗannan marasa lafiya sun bukaci numfashi na numfashi, wanda ya fi na masu cutar COVID-19 yawa, kuma ya yi daidai da yawan mutuwar MERS fiye da COVID-19.
A cikin marasa lafiya da MERS an kuma lura da zawo (26%) da ciwon makogwaro (21%).
Babban alamun marasa lafiya tare da SARS sune zazzabi mai zafi (99100 %), tari mai bushe (2975 %), numfashi mai sauƙi (4042 %), zawo (2025 %) da ciwon makogwaro (1325 %), kuma ana buƙatar iska mai iska ta 1420 % na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ya kai kashi 2%, kuma yawan adadin masu kamuwa da cutar a duniya ya kai 66,576.
Idan aka kwatanta da wannan, mutuwar SARS a watan Nuwamba na shekara ta 2002 ya kai kashi 10 cikin dari na mutane 8,096 da aka tabbatar da cutar.
A cikin yanayin MERS, binciken alƙaluma da aka gudanar a watan Yunin 2012 ya nuna mutuwar kashi 37% daga cikin mutane 2,494 da aka tabbatar.
Sakamakon binciken da aka yi a baya, an ƙaddara ƙimar haifuwa (R0) don SARS-CoV-2 a matakin 6.47 tare da 95% dogara (CI) a cikin 5.717.23, yayin da R0 don SARS-CoV ya kasance tsakanin 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV ta bayyanar cututtuka, yawan mutuwa da R0 an nuna su a cikin teburin Tebur 1.1.
Abubuwan da aka ambata a sama sun nuna cewa SARS-CoV-2 yana da ƙarfin watsawa fiye da MERS-CoV da SARS-CoV, amma yawan mutuwar sabon ƙwayar cuta ya fi ƙasa da na biyun.
Saboda haka, hana yaduwar SARS-CoV-2 zai fi wahalar da MERS-CoV da SARS-CoV.
Sau da yawa, cutar tana faruwa ne a cikin iyali ko kuma a cikin mutane da suka taru don wani dalili ko kuma a cikin jirgin ruwa.
Marasa lafiya sun yi tafiya zuwa Wuhan ko wasu yankuna da cutar ta shafa, sun zauna a can ko kuma sun yi hulɗa da waɗanda ke da cutar ko waɗanda ke da cutar a cikin makonni biyu kafin cutar ta fara.
Amma, rahotanni sun nuna cewa mutane za su iya kamuwa da cutar ba tare da nuna wata alama ba har tsawon makonni biyu, kuma marasa lafiya da suka warke daga asibiti za su iya sake kamuwa da cutar, kuma hakan ya nuna cewa ana bukatar a kara wa'adin killace su.
A farkon lokaci, marasa lafiya suna da adadin leukocytes (musamman lymphocytes) a cikin jini na al'ada ko ragewa.
Misali, an gano marasa lafiya 1 099 da ke da COVID-19 da cutar lymphopenia tare da ƙarancin ƙwayoyin cutar < 4×109/L, gami da ƙarancin ƙwayoyin cutar < 1×109/L, da kuma ƙaruwar asparagin-aminotransferase da cutar kwayar cuta.
Wasu marasa lafiya sun sami ƙaruwa a cikin ƙwayoyin hanta, ƙwayoyin tsoka, da kuma myooglobin, kuma yawancin marasa lafiya sun sami ƙaruwa a cikin furotin C-reactive da kuma ƙwayoyin red cells a cikin jini.
A cikin marasa lafiya da ke fama da ciwon, yawan D-dimer, wato wani abu da ke sa jini ya lalace, ya ƙaru kuma ƙwayoyin jini suna raguwa.
Yawancin marasa lafiya da ke da COVID-19 sun sami cututtuka a cikin ƙirjin su ta hanyar yin amfani da hoton hoto wanda ke nuna launin duhu a ɓangarorin biyu ko launin duhu a cikin huhu.
Sau da yawa marasa lafiya suna kamuwa da ciwon huhu, ciwon huhu da kuma ciwon numfashi.
A lokacin da ciwon ya ci gaba, ƙonewa da ruwa da kuma ci gaba da fibrosis yana haifar da mummunan lalacewar gas.
Rashin aiki na nau'in I da na II na ciwon huhu yana rage matakan haɗin gwiwa da kuma kara ƙarfin jiki, don haka rage ƙarfin ƙwayar huhu da kuma ƙara haɗarin ciwon huhu.
Saboda haka, sakamakon da ya fi muni a gwajin da aka yi a kan ƙwayar cuta sau da yawa yana nuna cewa cutar ta fi tsanani.
A ranar 18 ga Fabrairun 2020, bincike na farko na cutar COVID-19 ya nuna ɓarnawar ƙwayoyin huhu, samar da membrane na hyaline da kuma shigarwar ƙwayoyin cuta tsakanin ƙwayoyin cuta, kuma ƙwayoyin syncytial masu yawa a cikin huhu na marasa lafiya da suka mutu daga cutar sun dace da cututtukan cututtukan ƙwayar cuta da cutar SARS kuma suna kama da waɗanda aka samo a cikin marasa lafiya tare da SARS da MERS.
A matsayin babban ma'auni a cikin ganewar asali na COVID-19, an yi amfani da hanyar gano SARS-CoV-2 RNA ta hanyar maganin sarkar polymerase tare da baya transcriptase (PCR tare da baya transcriptase).
Koyaya, saboda yawan sakamakon da ba daidai ba, wanda zai iya hanzarta saurin yaduwar cutar, daga 13 ga Fabrairun 2020, a China an fara yin ganewar asali bisa bayyanar cututtuka (ba tare da dogaro da PCR kawai tare da baya ba).
Haka ma yake da cutar SARS.
Saboda haka, don yin bincike mai kyau, yana da muhimmanci a haɗa tarihin mutum da bayyanar cututtuka da gwaje-gwaje da kuma sakamakon hoton.
A ranar 14 ga Fabrairun 2020, ƙungiyar masana da Mista Feng Zhang ke jagoranta sun bayyana yarjejeniyar amfani da hanyar SHERLOCK, wanda ya dogara da maimaita CRISPR, don gano SARS-CoV-2; wannan hanyar tana ba da damar gano gutsuttsarin RNA na SARS-CoV-2 na roba a cikin yawa daga 20 × 1018 mol/L zuwa 200 × 1018 mol/L (10100 kwafi a kowace microliter na samfurin asali) ta hanyar nunawa a cikin ƙasa da awa ɗaya ba tare da amfani da kayan aiki mai rikitarwa ba.
Idan aka gwada wannan sabon tsarin a asibiti, zai iya sa gwajin ya fi dacewa kuma ya fi dacewa.
Saboda rashin kwarewar maganin cutar coronavirus da ba a sani ba a baya, likitoci na iya ba da magani na tallafi kawai ga marasa lafiya da ke da COVID-19, yayin ƙoƙarin yin amfani da duk wasu hanyoyin warkewa da aka yi amfani da su ko aka ba da shawarar a cikin maganin sauran coronavirus, kamar SARS-CoV da MERS-CoV, da sauran cututtukan ƙwayoyin cuta (tebur (Table 2).2).
Waɗannan hanyoyin maganin sun haɗa da amfani da magungunan rigakafin cutar ko yiwuwar amfani da su, masu hana rigakafi, steroids, plasma na marasa lafiya da suka warke, maganin gargajiya na kasar Sin da kuma tallafawa tunani.
An ba da shawarar yin amfani da jini na marasa lafiya da suka warke.
Kamfanonin ƙwayoyi suna hanzarin samar da rigakafi da alluran rigakafi don yaƙi da cutar.
A farkon matakan, SARS-CoV-2 ya fi kai hari ga huhu, kuma yana iya shafar wasu gabobin da ke nuna ACE2, kamar su hanji da kodan.
Amma, rashin aiki da kuma rashin numfashi ne ke jawo mutuwa.
Don haka, don sauƙaƙa alamun cututtuka da ceton rayuka, yana da mahimmanci a tallafawa aikin numfashi, gami da maganin oxygen gaba ɗaya, isar da iskar oxygen mai ƙarfi, iska mai ƙarancin iska da iska mai ƙarfi, waɗanda aka tsara dangane da tsananin cutar.
Marasa lafiya da ke fama da ciwon numfashi suna bukatar taimako ta hanyar yin amfani da maganin numfashi na waje (ECMO), wato, hanyar da aka yi amfani da ita wajen kula da ciwon zuciya ko kuma na numfashi.
Bugu da ƙari, yana da mahimmanci ga marasa lafiya tare da SARS-CoV-2 don kula da daidaiton ruwa da gishiri, hanawa da magance cututtukan na biyu da harin septic, da kare ayyukan gabobin rayuwa.
An san cewa guguwar cytokine sakamakon hawan jiki ne na marasa lafiya da suka kamu da cutar SARS da MERS.
Guguwar cytokine wani nau'i ne na tsarin kumburi wanda ke ci gaba da amsawa ga sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan sinadarin sun sa ƙwayoyin jikinmu su soma fitar da ƙwayoyin da ke hana ƙwayar cuta daga jikinmu, kuma hakan yana sa mu kamu da cututtukan da ke sa jiki ya yi sanyi da kuma ciwon ƙwayoyin da ke sa jiki ya kasa aiki.
A lokacin da ake maganin cutar, musamman ma a cikin marasa lafiya masu tsanani, yana da muhimmanci a rage rigakafi.
Don magance guguwar cytokine, an yi amfani da kwayoyin cutar corticosteroids da tocilizumab, ƙwayoyin rigakafi na monoclonal waɗanda ke aiki a matsayin mai hana interleukin-6.
Sauran hanyoyin maganin guguwar cytokine da ke kan hana rigakafi sun haɗa da daidaitawar amsawar rigakafi da ke nufin sarrafa ƙwayoyin T; toshe samar da cytokines IFN-γ, IL-1, da TNF; hana janus-kinase; amfani da blinatumomab, masu hana siginar cytokine 4 da masu hana histone acetalase.
Don rage yawan cututtukan ƙwayoyin cuta a cikin maganin SARS, ana amfani da kwayoyin steroid a matsayin masu hana rigakafi.
Amma, steroids a manyan allurai ba su da amfani wajen magance mummunan rauni a cikin huhu a cikin marasa lafiya da ke da SARS da COVID-19.
Maimakon haka, suna iya jawo mummunan sakamako, musamman cutar osteoarthritis, wanda ke sa yanayin ya yi muni sosai.
Koyaya, ana ba da shawarar yin amfani da gajeren lokaci na ƙananan ƙananan allurai na corticosteroids tare da taka tsantsan yayin kula da marasa lafiya masu cutar COVID-19 a cikin mawuyacin hali.
A lokacin da nake rubuta wannan, babu wata magani da aka tabbatar da cewa yana da amfani.
Amma, yin amfani da remdesivir a cikin jijiya, wanda yake kama da kwayar halitta, ya zama magani mai tasiri ga wani mai cutar COVID-19 a Amurka.
Remdesivir magani ne na sabon ƙwayar cuta wanda Gilead ta fara samarwa don magance cututtukan da ƙwayoyin cuta na Ebola da Marburg ke haifarwa.
Daga baya, remdesivir ya nuna cewa yana iya hana wasu ƙwayoyin cuta masu ɗauke da RNA guda ɗaya, ciki har da MERS da SARS.
Bisa ga wannan bayanin, Gilead ta samar da wannan magani ga China don yin gwaji tare da marasa lafiya da ke fama da SARS-CoV-2, kuma suna jiran sakamakon waɗannan gwaje-gwajen.
Bugu da ƙari, baricitinib, α-interferon, lopinavir/ritonavir, da ribavirin an ba da shawarar su zama zaɓuɓɓukan magani ga marasa lafiya da ke da cututtukan numfashi.
Maganin haɗin gwiwa tare da lopinavir / ritonavir na iya haifar da zawo, tashin zuciya, amai, cutar hanta da sauran sakamako masu illa.
Ya kamata a lura da yadda waɗannan magungunan ke hulɗa da sauran magungunan da aka ba marasa lafiya.
Tsarin jini na marasa lafiya da suka warke da kuma samar da kwayoyin cutar
An daɗe ana karɓan jini daga waɗanda aka warkar da su daga wata cuta mai yaduwa don a warkar da waɗanda suke da cutar ko kuma don a kāre lafiyar mutane.
A gaskiya ma, yawanci jinin marasa lafiya da suka warke suna da ƙwayoyin cuta da yawa da za su iya yaƙi da cutar.
Ana samun ƙwayoyin rigakafi a cikin ƙwayar cuta da ƙwayoyin B suke samarwa don su yaƙi ƙwayoyin cuta da kuma wasu abubuwa da ba su da alaƙa da su.
Bisa ga wannan ra'ayi, an ware jini daga samfurin jini na rukunin marasa lafiya da suka warke daga COVID-19, sannan aka yi amfani da shi ga marasa lafiya 10 masu fama da cutar.
A cikin sa'o'i 24 da suka shige, alamun cutar sun soma ƙaruwa, ƙwayoyin cutar sun ragu, kuma sun ƙara samun iskar oxygen a cikin jini.
Amma, don a ba da shawarar yin amfani da wannan hanyar sosai kafin a yi wani magani, ana bukatar a yi bincike sosai kafin a yi hakan.
Ƙari ga haka, idan aka yi la'akari da maganin, ya kamata a bincika wasu matsaloli da ke tattare da amfani da jini.
Alal misali, ƙwayoyin rigakafi suna iya sa jikin mutum ya yi sanyin gwiwa kuma su sa a soma cutar da ake kira cytokine release syndrome, kuma hakan yana iya sa mutum ya mutu.
Yawan ƙwayoyin cuta a cikin jini ba shi da yawa, kuma ana bukatar jini mai yawa don a kula da marasa lafiya da suke cikin mawuyacin hali.
Ba shi da sauƙi a yi amfani da ƙwayoyin cuta na musamman da sauri don magance cutar.
Saboda haka, yana da muhimmanci kuma ya fi dacewa a ware ƙwayoyin B daga marasa lafiya da suka warke kuma a gano lambar ƙwayoyin cuta masu aiki ko kuma a yi gwaji don a sami ƙwayoyin cuta masu aiki da ƙwayoyin cuta masu mahimmanci na kwayar cutar.
Hakan zai sa mu iya yin rigakafi da yawa nan da nan.
Shekaru dubbai da suka shige, mutanen ƙasar Sin sun yi amfani da maganin gargajiya don magance cututtuka dabam-dabam.
Amma, yadda yake aiki ya dangana ne a kan yadda ya haɗa abubuwa da yawa, kuma ya bambanta dangane da yadda ake gane cutar, wanda ya dogara da koyarwar maganin gargajiya na kasar Sin.
Yawancin abubuwan da ke aiki har yanzu ba a san su ba ko kuma ba su da tabbas saboda yana da wuya a ware da kuma gwada waɗannan abubuwan haɗin ko haɗuwa da su.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, maganin gargajiya na kasar Sin ya zama ɗayan manyan hanyoyin madadin magani ga marasa lafiya masu saurin bayyanar cututtuka ko marasa lafiya da ke murmurewa daga mummunan yanayin cutar.
Alal misali, an gano cewa shan Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen magance COVID-19.
Mafi yawan adadin masu warkewa daga COVID-19 sun kasance a wasu lardunan kasar Sin inda aka yi amfani da maganin gargajiya na kasar Sin don magance kashi 87 cikin dari na marasa lafiya, ciki har da Gansu (63.7 kashi), Ningxia (50 kashi) da Hunan (50 kashi), yayin da lardin Hubei, inda aka yi amfani da maganin gargajiya na kasar Sin don magance kusan kashi 30 cikin dari na marasa lafiya na COVID-19, ya sami mafi ƙarancin adadin masu warkewa (13 kashi).
Amma wannan kwatanci ne mai wuyan fahimta domin ana bukatar a yi la'akari da wasu abubuwa kamar yawan marasa lafiya da kuma yadda ciwon ya tsananta.
A ranar 18 ga Fabrairun 2020, Mista Boli Zhang da abokan aikinsa sun buga wani bincike da ya kwatanta maganin da ke amfani da magungunan Yammacin Turai da kuma maganin da ke amfani da magungunan Yammacin Turai da na gargajiya na kasar Sin.
Sun gano cewa lokacin da zazzabi ya koma daidai, bayyanar cututtuka ta warke, da kuma kulawar da ake yi a asibiti ya yi ƙasa da na waɗanda aka yi wa magani da magungunan gargajiya na Yammacin Turai da na China, fiye da waɗanda aka yi wa magani da magungunan Yammacin Turai kaɗai.
Abin mamaki shi ne, yawan marasa lafiya da suka fara samun mummunan cututtuka (daga mai sauƙi zuwa mai tsanani) ya kasance ƙasa da ƙasa a cikin rukunin da aka bi da shi ta hanyar haɗin hanyoyin Yammacin Turai da na gargajiya na kasar Sin fiye da rukunin da aka bi da shi kawai ta hanyar Yammacin Turai (7.4% vs. 46.2%), kuma yawan mutuwar a cikin rukuni na farko ya kasance ƙasa da na biyu (8.8% vs. 39%).
Duk da haka, inganci da amincin maganin gargajiya na kasar Sin har yanzu yana buƙatar ƙarin bincike mai kyau da aka gudanar a cikin manyan yankuna da yankuna.
Wani sha'awa kuma shine samun yiwuwar bayanin tsarin aiki da kuma bayanin abubuwan da ke cikin tasirin abubuwan da ake amfani da su a cikin hanyoyin maganin gargajiya na kasar Sin, ko haɗuwa da su.
Marasa lafiya da ake zargi ko kuma aka tabbatar da cewa suna da COVID-19 galibi suna jin tsoron kamuwa da cutar mai saurin yaduwa ko ma cutar da ke kashewa, kuma mutanen da aka keɓe suna jin kadaici, kaɗaici da kuma rashin jin daɗi.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi, rashin ƙarfi, da tari da kuma sakamako na gaba kamar rashin barci daga shan magungunan da ake kira corticosteroids suna iya sa mutum ya ƙara damuwa da kuma damuwa.
A farkon lokacin da cutar SARS ta ɓarke, an samu rahotanni game da wasu cututtuka na ƙwaƙwalwa, har da baƙin ciki mai tsanani, damuwa, tsoro, tashin hankali, alamun damuwa, hauka, har ma da kashe kansa.
Bunkasawa da keɓewa, a matsayin wani ɓangare na matakan da hukumomin kiwon lafiya ke ɗauka don hana yaduwar COVID-19, na iya ƙara damuwa da laifi ga mutane game da yaduwar kamuwa da cuta, keɓewa da kuma lakabi na zamantakewa ga danginsu da abokansu.
Saboda haka, ya kamata a ba da taimako na hankali da na tunani ga marasa lafiya da ke da COVID-19, waɗanda ake zargi da kuma waɗanda suka taɓa hulɗa da su, da duk wasu mutane da ke buƙatar taimako.
A matsayin tallafi na tunani, ya kamata a kafa ƙungiyoyin kula da cututtukan ƙwaƙwalwa da yawa, a samar da cikakken bayani tare da sabunta bayanai akai-akai da daidai game da cutar SARS-CoV-2 da tsare-tsaren magani da amfani da na'urorin lantarki na ƙwararru da aikace-aikace don kauce wa kusanci na mutum.
Magungunan rigakafi masu tasiri suna taka muhimmiyar rawa wajen katse sarkar watsa daga dabbobi masu dauke da cutar da kuma mutane masu kamuwa da cutar zuwa masu karɓar cutar kuma galibi ana amfani da su a matsayin kari ga maganin rigakafin cutar da ake amfani da ita don hana barkewar cutar da sabbin ƙwayoyin cuta ke haifarwa.
An yi aiki kan ƙirƙirar alluran rigakafi bisa tushen S-protein, wanda makasudin sa shine samar da ƙwayoyin cuta masu tsawan rai da aiki sosai da kuma (ko) rigakafin kariya ga SARS-CoV.
An yi amfani da dabbobi wajen yin gwaje-gwaje don a samar da alluran rigakafin cutar SARS.
Amma kafin a fara gwajin, har yanzu ana bukatar sanin ingancin alluran rigakafin a yanayin halitta idan aka yi amfani da su a cikin tsofaffi, da yadda ake kamuwa da cutar a cikin allurai masu kisa da kuma yadda za a kare su daga kamuwa da ƙwayoyin cuta.
Wataƙila, dalilin shi ne, cutar SARS ta ɓace shekaru 17 da suka shige, kuma ba a taɓa samun wani sabon mutum da ya kamu da ita ba.
A lokaci guda, ana ci gaba da samun wasu lokuta da kuma tarin cututtuka na cutar da cutar ta haifar da cutar MERS, wanda ya fara a Gabas ta Tsakiya kuma ya yada zuwa wasu yankuna saboda kiyaye tushen cutar a wuraren da ke zaune.
Don magance MERS, an tsara dabarun allurar rigakafi ta amfani da cutar da aka kashe, DNA plasmid, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta da ƙwayoyin furotin masu haɗuwa, kuma an gwada wasu daga cikin waɗannan dabarun akan dabbobi.
Samar da ingantaccen allurar rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi, gaggawa ce kuma muhimmiyar matsala da ke buƙatar mafita don dakile annobar.
Amma akwai matsaloli masu tsanani da ke tattare da tsawon lokaci (a matsakaita watanni 18) da ake bukata don samar da allurar rigakafi da kuma sauye-sauyen coronavirus.
A matsayin cutar da ba a san ta ba, COVID-19 tana fara nuna cikakken yanayin cutar a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna samun sauƙi a hankali ba tare da wata matsala ba.
Koyaya, COVID-19, kamar SARS da MERS, ana alakanta shi da yawan rikitarwa da yawan mutuwa tsakanin marasa lafiya masu ciwo mai tsanani.
Saboda haka, yana da muhimmanci hukumomin kiwon lafiya su tsara tsarin da zai nuna yadda za su magance cutar, musamman a wuraren da ba a samun isashen kayan aiki.
Dangane da bayanan binciken asibiti da aka gabatar a halin yanzu, abubuwan da ke gaba na iya tasiri ko alaƙa da tsinkayar cutar a cikin marasa lafiya tare da COVID-19 (tebur (Table 33):
Shekaru: Shekaru sune muhimmin abu wajen hango ko cutar SARS za ta ci gaba da yaduwa, kuma hakan ya yi daidai da cutar COVID-19.
COVID-19 ya fi shafar marasa lafiya masu shekaru 30 zuwa 65, kashi 47.7 cikin ɗari sun haura shekaru 50, a cewar binciken da aka ambata na mutane 8,866.
Marasa lafiya da ke buƙatar magani mai tsanani sun fi saurin samun cututtuka da rikitarwa kuma sun fi tsofaffi fiye da marasa lafiya da ba su buƙatar irin wannan magani (a matsakaita shekaru 66 da 51), wanda ke nuna cewa shekaru shine babban abin da ke haifar da cutar COVID-19.
Jima'i: yawan kamuwa da SARS-CoV-2 a tsakanin maza ya fi yawa fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka ambata a sama.
Yawan kamuwa da cutar da kuma rikitarwa: marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da cutar myocardial da arrhythmia.
Abubuwan da ke faruwa a zuciya sune babban dalilin mutuwar marasa lafiya da SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya haɗuwa da kwayoyin halittar ACE2-mai kyau, wanda zai iya haifar da lalacewar hanta a cikin marasa lafiya da COVID-19.
Yana da muhimmanci a lura cewa shekaru da kuma cututtuka suna da nasaba sosai kuma suna iya ɓata sakamakon.
Rashin daidaituwa da aka gano a lokacin gwaje-gwaje na gwaji: matakin C-reactive protein a cikin jini yana nuna yadda mummunan ƙwayoyin cuta ko lalacewar nama yake, kuma an ba da shawarar yin la'akari da shi a matsayin mai yiwuwa mai yiwuwa na cutar, amsawa ga magani da kuma warkewa.
An kuma ba da shawarar yin la'akari da alaƙar da ke tsakanin matakin furotin mai amsa C, tsananin cutar da tsinkayar COVID-19.
Ƙari ga haka, yawan ƙwayar lactate dehydrogenase, asparagin-aminotransferase, alanine-aminotransferase, da creatine kinase zai iya nuna sakamakon.
Ana fitar da waɗannan ƙwayoyin a cikin jiki da yawa, musamman a zuciya da hanta, kuma ana fitar da su idan akwai lahani a cikin nama.
Saboda haka, a al'adance, alamun cutar zuciya ko cutar hanta ne.
Babban alamun asibiti: Don hango sakamakon da rikitarwa a cikin maganin COVID-19, tare da wasu dalilai, ya kamata a yi la'akari da bayanan binciken kirji da ci gaban alamun asibiti a tsawon lokaci.
Amfani da steroids: Kamar yadda aka riga aka bayyana a sama, steroids  sune masu hana rigakafi, waɗanda ake amfani da su sosai a cikin cututtukan cututtuka a matsayin ƙarin magani don rage tsananin kumburi.
Tun da yake ana amfani da magungunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Don haka, idan ana buƙatar amfani da kwayoyin steroid don kula da marasa lafiya da COVID-19, ya kamata a ba da waɗannan magungunan a ƙananan allurai da gajeren lokaci.
Matsalolin tunani: Kamar yadda aka ambata a sama, a cikin annobar COVID-19, yawancin marasa lafiya suna fama da matsanancin damuwa saboda yawanci suna fuskantar keɓewa na dogon lokaci, jimrewa da rashin tabbas da yawa da kuma ganin mutuwar danginsu da sauran marasa lafiya.
Don a rage yawan damuwa da kuma taimaka wa irin waɗannan marasa lafiya su koma rayuwa ta yau da kullum, ya kamata a yi musu shawara da kuma tallafa musu a kan lokaci.
Bisa ga binciken alƙaluma da aka yi a yanzu, annobar COVID-19 ta bambanta da cutar SARS a alamun ta.
Baya ga kwayar cutar a cikin ƙananan hanyoyin numfashi, kwayar SARS-CoV-2, kamar sauran cututtukan coronavirus da ke haifar da sanyi, na iya samun nasarar haɓaka a cikin hanyoyin numfashi na sama kuma suna haifar da alamun rashin ƙarfi ko ba su haifar da alamun cutar ba a farkon lokacin kamuwa da cutar.
Saboda haka, marasa lafiya da ke cikin farkon cutar ko kuma waɗanda ba su gama lokacin kamuwa da cutar ba, za su iya yada kwayar cutar sosai, wanda hakan zai sa ya zama da wuya a sarrafa cutar.
Koyaya, an yi imanin cewa watsa kwayar cutar SARS-CoV yana faruwa ne lokacin da marasa lafiya ke rashin lafiya, kodayake yawancin lokuta ba a taɓa samun kamuwa da cutar ba a farkon lokacin.
Saboda haka, annobar COVID-19 da muke fama da ita a yau ta fi ta SARS tsanani kuma tana da wuyar sarrafawa.
A halin yanzu, akwai babban aiki a China, wanda ya ba da sanarwar keɓewar kowa a Wuhan da biranen da ke kewaye da ita, da kuma tsawaita keɓewar kusan duk jama'a don dakatar da sarkar yaduwar cutar SARS-CoV-2.
Ko da yake waɗannan matakan suna haifar da mummunan sakamako ga tattalin arziki da sauran fannoni na rayuwa, yawan sabbin marasa lafiya da aka gano suna raguwa, wanda ke nuna cewa annobar ta ragu.
A cewar masu sa zuciya, cutar za ta ƙare a watan Maris, kuma za ta yi tsawon watanni uku zuwa huɗu.
Amma, wasu masana ba su da ra'ayin da ya dace.
Mista Paul Hunter da abokan aikinsa sun kiyasta cewa annobar COVID-19, wadda ta fi SARS kamuwa da cuta, ba za ta ƙare a shekara ta 2020 ba.
Masu bincike a wani rukuni da Ira Longini ke jagoranta sun tsara wani tsari don hango ƙarshen annobar kuma sun yi hasashen cewa kwayar SARS-CoV-2 na iya shafar kashi biyu bisa uku na yawan mutanen duniya.
Wani rukunin masana na Kanada sun ba da rahoton cewa an gano kwayar cutar SARS-CoV-2 a cikin hanci da makogwaro da aka ɗauka daga marasa lafiya da suka warke kuma aka sallame su daga asibitoci makonni biyu da suka gabata, wanda ke nuna cewa sabon kwayar cutar na iya zama cuta mai kama da mura.
Amma, raguwar sabbin masu kamuwa da cutar a China na da ban sha'awa, yana nuna cewa dabarun da ake amfani da su a yanzu na iya yin tasiri.
A lokacin da aka soma cutar, an yi hasashen cewa cutar Ebola za ta kashe mutane miliyan ɗaya kuma ta kashe mutane miliyan biyar.
Amma ta hanyar keɓewa da keɓewa, an yi nasara wajen sarrafa cutar.
Akwai yiwuwar cewa, kamar SARS-CoV, ƙwayar cutar SARS-CoV-2 za ta iya raguwa kuma a tsawon lokaci za ta ɓace ko kuma ta zama ƙwayar cuta mai ƙarancin cuta da ke rayuwa tare da mutum.
A ƙasa akwai kwatancen annobar COVID-19 da annobar SARS da MERS (hoto (Hoto 55).
Kwayar SARS-CoV-2 tana yaduwa cikin sauri ta hanyar tari ko hancin, kuma wataƙila ta hanyar tuntuɓar kayan da ke da cutar.
An kuma gano kwayar cutar a cikin bargo, wanda ke nufin cewa ana iya samun kwayar cutar ta hanyar baki da ƙura.
Wani bincike da aka yi kwanan nan ya nuna cewa kashi 41 cikin ɗari na mutane 138 da aka bincika sun kamu da cutar a asibiti, har da 17 da suka kamu da wata cuta da aka riga aka gano da kuma ma'aikatan jinya 40.
Saboda haka, ya kamata a ɗauki matakan kariya don kare jama'a, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, danginsu, abokan aiki, har ma da baƙi da ke hulɗa da marasa lafiya ko waɗanda ke da cutar.
Layin farko na karewa don rage haɗarin kamuwa da cutar  shine sanya abin rufe fuska; duka abin rufe fuska na tiyata da kayan numfashi na N95 (jerin 1860s) suna taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana ƙananan ɗigon ruwa daga waɗanda ke da cutar daga tashi cikin iska da zama a kan farfajiyoyi da za su iya yaduwa.
Koyaya, kawai masks na aji na N95 (jerin 1860s) na iya karewa daga shan iska daga 10 zuwa 80 nm, suna wucewa kawai kashi 5% na virions; kwayar SARS-CoV-2 daidai take da SARS-CoV, kuma duka suna da girman kusan 85 nm.
Tun da yake ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya ya kamata su sa rigar kariya da ta dace da siffarsu don rage haɗarin kamuwa da ƙwayoyin cuta.
Ƙari ga haka, ƙwayoyin cuta suna iya shiga cikin jiki ta idanu.
A ranar 22 ga Janairun 2020, likitan ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska mai lamba N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar ƙone idanunsa.
Saboda haka, ma'aikatan kiwon lafiya suna bukatar su saka abin rufe fuska ko kuma tabarau.
Ana ba da shawarar cewa duk mutanen da ke yankunan da cutar ta shafa ko kuma waɗanda ke da haɗarin kamuwa da cutar su riƙa wanke hannayensu da kayan wankewa da za su kashe ƙwayoyin cuta, su guji fita daga gida, su ware kansu, kuma su guji hulɗa da mutanen da cutar ta kamu da su.
Nisa zuwa ga mai haƙuri yana da nisa kamar mita.
Waɗannan matakan suna rage haɗarin kamuwa da cutar kuma suna hana yaduwar kwayar cutar.
Duk da cewa cutar SARS-CoV-2 ba a san ta ba a baya, irin kamaninta da SARS-CoV da aka ruwaito a ranar 7 ga Janairu, 2020 ya kamata ya zama abin damuwa ga China, la'akari da kwarewar da ta samu a lokacin barkewar cutar SARS a 2003.
Amma sai bayan 19 ga Janairun 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankalin jama'a, yana cewa sabon kwayar cutar ba ta da cutar da yawa kuma ba ta da iyaka wajen haifuwa daga mutum zuwa mutum kuma hana yaduwar cutar da sarrafa ta ba zai zama matsala ba.
Wannan sanarwar ta rage tashin hankali a cikin al'umma, musamman a lokacin da kasar ke shirin bikin sabuwar shekara ta kasar Sin, kuma an rasa wani lokaci mai mahimmanci lokacin da za a iya sarrafa cutar a cikin Wuhan tare da asarar asarar rayuka.
Hukumomin kiwon lafiya na kasar Sin za su iya koyon darasi daga wannan mummunan darasi kuma su yi gagarumin ci gaba a nan gaba.
Misali, hukumomin kiwon lafiya ya kamata: (1) su yi taka tsantsan wajen yin maganganun jama'a, saboda kowane kalma da jama'a ke magana tana da tasiri a kan yadda suke ji da kuma yanke shawara; (2) su kara sa ido da kuma amsawa ga bayanan da ba a saba gani ba daga asibitoci maimakon jiran rahotanni daga likitoci da jami'ai; (3) su dauki tsauraran matakai don dakile wata annobar a farkon matakanta maimakon kwantar da hankalin jama'a; da kuma (4) gudanar da atisaye masu tasiri da tasiri don wayar da kan jama'a game da cututtukan cututtuka da kuma duba su akai-akai da inganta tsarin amsawar jama'a.
Cutar COVID-19, wadda wata kwayar cuta ce ta cutar sankara mai tsanani ta numfashi (SARS-CoV-2), ta fara a ƙarshen watan Disamba na 2019.
A cikin ƙasa da watanni biyu, cutar ta mamaye ƙasar Sin kuma a lokacin da aka rubuta wannan rahoton, ta bazu zuwa ƙasashe 50 a duniya.
Saboda kwayar cutar ta yi kama da kwayar cutar coronavirus mai saurin kamuwa da cutar SARS-CoV kuma alamun COVID-19 sun yi kama da na cutar SARS, cutar ta COVID-19 ta haifar da sake dawowa SARS.
Koyaya, akwai wasu manyan bambance-bambance tsakanin COVID-19 da SARS waɗanda ke da mahimmanci dangane da hana yaduwar cutar da kula da marasa lafiya.
COVID-19 tana shafar tsofaffi fiye da matasa, da maza fiye da mata; yawan masu fama da cutar da kuma yawan mutuwar tsofaffi ma ya fi na matasa.
Mutuwar SARS ta fi ta COVID-19 (10,91%, idan aka kwatanta da 1,44%).
Marasa lafiya da COVID-19 suna yada kwayar cutar ko da ba su da alamun cutar, yayin da marasa lafiya da SARS galibi ke yada cutar ne kawai a cikin mawuyacin hali, don haka hana yaduwar COVID-19 ya fi wahala fiye da SARS.
Wannan ya bayyana wani ɓangare na dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya fi SARS-CoV yawa.
Wasu marasa lafiya da ke da COVID-19 na iya samun mummunan gwajin RNA na SARS-CoV-2.
A wani ɓangare kuma, marasa lafiya da suka warke suna iya sake gwada cutar.
Hakan yana sa cutar ta yaɗu sosai.
Tare da ci gaban bincike na COVID-19 da sauri, wasu mahimman tambayoyi har yanzu ba a warware su ba, wato:
Menene asalin kwayar cutar SARS-CoV-2?
Duk da cewa an gano cewa SARS-CoV-2 da wasu cututtukan SARS-like guda biyu sun yi kama da juna da kashi 96 cikin ɗari, har yanzu ba za mu iya cewa cutar SARS-CoV-2 ta samo asali ne daga ƙuda ba.
Wane dabba ne ya zama ɗan tsakiya da ya ɗauki kwayar cutar daga wani da ya haife ta, kamar su jemage zuwa mutum?
Idan ba mu san amsoshin tambayoyi na farko da na biyu ba, ba za mu iya hana yaduwar cutar ba, kuma yanayin annobar zai iya ƙaruwa a kowane lokaci.
Tsarin kwayoyin halitta da gwaje-gwaje na sunadarai sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, amma ta yaya kwayar cutar ke shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na rashin lafiya?
Shin kwayar cutar tana haɗa kansa da ƙwayoyin da ke samar da ACE2 a wasu gabobin jiki?
Idan ba mu da amsoshin waɗannan tambayoyin ba, ba za mu iya ba da ganewar asali da kuma magani mai kyau ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar take juyin halitta yayin da take yaduwa daga mutum zuwa mutum?
Shin zai zama annoba a duniya, ko kuma zai ɓace kamar SARS, ko kuma zai sake dawowa kamar mura?
Waɗannan batutuwa suna da muhimmanci sosai, amma za mu ɗauki lokaci kafin mu sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Amma ba mu da wani zaɓi sai dai mu kawo ƙarshen annobar da wuri-wuri kuma mu koma rayuwa ta yau da kullun.
Asalin dabbobi na kwayar cutar coronavirus
Juyin halitta da daidaitawa sun haifar da juyin halitta na coronavirus (CoV) da masu ɗauke da su, gami da mutane, tsawon dubunnan shekaru.
Kafin 2003, an san cewa wasu cututtukan mutum guda biyu (HCoV) suna haifar da rashin lafiya mai sauƙi kamar sanyi.
Cutar cututtuka ta cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Fitowar cutar coronavirus mai tsanani ta numfashi mai tsanani na nau'in biyu (SARS-CoV-2) a tsakiyar China a ƙarshen 2019 ya sake jawo hankali ga coronavirus kuma ya ba mu mamaki da yawan yaduwar cutar amma rashin bayyanar cutar cutar ta wannan kwayar cutar idan aka kwatanta da SARS-CoV.
Cutar coronavirus ta mutum cuta ce ta dabbobi, kuma fahimtar asalinta zai taimaka sosai.
Yawancin cututtukan coronavirus na mutum sun fito ne daga barbashi, wanda ba su da cutar.
An kuma san wasu masu ɗauke da wasu cututtukan mutum.
Ƙayyade dabbobi masu ɗauke da cuta yana da tasiri a kan hana yaduwar cututtuka.
Binciken hulɗar da ke tsakanin dabbobi masu ɗauke da cutar korona zai iya ba da haske game da cutar coronavirus a cikin mutane.
A cikin wannan bita, mun kawo bayanan da muke da su game da cututtukan coronavirus guda bakwai na mutum, tare da mai da hankali kan tarihin gano su da kuma asalin su da kuma hanyoyin watsa su tsakanin jinsuna.
Yana da muhimmanci a lura cewa muna gwadawa da kuma kwatanta cututtukan coronavirus na mutane daban-daban dangane da juyin halitta na kwayar cutar da kuma sake haɗa kwayoyin halitta.
A cikin wannan mahallin, an kuma yi la'akari da annobar cutar da cutar coronavirus ta haifar a yau, wanda aka gano a cikin 2019 (COVID-19).
Ƙari ga haka, an kwatanta yanayin da ake bukata don maye gurbin masu ɗauke da cutar da kuma yadda juyin halitta na cutar zai shafi ciwon.
Kwayoyin cutar Coronaviridae suna cikin dangin Coronaviridae, wanda rukuni ne na ƙwayoyin cuta masu ƙwayoyin cuta tare da madaidaicin madaidaicin RNA.
Waɗannan ƙwayoyin cuta da suke da ƙwayoyin RNA da yawa, wato ƙwayoyin nucleotide dubu 26 zuwa 32, sun sami wannan sunan ne domin siffarsu tana kama da kambi idan aka duba su a cikin na'urar bincike ta lantarki.
A tsarin kwayoyin cutar, kwayoyin cutar korona suna da kwayoyin halitta da ba a rarraba su ba kuma suna da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna dauke da manyan manyan sassan karatun (ORF1a da ORF1b) wadanda aka bayyana a cikin pp1a da pp1ab polyproteins.
Waɗannan sunadarai suna sake sarrafawa don samar da sunadarai 16 da ba a tsara su ba, waɗanda ake kira nsp1~16.
Sauran ɓangaren kwayoyin halitta yana da tsarin ƙididdiga don gina jiki, ciki har da furotin (S), furotin (E), furotin (M) da kuma nucleoprotein (N).
A cikin sauran layin coronavirus, akwai wasu ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Dangane da bambance-bambance a cikin jerin sunadarai\ coronaviruses an raba su zuwa nau'ikan hudu (alpha, beta, gamma- da kuma delta coronaviruses), yayin da nau'in beta coronaviruses ya haɗa da yawancin coronaviruses na mutum kuma ya kasu zuwa layi huɗu (A, B, C da D).
Akwai shaidar ilimin halitta cewa asalin asalin yawancin alpha- da beta-coronavirus shine bera da rodents, yayin da tsuntsaye  babban tanki ne ga gamma da delta-coronavirus.
A cikin shekaru dubbai, cututtukan korona sun ci gaba da ƙetare shinge tsakanin nau'ikan, kuma wasu daga cikinsu sun samo asali zuwa cututtukan da ke da haɗari ga ɗan adam.
A yau an san cututtukan coronavirus guda bakwai na mutum.
Waɗannan sun haɗa da kwayar cutar alphacoronavirus ta mutum HCoV-229E da HCoV-NL63.
Sauran betacoronavirus biyar sun haɗa da HCoV-OC43, HCoV-HKU1, coronavirus mai ciwon numfashi mai tsanani (SARS-CoV), coronavirus na ciwon numfashi na Gabas ta Tsakiya (MERS-CoV) da coronavirus mai ciwon numfashi mai tsanani na SARS-CoV-2.
Kwayar cutar coronavirus ta mutum HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya kamar sanyi da / ko zawo.
Akasin haka, ƙwayoyin cuta na SARS-CoV, MERS-CoV da sabon SARS-CoV-2 suna da cutar cuta sosai, suna haifar da mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
An samo zaren farko na kwayar cutar coronavirus ta mutum HCoV-229E, B814, daga samfurin da aka cire daga hancin masu cutar sanyi a cikin shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi game da ƙwayoyin cuta na HCoV-229E da HCoV-OC43 waɗanda ke haifar da alamun kamuwa da cuta a cikin gida.
Hakika, kafin barkewar cutar SARS, an san cewa kamuwa da cutar korona ba ta da lahani.
Cutar SARS ta 2003 ta kasance ɗaya daga cikin bala'in da ya fi muni a tarihin yanzu; mutane fiye da 8,000 sun kamu da cutar, kuma yawan mutuwar ya kai kusan 10%.
Shekaru goma bayan haka, cutar MERS ta ɓarke kuma ta yi tsanani a yankin Larabawa, amma ba a kai ga a kai ga sauran ƙasashe ba.
Sabuwar kwayar cutar coronavirus ta mutum (2019-nCoV) da aka gano a shekarar 2019, wanda daga baya aka sake masa suna SARS-CoV-2, ita ce sanadin cutar annobar cutar coronavirus ta 2019 (COVID-19), wacce ta kashe mutane sama da 3,120 har zuwa 3 ga Maris, 2020, kuma yawan masu kamuwa da cutar ya wuce 91,000.
An samu siginar faɗakarwa kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa.
Dukkanin kwayar cutar coronavirus guda bakwai na mutum suna da asalin dabbobi, kuma tushen su kwari ne, beraye ko dabbobin gida.
Yawancin bayanan sun nuna cewa dukkanin cututtukan coronavirus na ɗan adam sun samo asali ne daga bera, waɗanda ƙwayoyin cuta suka dace da su sosai kuma ba su nuna cututtuka ba amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta jefa kasar Sin da duniya cikin kalubale mai tsanani ta fuskar kiwon lafiya, kimiyya, zamantakewa da ɗabi'a.
Binciken yanayin dabbobin da ke haifar da cutar coronavirus na mutum zai ba da damar fahimtar tarihin halitta, abubuwan da ke motsa juyin halitta da abubuwan da ke iyakance yaduwar jinsuna.
Zai iya kuma ba da shawara ko hanzarta gano wani tanki, mai ɗaukar SARS-CoV-2 da ke haɓaka, wanda ke da mahimmanci don hana sake yaduwar cutar a nan gaba.
Wannan bita ya ƙunshi cikakken bayani game da asalin dabbobi, yaduwar jinsuna da kuma cututtukan cututtukan mutum.
Musamman, mun gano kuma mun bincika wannan babban abu: ƙwayoyin cuta na asali waɗanda suka haifar da coronavirus na ɗan adam ba sa cutarwa ga masu ɗaukar su, amma suna zama masu cutarwa bayan watsawa tsakanin nau'ikan zuwa sabon mai ɗaukarwa.
Mun kuma bincika yanayin juyin halitta na coronavirus na mutum, wanda ke nuna cewa sau da yawa haɓakar watsawa yana tare da raguwar ƙwayoyin cuta.
A cikin wannan mahallin, sakamakon barkewar SARS-CoV-2 na yanzu ana la'akari da shi.
An san da cutar korona a cikin dabbobi tun daga ƙarshen shekarun 1930.
Kafin a fara gano nau'in B814 na kwayar cutar HCoV-229E daga samfurin da aka samo daga hancin marasa lafiya da suka kamu da mura, an gano wasu nau'ikan coronavirus a cikin dabbobi daban-daban da suka kamu da cutar, ciki har da tururuwa, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekaru goma da suka gabata, an gano mutane bakwai da ke da cutar korona.
Tebur na 1 ya ba da taƙaitaccen tarihin gano cututtukan coronavirus na mutum a cikin tsari na lokaci.
An samo nau'in farko na kwayar cutar HCoV-229E daga samfuran da aka ɗauka daga hanyoyin numfashi na marasa lafiya tare da cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan WI-38.
Marasa lafiya da ke dauke da kwayar cutar HCoV-229E sun nuna alamun sanyi, ciki har da ciwon kai, hancinsa, rashin jin daɗi da ciwon makogwaro, yayin da zazzabi da tari suka bayyana a kashi 10 zuwa 20%.
Daga baya, a shekara ta 1967, an gano kwayar cutar HCoV-OC43 daga jikin kwayoyin halitta da kuma ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙ
Alamun asibiti na kamuwa da cutar HCoV-OC43 suna kama da bayyanar cutar HCoV-229E, wanda alamun ba za a iya bambanta su da cutar wasu cututtukan cututtukan numfashi ba, kamar su cutar mura ta nau'in A da rhinoviruses.
Kwayar cutar HCoV-229E da HCoV-OC43 sun yadu a duk duniya kuma galibi ana yaduwa ne a lokacin hunturu a wurare masu tsaka-tsakin yanayi.
Yawancin lokaci, waɗannan ƙwayoyin cuta biyu ba sa wuce mako guda kafin su kamu da cutar.
Sakamakon binciken da aka yi a kan masu sa kai ya nuna cewa mutane masu lafiya da ke fama da cutar HCoV-229E sun kamu da mura mai sauƙi.
Wasu marasa lafiya da suka raunana garkuwar jiki suna fama da mummunar cututtukan ƙananan iska.
Cutar SARS, wadda aka fi sani da annobar cutar sankarar bargo, ita ce ta farko a tarihin 'yan adam da aka rubuta da kyau game da cutar da kwayar cutar coronavirus ta haifar, kuma cutar ta samo asali ne daga kwayar cutar SARS-CoV, kwayar cutar coronavirus ta uku da aka gano.
An gano mutum na farko da ya kamu da cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na ƙasar Sin.
A lokacin annobar SARS, an samu mutum 8,096 da suka kamu da cutar da kuma mutum 774 da suka mutu, kuma cutar ta yadu zuwa ƙasashe da yawa da nahiyoyi daban-daban.
Ba tare da la'akari da masu yaduwar da ke da tasiri ba, an kiyasta cewa kowane mai cutar zai iya cutar da wasu mutane biyu; lokacin kwantar da hankali ya kasance daga kwanaki 4 zuwa 7, kuma yawan adadin kwayar cutar ya kai ranar 10 na cutar.
Marasa lafiya da suka kamu da SARS-CoV sun fara fama da ciwon tsoka, ciwon kai, zazzabi mai zafi, rashin lafiya da rawar jiki, kuma daga baya alamun sun haɗa da numfashi, tari da rashin numfashi.
Abubuwan da suka saba faruwa a cikin SARS sune cutar lymphopenia, cututtukan hanta da ƙaruwa da creatinine kinase.
Hakanan ana samun lalacewar alveolar mai yaduwa, haɓakar ƙwayoyin epithelial da ƙaruwa a cikin macrophages a cikin marasa lafiya tare da SARS.
Kimanin kashi 20 zuwa 30 cikin ɗari na marasa lafiya suna bukatar jinya mai tsanani da kuma iska mai iska.
A irin waɗannan yanayi masu tsanani, ban da ƙananan hanyoyin numfashi, wasu gabobin jiki, har da na hanji, hanta, da kodan suna iya kamuwa da cutar, kuma yawanci ana samun guguwar cytokine, wanda zai iya zama mai kisa, musamman ga marasa lafiya da ke fama da rashin lafiya.
An fara gano kwayar cutar ne daga wani mutum da aka yi wa allurar huhu a fili, wanda danginsa ne suka zo Hong Kong daga birnin Guangzhou.
Tun daga lokacin, an yi ƙoƙari sosai wajen nazarin cututtukan da ke shafan mutum.
A ƙarshen shekara ta 2004, an gano HCoV-NL63 a cikin jariri ɗan wata 7 daga Netherlands.
Da farko an gano cewa cutar tana shafan yara ƙanana da tsofaffi da kuma marasa lafiya da ke fama da rashin lafiya da kuma cututtukan numfashi.
Cutar da HCoV-NL63 ke haifarwa tana da alamun bayyanar cututtuka kamar sanyi, cututtukan fuska, zazzabi mai zafi da kuma cutar sankarar bargo.
Wani bincike da aka yi ya nuna cewa an samu wannan kwayar cutar daga hancin wani yaro mai wata takwas a ƙasar Netherlands da yake fama da ciwon huhu.
An gano cutar a ƙasar Holland, amma a gaskiya tana ko'ina.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan numfashi da ke yaduwa, kuma yawan cututtukan da ke haifar da shi yana ƙaruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 an danganta shi da cututtukan laryngitis, wanda ake kira croup.
An gano HCoV-HKU1 a Hong Kong a wannan shekarar daga wani mutum mai shekara 71 da aka kwantar da shi a asibiti da ciwon huhu da kuma cutar sankarar bargo.
Baya ga ciwon huhu da kuma cutar sankarar bargo, HCoV-HKU1 yana da alaƙa da ciwon asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano kwayar cutar HCoV-HKU1 da ke haifar da cututtukan numfashi masu sauƙi a duk duniya.
Dukkanin waɗannan cututtukan coronavirus guda huɗu na mutum waɗanda ke haifar da kamuwa da cuta a waje da asibiti sun dace da mutane sosai, kuma maye gurbin su wanda ke haifar da cututtukan cututtuka masu saurin kamuwa da cuta ba shi da tabbas, kodayake an sami abubuwan da ba a sani ba kuma ba a san dalilin su ba, kamar a cikin wani yanayi mai wuya tare da mafi ƙarancin ƙwayar cuta HCoV-NL63, wanda kwanan nan aka ba da rahoton ya haifar da mummunan kamuwa da cutar ƙananan iska a China.
Yawancin lokaci, yayin da waɗannan coronavirus na ɗan adam suka sami damar watsawa da kuma kasancewa cikin jiki, suna zama marasa cutarwa ko cututtuka.
An fara gano cutar sankara ta gabashin gabashin (MERS-CoV) a shekarar 2012 a Saudiyya daga huhu na wani mutum mai shekaru 60 da haihuwa da ke fama da ciwon huhu da kuma rashin cin abinci.
Yawancin lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje sun faru ne a Gabas ta Tsakiya, amma an sami wasu ƙasashen Turai da Tunisia da ke da alamun shigo da cutar da kuma yaduwa ta hanyar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututut
Wani barkewar cutar ta biyu tare da tabbatar da mutane 186 ya faru a Koriya ta Kudu a 2015.
Alamun asibiti na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da MERS sun kamu da ciwon koda mai tsanani, wanda har yanzu ya bambanta MERS daga sauran cututtukan da ke haifar da coronavirus da ke yaduwa ga mutane.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna fama da cututtuka na ciki kamar zawo da amai.
A ranar 14 ga Fabrairun 2020, an sami sama da mutane 2,500 da ke fama da cutar sankarar numfashi ta Gabas ta Tsakiya tare da yawan mace-mace (34.4%), saboda haka MERS-CoV ana ɗaukarsa ɗayan ƙwayoyin cuta masu saurin mutuwa da aka sani.
A tsakiyar zuwa ƙarshen watan Disamba na 2019, an gano tarin marasa lafiya da cutar huhu a Wuhan, lardin Hubei na ƙasar Sin, wanda yanzu, idan aka duba baya, ana danganta shi da kamuwa da cutar coronavirus mai tsanani mai tsanani na 2 (SARS-CoV-2).
Hukumar Lafiya ta Duniya ta sanar da cewa barkewar cutar sankara ta kasa da SARS-CoV-2 ke haifarwa, ta zama gaggawa ta kiwon lafiyar jama'a a duniya, kuma an kira cutar coronavirus infection 19 (COVID-19).
A ranar 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duniya, tare da mutuwar kusan kashi 3,4%.
Ya kamata a lura cewa yawan mutuwar a lardin Hubei na kasar Sin ya kai kashi 4.2 cikin dari, kuma a waje da shi ya kai kashi 1.2 cikin dari.
SARS-CoV-2, kamar SARS da MERS, yana haifar da mummunar kamuwa da cuta ta numfashi, wanda ke haifar da zazzabi, tari da rashin numfashi.
Wasu marasa lafiya suna fama da zazzabi.
Ciwon huhu yana da tsanani sosai kuma yana iya saurin saurin ciwo.
Duk da kamanceceniya tsakanin SARS-CoV da SARS-CoV-2, la'akari da babban daidaiton jerin nucleotide (82%), waɗannan ƙwayoyin cuta duk da haka suna samar da rassa daban-daban na itacen phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar amma yana da damar watsawa fiye da SARS-CoV da MERS-CoV.
An samu wasu mutane da ba su nuna alamun cutar SARS-CoV-2 ba, wanda hakan ya nuna cewa cutar tana iya yaduwa cikin sauri a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran kwayar cutar coronavirus guda shida, za a ga muhimman kamanceceniya da bambance-bambance.
Na farko, cututtukan da ke kama da na mutum suna da irin wannan lokacin da suke ci gaba da yaduwa.
A wannan yanayin, SARS-CoV-2 yana nuna irin yanayin da sauran cututtukan coronavirus guda shida na ɗan adam.
Na biyu, a cikin yanayin cutar COVID-19, cutar SARS-CoV tana tsakanin cutar coronavirus guda huɗu da ke haifar da kamuwa da cuta a waje da asibiti (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, bayyanar cutar SARS-CoV-2 ta yi kama da na kwayar cutar coronavirus ta mutum da ke haifar da kamuwa da cuta a waje da asibiti, gami da bayyanar cututtuka marasa ƙayyadaddun, alamu masu sauƙi ko ma babu alamomi.
A gefe guda kuma, kamar yadda yake da SARS-CoV, za a iya rarrabe ƙananan ƙananan masu cutar COVID-19, ko da yake ƙimar ta ɗan ƙasa.
Na uku, akwai wasu abubuwa masu ban sha'awa game da watsa SARS-CoV-2 da ke faruwa a cikin kwayar cutar coronavirus ta mutum da ke haifar da kamuwa da cuta a waje da asibiti da kuma SARS-CoV.
A gefe guda, yaduwar SARS-CoV-2 tana da girma kamar na coronavirus na mutum, wanda ke haifar da kamuwa da cuta a waje da asibiti.
A gefe guda, har yanzu ba a tabbatar da ko yaduwar SARS-CoV-2 ta ragu ba tare da kowane sauyawar cutar (watau kamuwa da kowane mutum na gaba), kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran cututtukan coronavirus na mutum da ke haifar da kamuwa da cuta a waje da asibiti, ana iya gano SARS-CoV-2 a cikin kayan ƙwari.
Har yanzu ba mu san ko hanyar SARS-CoV-2 ta baki da na ƙwanƙwasa ba tana da mahimmanci (aƙalla a wasu yanayi) kamar yadda yake a cikin SARS-CoV.
Wani abin sha'awa musamman shi ne yiwuwar SARS-CoV-2 na yanayi, wanda ya shafi kwayar cutar coronavirus ta mutum, wanda ke haifar da kamuwa da cuta a waje da asibiti.
Koyaya, ci gaban cutar COVID-19 mai gudana zai dogara ne akan halaye na SARS-CoV-2, gami da watsawa, cutarwa da ci gaba da yaduwa bayan wucewa ta hanyar mutane.
Dukkanin kwayar cutar coronavirus guda huɗu da ke haifar da kamuwa da cuta a waje da asibiti tare da alamun rashin lafiya sun dace da mutane.
A wani ɓangaren kuma, wataƙila mutane sun saba da waɗannan ƙwayoyin cuta huɗu na ɗan adam.
A wasu kalmomi, duka biyun za a iya cewa su ne kawai waɗanda suka tsira daga annobar coronavirus na ɗan adam a baya.
Kwayar cutar korona ta mutum da ke haifar da mummunan cuta a cikin mutane da kuma mutanen da cutar korona ta haifar da mummunan cuta a cikin su ba su tsira ba.
Don hakan ya faru, kwayar cutar coronavirus ta mutum dole ne ta ninka a jikin mutum sosai don samun juyin halittar da za ta iya magance abubuwan da ke hana mai ɗaukar ta.
A wannan ma'anar, idan cutar SARS-CoV-2 ta ci gaba da ci gaba da yawa kuma mutane da yawa sun kamu da ita, to, za a iya samun damar kamuwa da cutar ga mutane.
Idan ya daidaita da kyau, zai yi wuya a hana yaduwar cutar tsakanin mutane ta hanyar keɓewa ko wasu matakan kula da cututtuka.
A cikin shekaru da yawa, mutane da yawa sun kamu da cutar korona guda huɗu da ke haifar da sanyi a cikin marasa lafiya.
Waɗannan ƙwayoyin cuta ba sa bukatar dabba mai riƙe da su.
Kwayoyin cutar SARS-CoV da MERS-CoV ba su dace da mutane sosai ba kuma ba za a iya ci gaba da yaduwar su tsakanin mutane ba.
Suna bukatar su ci gaba da rayuwa da kuma haifuwa a cikin wuraren da suke zama, kuma su nemi zarafin shiga cikin mutane masu saurin kamuwa da cutar, wataƙila ta hanyar ɗaya ko fiye da masu ɗauke da cutar ko masu ƙarfafawa.
SARS-CoV-2 yana da halaye kamar SARS-CoV/MERS-CoV da kuma ƙwayoyin cuta huɗu na HCoV.
Yana da sauƙin yaduwa kamar HCoVs da ba sa zuwa asibiti, aƙalla a yanzu.
Amma ya fi HCoVs na waje cutarwa kuma ba ya cutar da SARS-CoV ko MERS-CoV.
Za mu ga ko zai iya zama mai amfani sosai ga mutane kuma ya yi tafiya a cikin yanayin da ba shi da tanki ko kuma ya yi tafiya tare da dabba mai ɗaukarwa.
Kafin mu tattauna asalin dabbobi na HCoVs, zai zama da amfani mu tattauna ma'anoni da halaye na juyin halitta, na halitta, na tsaka-tsaki, masu haɓaka da masu riƙe da HCoVs.
Dabbobi suna ɗaukar HCoV ta hanyar juyin halitta idan sun ɗauki dangi na kusa da ke da daidaituwa a matakin jerin nucleotides.
Kwayar cutar ta asali tana da kyau kuma ba ta haifar da cututtuka a cikin wannan mai ɗaukar hoto.
Hakazalika, mai ɗaukar hoto yana ɗaukar HCoV a cikin dogon lokaci.
A cikin duka biyun, masu ɗaukar hoto sun kamu da cutar ta hanyar halitta kuma suna ɗaukar hoto na HCoV ko kuma kwayar cutar mahaifa.
Akasin haka, idan HCoV ya kamu da cutar ne kawai a cikin mai ɗaukar hoto kafin ko a lokacin da aka kawo shi ga ɗan adam, ba ya dace da sabon mai ɗaukar hoto kuma sau da yawa yana haifar da cuta.
Wannan mai ɗaukar hoto na iya zama tushen cutar ta mutum kuma ya zama mai ɗaukar hoto mai haɓaka, yana ba da damar kwayar cutar ta ninka da sauri, sannan ya watsa ta ga mutane, yana ƙara yawan kamuwa da mutane.
HCoV na iya ɗaukar kamuwa da cuta ta hanyar kamuwa da cuta idan ba zai iya jurewa watsawa a cikin mai ɗaukarwa ba.
Akasin haka, ƙwayoyin HCoVs na iya daidaitawa da mai ɗaukar hoto na tsakiya har ma da kafa ƙarancin lokaci.
A wannan yanayin, mai ɗaukarwa na tsakiya ya zama mai ɗaukar ruwa na halitta.
Bayanan cututtuka sun nuna cewa mai cutar SARS ba shi da dangantaka da dabbobi masu farauta.
Ƙarin binciken da aka yi game da cutar ya nuna cewa masu sayar da dabbobi suna da ƙwayoyin IgG da ke hana cutar SARS-CoV fiye da sauran mutane.
Kwayoyin Himalayan (Paguma larvata) da kare mai kama da kare a kasuwannin dabbobi masu rai sune farkon masu dauke da kwayar cutar da ta yi kama da SARS-CoV.
Wannan ya nuna cewa bayan an kawar da dukan ƙwayoyin cuta a kasuwa, ba a sake samun rahoton cutar SARS ba.
A lokaci guda, an ba da rahoton cewa yawancin masu cutar da ba a sayar da su ba a cikin mazaunan Himalayan da ke cikin daji ko gonaki ba su da SARS-CoV, wanda ke ba da shawarar cewa mazaunan Himalayan na iya zama matsakaiciyar mai ɗaukar hoto ne kawai maimakon tanadin SARS-CoV na halitta.
Abin lura, tunda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da ƙwayoyin cuta ga SARS-CoV, ba za a iya kawar da yiwuwar cewa yawancin ƙananan dabbobi masu shayarwa na iya zama masu ɗaukar ƙarfi na tsaka-tsaki ba.
Dukansu sun zama masu ɗauke da cutar SARS-CoV.
Binciken da aka yi na dabbobi masu dauke da SARS-CoV ya gano CoV na bera wanda ke da alaƙa da cutar sankarar bargo mai suna HKU3 (SARSr-Rh-BatCoV HKU3) kuma yana cikin bargo na kasar Sin.
Waɗannan berayen sun sami ƙwayoyin cuta na SARS-CoV da jerin kwayoyin SARSr-Rh-BatCoV HKU3.
Waɗannan da sauran ƙwayoyin cuta na corona na bera suna da daidai da tsarin nucleotide na 8892% kamar SARS-CoV.
Waɗannan binciken sun sa aka soma wani sabon ra'ayi cewa jemage suna ɗauke da sababbin cututtuka da ke shafan mutane.
An kuma gano wasu cututtukan coronavirus masu kama da SARS (SL-CoV) a cikin barbashi, amma babu ɗayansu da za a iya warewa a matsayin kwayar cuta mai rai sai dai ɗaya da ake kira WIV1.
An san cewa mai karɓar SARS-CoV shine enzymes mai canza angiotensin na mutum 2 (ACE2).
An nuna cewa WIV1, wanda aka samo daga samfurin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Abin mamaki, ƙwayar SARS mai warkewa ta iya kawar da WIV1.
A yau, WIV1 shine mafi kusa da kakanin SARS-CoV a cikin bera, yana raba kashi 95% na daidaiton jerin nucleotide.
Duk da kamanceceniya tsakanin waɗannan ƙwayoyin cuta guda biyu, ana ɗaukar WIV1 ba kwayar cutar SARS-CoV ta kai tsaye ba, kuma ba sauro ba ne masu ɗaukar SARS-CoV kai tsaye.
Binciken kwayoyin halitta ya sanya MERS-CoV a cikin rukuni ɗaya kamar CoV-HKU4 na bera da CoV-HKU5 na bera.
CoV-HKU4 na bera da MERS-CoV suna amfani da mai karɓar mai ɗaukar hoto ɗaya, diphtyldipeptidase-4 (DPP4), don shiga cikin ƙwayoyin cuta.
Tsarin RNA-dogara RNA-polymerase na kwayar cutar MERS-CoV yana da kusanci da tsarin kwayoyin halitta daga betacoronavirus na bera da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a taɓa samun kwayar cutar MERS-CoV a cikin kuraje ba.
Halin da ke tsakanin MERS-CoV da CoV-HKU25 na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Hakan yana nufin cewa ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwarƙun ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuma masu ƙwanƙwasawa suna da ƙwayar cuta mai ƙarancin ƙwayar cuta, kamar yadda raƙuma na Gabas ta Tsakiya a ƙasashen Afirka da yawa.
An gano MERS-CoV mai rai, wanda ya yi kama da wanda aka gano a cikin mutane, daga hancin raƙuma masu ƙwanƙwasawa, wanda ya ƙara tabbatar da rawar raƙuma a matsayin masu ɗaukar MERS-CoV na gaskiya.
Ya kamata a lura cewa raƙuma da aka yi gwaji da su da cutar MERS-CoV sun nuna alamun rashin lafiya amma sun nuna yawan cutar.
Abin lura shi ne, raƙuman da suka kamu da cutar sun fitar da kwayar cutar ba kawai ta hanyar numfashi ba amma ta hanyar ƙwayoyin cuta, wanda kuma shine hanyar da ta fi dacewa ta fitar da kwayar cutar a cikin bera.
Duk da haka, har yanzu akwai tambayoyi saboda yawancin mutanen da aka tabbatar da cutar ta gabashin gabashin ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka kuma ana iya ɗauka cewa an watsa su ne daga mutum zuwa mutum ko kuma an watsa su ta hanyoyin da ba a sani ba, waɗanda suka haɗa da nau'ikan da ba a sani ba na dabbobi waɗanda ke ɗauke da MERS-CoV.
Kwayar halittar SARS-CoV-2 ta yi daidai da CoV RaTG13 na bera da aka gano a cikin Rhinolophus affinis na Asiya.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin jerin abubuwa tsakanin SARS-CoV-2 da RaTG13 ya yi yawa sosai don a danganta su da dangantaka ta iyaye.
Hakan yana nufin cewa ƙuda ba za ta iya zama mai ɗaukar SARS-CoV-2 kai tsaye ba, sai dai idan a nan gaba za a sami kwayar cutar coronavirus ta ƙuda da ta yi kama da juna.
Ana tsammanin cewa dabbobi masu dauke da kwayar cutar SARS-CoV-2 suna cikin dabbobin daji da ake siyarwa da kashewa a kasuwar sayar da kayan kifin na Wuhan, wanda ya shafi yawancin shari'o'in COVID-19 na farko, wanda ke nuna yiwuwar yaduwar daga dabba zuwa mutum.
Bincike da yawa na kwanan nan da aka yi ta hanyar tsara tsarin metagenome sun yanke shawarar cewa rukuni na ƙananan dabbobi masu shayarwa da ke cikin haɗarin ɓacewa, waɗanda aka sani da pangolins (Manis javanica), na iya ɗaukar betacoronavirus na iyaye, wanda ke da alaƙa da SARS-CoV-2.
Halin daidaiton jerin nucleotides na waɗannan sabbin kwayoyin halittar kwayar cutar coronavirus na pangolin ya dace da 8592% tare da SARS-CoV-2.
Amma kuma suna da dangantaka da RaTG13, inda a cikin jerin kwayoyin halitta, kusan kashi 90 cikin dari na ainihin juna ne.
Suna haɗuwa cikin ƙananan layi biyu na bambancin ƙwayoyin cuta kamar SARS-CoV-2, a cikin itacen phylogenetic, ɗayan wanda ke da yankin haɗin mai karɓa (RSD) mafi kusa da SARS-CoV-2 tare da daidaiton jerin amino acid a matakin 97,4%.
Akasin haka, RSD na SARS-CoV-2 da RaTG13 sun fi bambanci, duk da cewa sun fi dacewa da juna a cikin kwayoyin halitta.
A cikin binciken da aka yi a baya game da marasa lafiya na pangolin, an kuma ba da rahoton gano ci gaba na kwayar cutar a cikin samfurin huhu wanda ya kasance kamar haka da SARS-CoV-2.
A wannan binciken, an yi amfani da wasu hanyoyin tattarawa da sarrafawa don samun jerin kwayoyin halitta, wanda ya ƙunshi kusan kashi 86.3 cikin dari na cikakken kwayar cutar.
Ba za a iya kawar da yiwuwar cewa pangolin ya zama ɗaya daga cikin dabbobi masu ɗaukar SARS-CoV-2 ba.
Koyaya, saboda bambancin jerin tsakanin SARS-CoV-2 da kuma dangin SARS-CoV-2 beta-coronavirus, a halin yanzu babu wata hujja da ke tallafawa asalin SARS-CoV-2 kai tsaye daga pangolin.
Bugu da ƙari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi ta tsakanin SARS-CoV-2 da kuma beta-coronavirus na pangolin da ke da alaƙa da SARS-CoV-2.
Har yanzu ba a gano hanyar juyin halitta na SARS-CoV-2 a cikin barbashi, pangolin da sauran dabbobi masu shayarwa ba.
Duk da yake an sami daidaituwa mafi girma a cikin RCD tsakanin SARS-CoV-2 da dangin SARS-CoV-2 beta-coronavirus, SARS-CoV-2 da RaTG13 suna da daidaituwa mafi girma a cikin tsarin kwayoyin halitta.
A ka'idar, babban kamanceceniya tsakanin beta-coronavirus na pangolin, dangin SARS-CoV-2, da SARS-CoV-2 ya danganta da juyin halitta tare ta hanyar zaɓi.
Wani ra'ayi na gaba shine sake haɗuwa tsakanin beta-coronavirus na pangolin, wanda ke da alaƙa da SARS-CoV-2, da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin abin da ke motsa juyin halitta, sake haɗuwa ya zama ruwan dare gama gari tsakanin betacoronavirus.
Har yanzu babu wata tabbatacciyar hujja game da asalin SARS-CoV-2 kai tsaye.
Baya ga ƙwayoyin cuta masu cutarwa na HCoV, ana kuma nazarin asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halitta ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga kwayar cutar coronavirus na bera, yayin da aka gano kwayoyin cutar HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An bayar da rahoton cewa cutar coronavirus ta bera, da aka kira ARCoV.2 (Appalachian Ridge CoV) kuma aka gano a cikin dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dab
A gefe guda, HCoV-229E yana da alaƙa da wata kwayar cutar coronavirus ta bera mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kodayake akwai shakku cewa raƙuma na iya zama masu ɗaukar sa.
Don a bayyana, ilimin zamani game da asalin dabbobi na sanannun cututtukan coronavirus an taƙaita su a hoto na 1 da tebur na 2.
Binciken kwayoyin halitta ya ba da tabbacin abubuwan da suka faru na watsa HCoV tsakanin jinsuna a cikin tarihin.
Lokacin da cutar HCoV-OC43 ta kamu da mutane daga dabbobi a cikin shekara ta 1890, an sami cutar ta hanyar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna ba shi da kyau.
An gano alphacoronavirus na bera, wanda ke da alaƙa da HCoV-229E.
A tsakanin su akwai kwayar cutar alpaca.
Akwai wasu bayanai da suka nuna cewa cutar ta kai tsaye daga bara zuwa mutum.
Na farko, mutane ne, ba alpacas ba, waɗanda za su iya haɗuwa da waɗannan ƙwari a cikin yanayin muhalli.
A wannan lokacin, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, alphacoronavirus na bera, dangin HCoV-229E, a cikin bera suna da bambanci kuma ba su da cutar, yayin da alphacoronavirus na alpaca ya haifar da kamuwa da cutar numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a taɓa samun cutar alpaca ba a cikin dabbobin daji.
Saboda haka, ba za a iya kawar da yiwuwar alpacas sun sami alpha coronavirus, wanda ke da alaƙa da HCoV-229E, daga mutane ba.
A gaskiya, jemage ne tushen cututtukan da ke shafar mutane, har da cutar hauka, Ebola, Nipah da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa jemage na iya yaɗa HCoV-229E kai tsaye ga mutane.
A gefe guda, yayin da alphacoronavirus na bera na iya zama tushen kwayoyin HCoV-229E, alpacas da raƙuma masu ƙwanƙwasawa na iya zama masu ɗaukar hoto na ɗan lokaci waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake tare da MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar jinsuna daga barbashi zuwa raƙuma masu ƙwanƙwasawa da kuma daga raƙuma masu ƙwanƙwasawa zuwa mutum.
An san asalin juyin halitta na kwayar cutar MERS-CoV daga bera tun lokacin da aka fara gano ta sannan kuma an tabbatar da ita ta hanyar bincike na gaba.
A bayyane yake cewa jemage suna da tarin ƙwayoyin cuta don musayar kwayoyin halitta da kuma watsawa tsakanin jinsuna.
Tsawon rayuwarsu, yawan mazauna, da kuma yadda suke yin hulɗa da mutane da kuma iyawarsu na yin yawo, sun sa su zama masu rarraba abubuwa sosai.
A wani ɓangare kuma, an kawo MERS-CoV a cikin raƙuma masu ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwarar ƙwarƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwararƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙ
Ya yi amfani da waɗannan raƙuman da kyau, kuma daga matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakai matsakaiciyar matsakaiciyar matsakaiciyar
A cikin waɗannan dabbobi, kwayar cutar MERS-CoV tana haifar da rashin lafiya mai sauƙi kuma tana da ƙananan sauye-sauye.
Ana iya samun cutar ta hanyar haɗari ga mutum, kuma mutum ya kasance mai ɗaukar MERS-CoV, saboda ba a tallafawa watsa shi.
Ba kamar raƙuma ba a cikin watsa MERS-CoV, bangolin suna da wani aiki daban, idan akwai, a cikin watsa SARS-CoV-2.
Musamman, kwayar cutar ta betacoronavirus ta pangolin tana da cutarwa sosai a cikin pangolin.
Suna iya zama masu ɗauke da betacoronavirus na SARS-CoV-2 kamar yadda ciwon daji yake a cikin SARS-CoV.
A cikin binciken da za a yi a nan gaba, ana buƙatar tabbatarwa ko kawar da yiwuwar sauyawar SARS-CoV-2 daga dabbobi zuwa mutane.
Na farko, jemage na iya zama mai ɗaukar kwayar cutar da ke da alaƙa da SARS-CoV-2, kusan daidai da SARS-CoV-2.
Mutane suna iya zama tare da waɗannan ƙwari ta wajen haƙa su da kuma rarraba naman su.
Na biyu, pangolins na iya zama ɗaya daga cikin masu ɗauke da ƙwayar cuta da ke ɗauke da ƙwayar cutar SARS-CoV-2 da aka kamu da ita kwanan nan.
Mutane suna kamuwa da cutar ta hanyar yankan naman daji da kuma cin naman daji.
Da alama dabbobi da yawa, har da dabbobin gida suna da saukin kamuwa da SARS-CoV-2.
Ana iya gwada dabbobi a gida da kuma daji don gano ƙwayoyin cuta.
Na uku, kamar yadda aka nuna a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'i na uku wanda ya haɗu da duka bat da pangolin.
Ana ci gaba da neman asalin SARS-CoV-2 a cikin dabbobi.
Ban da dabbobi masu ɗauke da ƙwayoyin cuta, akwai abubuwa uku da suka sa ƙwayoyin cuta suka ƙetare iyakar ƙwayoyin.
Na farko, suna da saurin sauyawar RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta masu ɗauke da RNA guda ɗaya, ana iya ɗaukar ƙididdigar sauye-sauyen kwayar cutar coronavirus a matsayin  matsakaici-mafi girma  tare da matsakaicin sauye-sauye na sauyawa kusan sau 104 a shekara a yanki ɗaya 2 dangane da matakin daidaitawar kwayar cutar zuwa sabbin masu masaukin.
Kwayoyin cutar korona suna da kwayar cutar exoribonucleosis mai gyarawa, cirewa wanda ke haifar da sauye-sauye da yawa da kuma raunana ko ma rashin iya rayuwa.
Abin sha'awa, maganin nucleotide na Remdesivir yana hana kwayar cutar coronavirus ta hanyar hana wannan exoribonuclease da RNA-da ke da alaƙa da RNA polymerase.
Remdesivir  yana daya daga cikin magungunan da suka fi dacewa da SARS-CoV-2 da ya kamata a gwada su a gwajin asibiti.
Duk da haka, yawan canjin kwayoyin cutar korona ya fi na masu ɗauke da ita sau miliyan.
Bugu da ƙari, sau da yawa sauyin halitta zai iya zama mafi girma idan coronaviruses ba su dace da mai ɗaukar su ba.
Idan aka kwatanta da SARS-CoV mai yawan maye gurbi, yawan maye gurbin SARS-CoV-2 ya yi ƙasa, wanda ke nuna cewa ya fi dacewa da mutane.
An ce wannan kwayar cutar ta riga ta daidaita da wata wadda ta fi kusa da mutum.
Ban da SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuma masu ƙwanƙwasawa.
A ka'idar, ba zai yiwu ba cewa alluran rigakafi da magungunan rigakafin SARS-CoV-2 za su yi saurin rasa ingancinsu saboda maye gurbin kwayoyin halitta.
Na biyu, babban RNA genome a cikin coronaviruses yana haifar da ƙarin sassauci a cikin gyaran genome game da maye gurbi da sake haɗawa, don haka ƙara yiwuwar coevolution tsakanin jinsuna, wanda ke da kyau don haifar da sababbin coronaviruses idan akwai yanayi mai dacewa.
Wannan yana taimakawa da yawa na musamman bude frameworks na ƙidaya da kuma ayyuka na sunadarai, wanda aka tsara a cikin 3′-karshen genome.
Na uku, saboda yadda kwayoyin cutar korona suke zaɓar matrix, suna sauya matrix a lokacin da suke yin kwafin RNA.
A lokacin da ake rubuta kwayar cutar korona a cikin wani abu da ke aiki a matsayin matattarar jini, ana sauya zaren sau da yawa.
RNA mai girma da kuma RNA mai ƙananan ƙwayoyin cuta na iya haɗuwa da kuma haifar da sababbin cututtukan corona.
An gano shaidar ilimin halitta na sake haɗuwa a cikin HCoV-HKU1 da HCoV-OC43 da kuma coronavirus na dabbobi kamar SL-CoV da batCoV-HKU9 na bera.
Hadin gwiwar mai dauke da kwayar cutar game da watsawa
Baya ga waɗannan abubuwa uku na kwayar cutar da aka ambata a sama, wani muhimmin abu mai mahimmanci don watsawa tsakanin jinsuna shine hulɗar kwayar cutar tare da mai karɓar mai ɗaukar hoto.
Wannan labarin ya ba da misali na yau da kullun wanda kuma ya nuna hujja game da zaɓin zaɓi mai kyau a cikin abubuwan watsawa tsakanin nau'ikan halittu, sake haɗuwa da SARS-CoV.
Bisa ga nazarin kwatancen tsakanin SARS-CoV na mutum da kuma na civet, an yi imanin cewa SARS-CoV yana da saurin daidaitawa a cikin masu ɗaukar hoto daban-daban, musamman game da maye gurbi a cikin RSD na furotin S.
Gabaɗaya, ƙwayar cuta ta S ta ƙwayar cuta ta ƙwayar cuta tana hulɗa da mai karɓar ƙwayoyin cuta, kuma amsar ƙwayar cuta ta ƙwayar cuta tana karɓar shi sosai.
RSD a cikin SARS-CoV  amino acid ne, daga 318th zuwa 510th, akan S1 yanki wanda don shigar da kwayar cutar cikin tantanin halitta yana haɗuwa da enzyme mai canza angiotensin 2 na mutum (APF2), da kuma masu karɓar sa.
SARS-CoV RSD yana iya gane masu karɓar APF2 na dabbobi daban-daban, gami da bera, civet, linzamin kwamfuta da kare, yana ba da damar watsa kwayar cutar tsakanin nau'ikan.
A zahiri, an gano ragowar amino acid guda 6 ne kawai a cikin RSD waɗanda suka bambanta da nau'ikan kwayar cutar ɗan adam da civet, tare da 4 daga cikinsu suna cikin ƙwayar haɗin mai karɓa don hulɗa tare da mai karɓar APF2.
SARS-CoV civet yana da maye gurbi K479N da S487T a cikin RCD, wanda zai iya haɓaka alaƙar haɗin gwiwar furotin mai ƙwanƙwasa tare da mai karɓar APF2 na ɗan adam.
Watau, waɗannan amino acid biyu da aka maye gurbin su suna da muhimmanci sosai wajen sa kwayar cutar ta zama ta mutum.
Ya kamata a lura cewa SARS-CoV-2 yana da irin wannan mai karɓar ƙwayoyin cuta kamar SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin ɓangaren S1 na furotin S yana haifar da cewa alaƙar S protein zuwa APF2 na mutum na iya canzawa.
A gaskiya, binciken da aka yi da na'urar daukar hotan lantarki ya nuna cewa wannan dangantaka ta fi ta mutum 10 zuwa 20 fiye da ta APF2 da kuma SARS-CoV S protein.
Hakanan zai zama mai ban sha'awa don gano ko ana buƙatar wasu masu karɓar kwayar cutar don watsa SARS-CoV-2.
Abin mamaki, HCoV-NL63 kuma yana ɗaure da APF2, amma da wani ɓangaren S protein.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidease N don HCoV-229E da 9-O-acetylsilic acid don HCoV-OC43.
Hakanan suna iya zama masu alhakin nasarar daidaita waɗannan coronaviruses a cikin mutane bayan watsawa tsakanin nau'ikan daga dabbobi masu ɗaukar su.
Baya ga masu karɓar ƙwayoyin halitta, sakamakon watsa HCoV tsakanin jinsuna yana sarrafawa ta wasu abubuwan dogaro da iyakance mai ɗaukar hoto.
Bambancin waɗannan furotin masu ɗaukar hoto tsakanin mutane da masu ɗaukar hoto na HCoVs na halitta kamar barbashi, raƙuma masu ƙwanƙwasawa da rodents na iya zama shinge don watsawa tsakanin jinsuna.
Don samun nasarar yaduwar HCoVs tsakanin jinsuna, dole ne su mamaye abubuwan dogaro da kuma sarrafa abubuwan ƙuntatawa na masu ɗaukar su.
A wannan yanayin, ƙwayoyin ƙwayoyin halitta a cikin wannan muhimmin yanki na hulɗa tsakanin kwayar cuta da mai ɗaukar hoto har yanzu suna buƙatar ƙayyadewa da rarrabuwa.
Za a iya samun sakamako mai kyau ta hanyar bincika kwayoyin halittar SARS-CoV-2 ta hanyar amfani da sabuwar fasahar CRISPR.
Sabuwar HCoV ta bayyana: koma baya zuwa alamar sifili
Bambancin kwayar cutar coronavirus na bera yana ba da dama ga sababbin HCoVs.
A wannan ma'anar, ƙwayoyin cuta na corona na ƙwari suna aiki a matsayin tarin kwayoyin halitta don HCoV.
Bugu da ƙari, sauye-sauye da sauye-sauyen kwayoyin halitta suna motsa juyin HCoV kuma suna aiki a matsayin matakai biyu masu muhimmanci a cikin wannan tsari.
Alal misali, samun ko kuma rasa sababbin kwayoyin halittar da ke ƙunshe da furotin yana iya canja yanayin ƙwayoyin cuta.
Daga cikin furotin na SARS-CoV, ORF8 yana da mahimmanci don daidaitawa ga mutane, saboda an ware ƙwayoyin cuta na bera, waɗanda ke da alaƙa da SARS-CoV, amma an gano cewa suna ɓoye furotin masu bambancin ORF8.
An gano raguwar kwayoyin halittar 29-nucleotide a cikin nau'ikan da aka ware a farkon annobar ɗan adam, wanda ya dace da coronavirus SARS-CoV.
Wannan canjin ya raba ORF8 zuwa ORF8a da ORF8b, kuma an ɗauka cewa canjin canji ne wanda ke saurin sauya masu ɗauke da shi.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa tare da layin alpha da gamma coronaviruses, inda aka gano ƙananan ƙananan wuraren haɗuwa a cikin RNA-da ke da alaƙa da RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin furotin mara tsari na nsp9, yawancin nsp10, da kuma sassan nsp14.
Hakazalika, an nuna cewa cutar MERS-CoV ta sake haɗuwa tsakanin layi daban-daban, kamar yadda ya faru a cikin raƙuman raƙumi a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru a cikin wasu HCoVs waɗanda HCoVs suka sake haɗuwa da sauran coronavirus na dabbobi a cikin kwayoyin halittar su.
Ya kamata a kuma yi gargadin cewa zabin wucin gadi na iya haifar da canje-canje ba da gangan ba a cikin kwayoyin halittar kwayar cutar, wanda zai iya faruwa ne ta hanyar kawar da kwayar cutar daga matsin lamba na zabin, misali, daga tsarin rigakafin mai ɗaukar hoto.
Misali na irin wannan tasirin shine asarar cikakken girman ORF4 a cikin samfurin samfurin HCoV-229E ta hanyar raguwar kwayar halitta.
Yayin da za a iya ganin cikakkiyar buɗewar ƙididdigar ORF4 a cikin ƙwayoyin cuta na bat da raƙumi, waɗanda ke da alaƙa da HCoV-229E, alpha coronavirus alpaca yana nuna shigar da nucleotide guda ɗaya wanda ke haifar da sauyawar ƙira.
A ƙarshe, juyin halitta na sababbin HCoVs yana da nasaba da matsin lamba a kan masu ɗauke da su.
A lokacin da kwari suka kamu da cutar korona, an samu alamun rashin bayyanar cutar ko kuma ba a nuna su ba, wanda ke nuna cewa cutar korona da kwari sun saba da juna.
An gano cewa jemage suna da kyau a tsarin jiki da kuma yanayin jiki don cutar korona.
Alal misali, rashin aiki na ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Bugu da ƙari, an hana ayyukan kwayoyin halitta a cikin ƙwayoyin kwari ta hanyar maganin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Bugu da ƙari, yawan iskar oxygen mai aiki, wanda ke haifar da ƙarancin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Ƙarin cututtukan cututtukan coronavirus na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin furotin ko halayen furotin don daidaitawa da mai ɗaukarwa.
Saboda haka, ba zato ba tsammani ba ne cewa an samu sababbin cututtukan mutum guda uku a cikin shekaru ashirin da suka gabata.
Kwayoyin cutar corona ba su haifar da cututtuka ko kuma suna haifar da alamun rashin lafiya a cikin masu ɗaukar su, kamar barbashi ko raƙuma.
Suna iya yin kwafi ba tare da haifar da amsa mai karfi ba.
Wannan shi ne asirin abin da ke sa mu ga masu ɗauke da cutar ba tare da alamomi ba, da kuma abin da ke haifar da kamuwa da cutar a cikin mutane.
Alamun cututtuka masu tsanani sun fi yawa daga cikin halayen jiki da kuma hadarin cytokine, wanda idan an yi amfani da shi sosai, zai iya cutar da huhu.
Akasin haka, masu ɗauke da cutar ba su da alamun cutar.
Wannan dabarar ta hana amsawar rigakafi na iya samun sakamako mai kyau a maganin SARS-CoV-2.
Ƙwari suna da ƙwayar cutar interferon sosai.
Saboda haka, shan maganin Interferon Type I aƙalla a farkon lokacin kamuwa da SARS-CoV-2 a cikin mutane ya kamata ya zama mai amfani.
Ƙari ga haka, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Bisa ga wannan, hana NLRP3-inflammasome ta hanyar MCC950 na iya zama da amfani wajen maganin COVID-19.
SARS-CoV-2 ya samo asali ne daga tsarin SARS-CoV da MERS-CoV.
Yayin da aka gano beta coronavirus na bera wanda yake da kashi 95% na kwayar halittar SARS-CoV, akwai kuma kwayar cutar corona ta bera wanda kwayar halittar sa ta 96% ta dace da SARS-CoV-2.
Ko da yake an gano cewa ciwon daji da sauran dabbobi a kasuwa suna dauke da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano masu ɗaukar SARS-CoV-2 kai tsaye ba.
An gano beta-coronavirus na pangolin, masu kama da SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu ɗaukar hoto na tsaka-tsaki ko kuma ɓangarorin kwayoyin halittar beta-coronavirus na pangolin na iya shiga cikin sigar SARS-CoV-2 ta ƙarshe.
Duk da sauran tambayoyin, babu wata shaida da ta nuna cewa SARS-CoV-2 an ƙirƙira shi ne da gangan ko kuma da gangan.
Cutar coronavirus ta jawo hankalin duniya saboda barkewar cutar SARS-CoV-2 kwanan nan.
Binciken coronavirus a cikin barbashi da sauran dabbobi ya canza yadda muke ɗaukar mahimmancin asalin dabbobi da dabbobi masu ɗaukar HCoV a cikin watsawa ga mutane.
Tabbacin da ke nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga barbashi kuma an watsa su ga mutane ta hanyar masu ɗauke da su.
Idan kamuwa da SARS-CoV ya samo asali ne daga haɗuwa tsakanin mutane da ƙudaje a kasuwanni, rufe kasuwannin daji da kuma kawar da ƙudaje a cikinsu zai iya kawo ƙarshen cutar SARS.
Saboda wannan dalili, saboda gano wasu nau'ikan beta-coronavirus na pangolin da ke da alaƙa da SARS-CoV-2, ya kamata a cire pangolins daga kasuwannin abinci don hana yaduwar cutar ta hanyar dabbobi.
Koyaya, ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa da kuma yadda hakan zai iya faruwa ya kasance batun bincike na gaba.
A wani ɓangare kuma, kwayar cutar MERS-CoV ta daɗe tana cikin raƙuma masu ƙwanƙwasawa.
Waɗannan raƙuman suna da muhimmanci wajen sufuri, kuma su ne tushen nama, madara, fata, da kayayyakin ulu na mazauna yankin.
An san su sosai a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a ba da dukan raƙuman don a magance MERS ba kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar MERS, ana buƙatar ɗaukar cikakkiyar hanyar don haɓaka ingantaccen allurar rigakafin MERS-CoV don raƙuma a haɗe tare da sauran matakan kula da kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za su iya haifar da sababbin ƙwayoyin cuta da ke haifar da cutar.
Akwai cututtuka iri-iri da ke kama da na dabbobi a duniya.
Musamman, akwai cututtuka masu yawa na coronavirus na bat da ke da yiwuwar cutar.
Akwai dama da yawa don juyin halitta da sake haɗuwa da waɗannan coronavirus na dabbobi, wanda zai haifar da sababbin coronaviruses a nan gaba waɗanda ke da sauƙin yaduwa da / ko kashewa ga mutane.
Don rage yawan hulɗar da ke tsakanin mutane da dabbobi, ya kamata a daina cin abincin dabbobin daji a wasu yankuna na kasar Sin.
Bayan gwaji mai tsanani kamar SARS, MERS da COVID-19, ana buƙatar shiri da kuma shirin amsawa mafi kyau ga irin waɗannan yanayi.
A gaskiya, akwai ƙwayoyin cuta da yawa da suka daɗe suna wanzuwa a duniya.
Suna zama a cikin tafkunansu na halitta har sai sun sami damar yin amfani da sababbin yankuna.
Ko da yake yawancin halaye na jemage suna da kyau wajen yaɗa ƙwayoyin cuta, idan aka koya wa mutane su guji su, za a iya rage haɗarin haɗuwa da jemage da kuma wasu dabbobin daji.
Don fahimtar yanayin halittu na coronavirus da masu ɗaukar su na halitta, ana buƙatar ci gaba da lura da cututtukan cututtukan dabbobi masu shayarwa, wanda zai taimaka wajen hana yaduwar coronavirus daga dabbobi zuwa mutane da ɓarkewar cututtuka a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar ta hanyar kwayar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta cutar ta hanyar cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar
Har yanzu akwai wasu abubuwa da ba a gano ba game da asalin SARS-CoV-2 daga dabbobi.
Na farko, idan jemage sun ba da kwayar SARS-CoV-2 ga pangolins, yana da ban sha'awa mu ga yadda jemage da pangolins suke da wuri ɗaya.
Na biyu, idan jemage suna da matsayi na musamman wajen watsa cutar ga mutane, muna bukatar mu san yadda mutane suka yi hulɗa da jemage.
Na uku, idan dabba ta uku ce ta zama mai kawowa, za mu bukaci sanin yadda take shafar halittu dabam-dabam, har da mutane da kuma jemage da kuma pangolins.
A ƙarshe, saboda dabbobi masu shayarwa da yawa, gami da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2, ya kamata a gudanar da sa ido kan cutar da kuma kamuwa da cutar ta gwaji.
Ko jemage ne, ko kuma wani dabba mai shayarwa, ana sa ran a nan gaba za a gano SARS-CoV-2 ko kuma wasu ƙwayoyin cuta a cikin masu ɗauke da su.
Ƙarin bincike a wannan fannin zai ba da haske game da hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, wanda zai sami mahimman sakamako don rigakafi da sarrafa COVID-19 a cikin mutane.
Ya kamata a sabunta ka'idodin bincike don al'amuran da ake zargi da cutar  da al'amuran da aka tabbatar  COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga taƙaitaccen jagorar bincike da magani don sabon kamuwa da cutar coronavirus na 2019 (2019-nCoV), wanda ke ba da ƙwarewarmu da kuma shawarwari masu kyau don magance wannan annoba a duk duniya.
Koyaya, kamuwa da cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, don haka fahimtarmu da iliminmu suna ƙaruwa a hankali bisa sakamakon bincike na yanzu da ƙwarewar asibiti; don haka dabarun bincike da hanyoyin magani suma suna ci gaba da sabuntawa.
A cikin wannan wasiƙar, mun amsa ga tsokaci guda game da shawarwarinmu kuma mun ba da sababbin ka'idojin bincike don al'amuran da ake zargi da cutar da al'amuran da aka tabbatar bisa ga Shawarwarin Ganowa da Kula da COVID-19 (Safari na Bakwai) da Kwamitin Kiwon Lafiyar Kasa na kasar Sin ya fitar.
A watan Disamba na shekarar 2019, an sami sabon kamuwa da cutar coronavirus 2019 (2019-nCoV), wanda yanzu aka ba shi sunan hukuma na kamuwa da cutar coronavirus 2019 (COVID-19), kuma cutar ta kwayar cutar kanta an kira ta muguwar cutar numfashi mai tsanani 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta tsara taƙaitaccen jagorar bayani kuma ta buga shi a kan yanar gizo a kan mujallar binciken likitancin soja a ranar 6 ga Fabrairu, 2020.
Wannan littafin ya jawo hankalin mutane sosai.
Ka lura cewa COVID-19 sabuwar cuta ce, saboda haka fahimtarmu da iliminmu suna ƙaruwa a hankali bisa sakamakon bincike na yanzu da ƙwarewar asibiti; don haka dabarun bincike da hanyoyin magani suma suna ci gaba da sabuntawa.
Alal misali, daga ranar 16 ga Janairu zuwa 3 ga Maris, 2020, an buga littattafai bakwai na Shawarwarin Ganowa da Kula da COVID-19 da Kwamitin Kiwon Lafiya na kasar Sin (http://www.nhc.gov.cn/) ya wallafa, tare da wasu abubuwa da suka canza.
A kwanan nan, wani bincike da Zhou da abokan aikinsa suka yi ya ba da bayani game da shawarwarinmu, kuma sun ba da shawarwari masu sauƙi game da cututtuka bisa ga abin da aka gani a asibiti.
Wannan aikin ya ƙara sabon shaida mai amfani ga shawarwarinmu kuma ya ba da mahimman bayanai game da wannan annoba ta duniya.
Mun amince da muhimmancin aikin da suke yi kuma mun nuna godiyarmu.
Amma, bisa ga sabon fitowar Shawarwarin Ganowa da Kulawa don COVID-19 (Fitarwa ta bakwai) da kuma sakamakon binciken da ake yi, aikin su yana buƙatar sabuntawa.
Dangane da fitowar ta bakwai ta wannan takaddar (daga 3 ga Maris 2020). Don gudanar da bincike mai zurfi yayin tabbatar da yanayin shakku game da cutar, ya zama dole a haɗa kowane ɗayan abubuwan da ke cikin halayen tarihin cututtukan cututtuka tare da bayyanar cututtuka biyu:
Tarihin cututtuka: (1) tarihin tafiya ko kasancewa a Wuhan da kewayenta ko wasu yankuna da ke da cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) tarihin saduwa da marasa lafiya da ke da cutar SARS-CoV-2 (wanda ya sami gwajin nucleic acid mai kyau); (3) tarihin saduwa da marasa lafiya da zazzabi ko alamun numfashi daga Wuhan da kewayenta ko wasu yankuna da ke da cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) tarihin saduwa da rukunin mutanen da ke da tabbacin cutar (≥ 2 masu zazzabi ko alamun numfashi a cikin makonni 2 a cikin ƙananan wurare kamar aji ko gida, makaranta, ofis, da sauransu).
Bayyanar asibiti: (1) zazzabi mai zafi da / ko alamun numfashi; (2) bayyanar bayyanar COVID-19; (3) yawan adadin leukocytes na al'ada ko raguwa tare da rage adadin lymphocytes a farkon bayyanar cututtuka.
Yin ganewar asali don tabbataccen yanayin cutar ya kamata ya dogara ne akan yanayin da ake zargi da cutar tare da ɗayan waɗannan abubuwan pathogenetic ko serological, wato: (1) gwajin PCR na ainihi yana da kyau ga SARS-CoV-2; (2) cikakken tsarin kwayoyin cuta na kwayar cutar yana nuna daidaito mai yawa game da sabbin coronavirus; (3) sakamako mai kyau na gwajin ƙwayar cuta don ƙwayoyin cuta na IgM da IgG na SARS-CoV-2; ko canjin sakamako na gwaji daga mara kyau zuwa tabbatacce ga ƙwayoyin cuta na IgG na SARS-CoV-2, ko ƙaruwa aƙalla sau 4 a cikin fasfo na farfadowa dangane da yanayin yanayin yanayin da ya dace.
Hakanan za'a iya lura cewa a cikin na biyu (18 ga Janairu, 2020) da na uku (22 ga Janairu, 2020) na wannan takaddar an ƙara gwajin PCR a cikin ainihin lokacin don nucleic acid a cikin hanyoyin numfashi ko samfuran jini.
An ƙara maganin cututtukan cututtukan jini a fitowar ta huɗu (27 ga Janairu, 2020) da ta biyar (8 ga Fabrairu, 2020); sannan a fitowar ta bakwai an ƙara buƙatar tabbacin ƙwayar cuta.
Waɗannan canje-canjen sun dogara ne da ci gaba da aikin masu bincike don nemo mafi kyawun saiti don gano nucleic acid don saurin ganewar asali, da kuma nazarin samfuran da aka ɗauka daga hanyoyin numfashi, gami da ɗaukar jini, wanda ke haɓaka wadatar samfuran daban-daban da haɓaka sakamakon tabbatacce na gwaje-gwaje don takamaiman ƙwayoyin cuta a cikin ƙa'idodin tabbatar da cutar.
Amma, akwai ƙarin tabbaci da ke nuna cewa ya kamata a yi hankali sa'ad da ake kula da marasa lafiya da ba su da alamun cutar.
Saboda haka, taswirar hanyar da aka gabatar a cikin aikin Zhou da sauransu, ya kamata a sabunta, saboda a ciki, mutane ba tare da alamun asibiti ba, an rarraba su a matsayin ƙungiyar  low risk .
Har ila yau, tsarin kimantawa yana bukatar a sake gyara shi a cikin ƙarin gwaji da bincike.
A ƙarshe, muna fatan samun ƙarin hujjoji kai tsaye kuma muna gayyatar masu karatu su bar bayanan su.
Idan ya zo ga ganewar asali na "al'amuran da ake zargi da cutar" da kuma "al'amuran da aka tabbatar", muna ba masu karatu shawarar su bi umarnin da aka bayar a ƙasashen da suke.
Ƙungiyarmu za ta ci gaba da ba da shawarwari don taimaka wa mutane.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu sakamakon COVID-19  mafi girma a rana
A jiya Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu a rana daya sakamakon COVID-19.
Wannan shi ne adadin mutane da suka mutu a rana daya sakamakon cutar.
A jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton cewa an samu kamuwa da cutar 114 da ke gudana, da kuma 33 da suka warke a gida.
An samu mutuwar mutane 17 a cikin wannan hari.
A wani taron da aka yi a yanar gizo, Daraktan IEDCR, Dakta Mirjabi Sabrina Flora ta ce maza hudu da mace daya ne suka mutu.
Dokta Mirjabi ya ce, mutane biyu da suka mutu sun haura shekaru 60, biyu kuma suna tsakanin shekaru 51 zuwa 60, daya kuma yana da shekaru 41 zuwa 50.
Ta kuma ce duka mutanen biyu da suka mutu 'yan Dhaka ne.
A ranar 11 ga Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 a matsayin annoba.
Wani ma'aikacin asibitin ya shaida wa kamfanin dillancin labarai na Anadolu cewa, daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke jinya a asibitin Meitri na Kuwait.
A ranar Asabar, a cikin wani bidiyo da aka buga a yanar gizo, Ministan sufuri da gadoji na Bangladesh, Obaidul Quader ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
An dakatar da aikin sufuri na jama'a daga ranar 26 ga Maris kuma ya kamata a ci gaba a ranar Asabar, 4 ga Afrilu.
Har ila yau, an ba da izinin jigilar kayayyaki na yau da kullun  magunguna, mai da abinci .
An samu mutum biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu da cutar COVID-19 a ranar 8 ga Maris a Bangladesh.
A ranar 19 ga watan Maris, mutanen uku sun warke.
SARS-CoV-2 ya wuce miliyan daya a duniya
A cewar Jami'ar Johns Hopkins, a ranar Alhamis, yawan masu kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya.
Aƙalla mutane dubu 52 ne suka mutu sakamakon cutar COVID-19.
Wannan ya faru ne a ranar da aka tabbatar da cutar a Malawi da kuma mutuwar farko a Zambiya.
Koriya ta Arewa ta ce a ranar Alhamis ta kasance daya daga cikin kasashe kadan da ba a samu wani mutum da ya kamu da cutar coronavirus ba.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 a cikin sa'o'i ashirin da huɗu kafin karfe 10:00 na yammacin Turai (0800 UTC) a ranar 4 ga Afrilu.
A Amurka an samu mutane sama da dubu 244 da suka kamu da cutar coronavirus, kuma akalla 5,900 daga cikinsu sun mutu.
CBS News ta ruwaito bayanan Jami'ar Johns Hopkins cewa an samu mutuwar mutane sama da 1,000 a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
Kasashen duniya sun sanar da tsaurara matakan hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergey Sobyanin ya tsawaita dokar killace mutane har zuwa ranar 1 ga watan Mayu.
Tun da farko shugaban kasar Vladimir Putin ya ce duk 'yan kasar Rasha za su ci gaba da samun albashi har zuwa ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar da ta ba da izinin tsawaita dokar ta baci na kwanaki 15; sakamakon zaben: kuri'u 215 a, goma sun ki amincewa da kuri'a daya a.
Saudiyya ta tsawaita dokar hana fita a biranen Makka da Madina da rana guda, yayin da a baya dokar hana fita ta kasance daga karfe 3 na rana zuwa 6 na safe.
Thailand ta shirya kafa dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan jihar Ohio, Mike DeWine, ya sanar da cewa an tsawaita dokar killace mutane a gida har zuwa ranar 1 ga watan Mayu.
Shaguna a Ostareliya sun ƙayyade adadin takarda na bayan gida da za a iya saya a lokaci guda
A ranar Lahadi da Asabar da yamma, manyan kantunan sayar da kayayyaki na Woolworths da Coles na Australiya sun rage adadin takardar bayan gida da za a iya saya a lokaci guda a duk shagunan kasar zuwa biyu da daya.
A ranar Litinin, ALDI ta kuma sanya takunkumi kan kunshin daya.
An sanar da wannan ƙuntatawa a cikin tallace-tallace a kan kantin sayar da kaya da kuma shafin Facebook na cibiyar sadarwa.
An bayar da rahoton cewa 'yan ƙasa sun fara yin ajiyar gaggawa saboda tsoron cewa COVID-19 na iya haifar da aiwatar da keɓe kai gaba ɗaya.
A ranar Laraba, kamfanin sayar da takarda na Woolworths ya rage adadin takarda na bayan gida zuwa fakiti daya.
Tun da farko, a ranar 4 da 5 ga Maris, Woolworths da Coles sun riga sun iyakance wannan adadin zuwa fakiti 4.
Coles a cikin sanarwar manema labarai ta 8 ga Maris ta ce tare da iyakancewar fakiti hudu  a shaguna da yawa takardar bayan gida har yanzu tana sayarwa da sauri  kaya daya a cikin awa , kuma ta kira wannan buƙatar  ba a taɓa gani ba , yayin da ALDI a cikin wani sakon Facebook da aka buga a ranar Talata ya kira wannan yanayin  abin mamaki .
Wani wakilin kamfanin Woolworths ya ce, a makon da ya gabata, an samu ƙaruwa sosai a tallace-tallace.
A makon da ya gabata, kantin sayar da kayayyaki na Costco a Canberra ya rage adadin zuwa fakiti biyu.
Don cike rashi, Coles ya fara yin odar manyan batutuwa daga masu samarwa kuma ya ƙara yawan jigilar kayayyaki, Woolworths ya ba da umarnin ƙarin batutuwa, yayin da ALDI ta yi ajiyar kaya don tallace-tallace na musamman na farko a ranar Laraba.
Russell Zimmerman, darektan zartarwa na kungiyar masu sayar da kaya ta Australiya, ya ce masu sayar da kayayyaki suna kokarin sake cika kayayyaki amma hakan yana fuskantar matsaloli saboda takunkumin da hukumomin yankin suka yi kan jadawalin zirga-zirgar motocin hawa.
Yana tsammanin farashin kayayyaki zai ƙaru yayin da masu kawo kayayyaki suke ƙoƙarin biyan bukatar, amma ba sa samun isashen kayayyaki.
A ranar Talata, ALDI ta sanar da cewa wasu shaguna ba za su iya gudanar da tallace-tallace a ranar Laraba ba saboda karancin kayayyaki.
A wani rahoto da News.com.au ta wallafa, Dokta Gary Mortimer, wani masanin sayar da kayayyaki a Jami'ar Queensland na Fasaha, ya ce, ana cika shaguna da dare.
Ya ce takardar bayan gida abu ne mai girma, saboda haka, ajiyar kayan ajiya ba ta da yawa, kuma bayan an sayar da kayan, doguwar jerin ɗakunan suna zama fanko, suna ƙara jin ƙarancin kayan.
Coles da Woolworths sun yi imanin cewa idan za a iya cika ɗakunan ajiya, kuma za a iya sanya kayayyaki kamar takarda na bayan gida da kuma maganin kashe ƙwayoyin cuta a kan ɗakunan ajiya, masu sayen ba za su firgita ba, in ji Russell Zimmerman.
A ranar Laraba da ta gabata, wani kamfanin kera takarda na bayan gida mai suna Who Gives a Crap ya sanar da cewa kayayyakin da yake da su sun kare.
A cewar News.com.au, Kamfanin Kimberly-Clark, mai kera takardar wanka Kleenex da Solaris Paper, wanda kuma ke kera kayayyakin Sorbent, sun ce suna aiki a kowane lokaci don samar da isasshen kayayyaki.
Domain.com, wani shafin yanar gizon sayar da gidaje, ya ruwaito cewa lokacin da farashin gwanjo a Melbourne ya ragu saboda rashin masu sayayya a ranar ranar ranar aiki, wasu masu sayar da gidaje sun fara ba da takarda na kyauta ga masu sayarwa na farko.
Na huɗu na jaridar NT News da ake bugawa a Darwin ya ƙunshi shafi takwas da aka yi amfani da su a matsayin takarda na bayan gida.
A cewar rahoton ABC Australia na ranar 3 ga Maris, a farko shagunan ba su son sanya iyaka kan yawan kayan da ake saya, suna cewa ba su da niyyar yin hakan.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna da bukatar, ciki har da masks na likita, kayan kashe kwayoyin cutar hannu, kayan kwalliya, kayan wanke hannu da gari.
Hakazalika, ban da abubuwan da suka faru a Ostiraliya, a ranar Lahadi da yamma an lura cewa kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kayan sayar da kayan sayar da kayan sayar da kayan
Hukumar Lafiya ta Duniya ta ayyana cutar COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta sanar da cutar COVID-19 da ke haifar da cutar coronavirus SARS-CoV-2 a matsayin annoba.
Duk da cewa kalmar annoba tana nuna girman cutar ne kawai, ba haɗarin takamaiman lokuta ba, WHO ta ce gwamnatocin ƙasashe suna buƙatar ɗaukar matakan:
Dukkanin kasashen duniya suna da damar yin tasiri a kan cutar 
Wannan zai yiwu idan kasashe suka yi aiki tare wajen ganowa, gwaji, magani, killace mutane, lura da cutar, da kuma tattara 'yan kasarsu", in ji Darakta Janar na WHO, Tedros Adhanom Ghebreyesus.
Muna matukar damuwa game da yadda cutar ke yaduwa da kuma yadda take da tsanani, da kuma yadda ba a yi wani abu game da ita ba.
Dokta Tom Friedan, tsohon darektan Cibiyar Kula da Cututtuka ta Amurka, ya ce wannan annoba "ba ta da misali".
Ya ce a wata hira da aka yi da CNN a watan Fabrairu cewa babu wata kwayar cutar numfashi da aka gano banda mura tun lokacin da ta fara zuwa ci gaba da yaduwa a duniya.
Mista Gebreyesus ya bayyana irin wannan ra'ayi, yana cewa ba mu taɓa ganin annobar da cutar coronavirus ta haifar ba.
Ba mu taɓa ganin annobar da za a iya sarrafawa ba.
Da farko, a watan Janairu, Hukumar Lafiya ta Duniya ta bayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a da ke da muhimmanci a duniya, sannan ta sake ba ta sabon matsayi na  annoba.
Dokta Anthony Fauci, darektan Cibiyar Kula da Cututtuka da kuma Ciwon Ƙwayoyin cuta ta Amirka, ya ce: "Wannan ne kawai farkon annobar.
A cewar Associated Press, a ranar Alhamis, an samu aƙalla mutane 126,000 da suka kamu da cutar COVID-19, kuma sama da 4,600 sun mutu.
Cutar kwayar cutar coronavirus ta 20192020  annobar cutar coronavirus ta 2019 (COVID-19) ce a halin yanzu, wacce cutar coronavirus ta haifar da mummunan ciwon numfashi mai tsanani-2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, kuma a ranar 30 ga Janairun 2020, an ayyana gaggawa ta lafiyar jama'a ta duniya, wanda daga baya, a ranar 11 ga Maris, 2020, an amince da cutar.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, kuma kusan mutane 97,000 ne suka mutu.
Mutane kusan 364,000 sun warke.
Yawan mutuwar a kasar Sin ya kai kashi 4 cikin dari, yayin da a duniya ya bambanta daga 13.04% a Algeria zuwa 0.08% a New Zealand.
Alamun da aka fi gani a cikin wannan yanayin su ne zazzabi, tari, da kuma numfashi cikin wuya.
Ƙari ga haka, za a iya samun ciwon huhu da kuma ciwon sanyin jiki.
Lokaci daga farkon bayyanar cututtuka zuwa lokacin da cutar ta kai matsakaicin lokaci yawanci kwanaki biyar ne, amma kuma zai iya zama daga kwana biyu zuwa goma sha huɗu.
A yanzu haka, ba a gano wata riga ko magani na musamman ba.
Maganin farko shine bayyanar cututtuka da kuma kulawa. Matakan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki lokacin tari, kiyaye nesa tsakanin mutane, ganowa da tabbatar da keɓewar kai ga mutanen da suke da shakkar kamuwa da cutar.
Hukumomi a duk duniya sun amsa wannan matsalar ta hanyar sanya takunkumin tafiya, keɓewa, dokar hana fita, kula da haɗarin aiki da rufe wurare.
Cutar ta haifar da mummunan tasirin tattalin arziki da zamantakewar duniya, jinkirta ko soke ayyukan wasanni, addini, siyasa da al'adu, da kuma ƙarancin kayayyaki da yawa, wanda ya haifar da tashin hankali.
An rufe makarantu da jami'o'i a ƙasashe 193 ko kuma a yankuna, kuma hakan ya shafi kashi 99.4 cikin ɗari na ɗaliban duniya.
An fara yada labaran karya game da cutar a yanar gizo, akwai kuma nuna kyamar baki da nuna bambanci ga 'yan kasar Sin, da sauran mutanen Gabas da kudu maso gabashin Asiya, ko kuma mutanen da suke kama da su a waje, da kuma sauran kungiyoyin mutane da ke zaune a yankunan da cutar ta fi yaduwa.
Saboda rage yawan tafiye-tafiye da kuma rufe masana'antun masana'antu, munanan abubuwa da ke cikin iska da kuma iskar carbon sun ragu.
A ranar 31 ga Disamba, 2019, hukumomin kiwon lafiya na Wuhan (babban birnin lardin Hubei), China, sun ba da rahoton cewa akwai wasu cututtukan huhu da ba a san dalilin su ba, kuma a farkon Janairu, 2020, an fara binciken lamarin.
Yawancin masu kamuwa da cutar sun kasance a cikin kasuwar sayar da abincin teku ta Huan'an, don haka ana tsammanin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar an san ta da SARS-CoV-2. Wannan sabuwar kwayar cuta ce da aka gano kwanan nan wacce ke da kamanceceniya da kwayar cutar coronavirus na bat, kwayar cutar coronavirus na pangolin da SARS-CoV. Daga baya an gano cewa farkon cutar ta faru ne a ranar 1 ga Disamba, 2019, kuma mai cutar bai ziyarci kasuwa ba bayan wannan ranar.
Kashi biyu bisa uku na masu kamuwa da cutar da aka samu a watan Disamba na shekarar 2019 sun shafi wannan kasuwa.
A ranar 13 ga watan Maris, 2020, wata sanarwa da jaridar Morning Post ta kasar Sin ta fitar, wadda ba a tabbatar da ita ba, ta yi hasashen cewa mutum 55 ne ya kamu da cutar a lardin Hubei a ranar 17 ga watan Nuwamba, 2019. A ranar 26 ga watan Fabrairun, 2020, WHO ta ce yawan sabbin masu kamuwa da cutar a kasar Sin ya ragu, amma ya karu ba zato ba tsammani a Italiya, Iran da Koriya ta Kudu, kuma adadin sabbin masu kamuwa da cutar a wajen kasar Sin ya zarce adadin sabbin masu kamuwa da cutar a kasar Sin a karon farko.
Yawan mutanen da ke fama da cutar zai iya zama ƙasa da yadda ake gani, musamman ma saboda yawan mutanen da ba su da alamun cutar sosai.
A ranar 26 ga Fabrairu, an samu ƙananan cututtukan a tsakanin matasa, tare da marasa lafiya masu shekaru 19 zuwa ƙasa da ƙasa da kashi 2.4% na cututtukan a duk duniya.Babban mai ba da shawara kan kimiyya na Burtaniya Patrick Vallance ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su kamu da cutar kafin a samar da ingantaccen garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garkuwar garku
Ƙididdigar ta haɗa da mutanen da aka gwada su don COVID-19 kuma suka gwada su da kyau bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga watan Maris, babu wata ƙasa da ta iya gwada fiye da kashi 3 cikin ɗari na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland sun kafa ƙa'idodin hukuma da ke hana yin gwaji idan sun nuna alamun rashin lafiya.
Binciken da aka buga a ranar 16 ga watan Maris ya nuna cewa har zuwa ranar 23 ga watan Janairu, kashi 86 cikin 100 na masu kamuwa da COVID-19 ba a gano su ba a kasar Sin, kuma irin waɗannan marasa lafiya da ba a yi rajista da su ba sun zama tushen kamuwa da kashi 79 cikin 100 na masu kamuwa da cutar.
Binciken kididdiga da aka buga a ranar 30 ga Maris ya nuna cewa adadin masu kamuwa da cutar a Italiya ya fi yawan adadin da aka samu.
Aƙalla, ƙididdigar asali na yawan masu kamuwa da cutar (R0) a kan COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa wannan adadin zai iya kaiwa 5.7.
Yawancin marasa lafiya da ke da COVID-19 suna murmurewa.
A wasu lokuta, lokacin da alamun cutar suka fara bayyana har zuwa lokacin mutuwa ya kasance daga kwanaki 6 zuwa 41, mafi yawan lokuta kwanaki 14.
A ranar 10 ga Afrilu, 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A kasar Sin, a ranar 5 ga watan Fabrairu, kusan kashi 80 cikin 100 na mutuwar mutane sun kai shekaru 60 da haihuwa, kuma kashi 75 cikin 100 na wadanda suka mutu suna da cututtuka masu kama da cututtukan zuciya da ciwon sukari.
Adadin mutanen da suka mutu da COVID-19 na iya zama mafi girma saboda ƙididdigar hukuma na iya ƙyale mutanen da suka mutu ba tare da yin gwaji ba  misali, idan sun mutu a gida, gidajen tsofaffi, da sauransu.
Bayanai marasa cikakke a Italiya sun nuna cewa ainihin adadin mutuwar a lokacin annobar ya wuce adadin COVID da aka bayar sau 45.
Wani mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ya yarda: Mun san cewa [adadin da aka bayyana] ya fi ƙasa da yadda yake.
An samu mutuwar farko a waje da kasar Sin a ranar 1 ga watan Fabrairu a Philippines, kuma a waje da Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da goma a kasashen Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, fiye da ƙasashe arba'in da yankuna a duk nahiyoyi sai Antarctica sun ba da rahoton mutuwar.
Dukkanin alamomi sun bambanta dangane da yanki da lokacin yaduwar cutar; Hakanan ana iya yin tasiri da su ta hanyar gwadawa, ingancin tsarin kiwon lafiya, tsarin kula da magani da aka yi amfani da shi, lokacin da cutar ta fara, da kuma sigogin yawan jama'a kamar shekaru, jinsi da yanayin lafiyar gaba ɗaya.
Dangane da ƙididdigar Jami'ar Johns Hopkins, a ranar 10 ga Afrilu, 2020, yawan mutuwar duniya da kamuwa da cutar ya kai kashi 6.0% (97 039/1 617 204).
Amma, yawan mutanen da ke wannan yankin ya bambanta.
A kasar Sin, yawan mace-macen da ke mutuwa ya ragu daga kashi 17.3% (ga wadanda suka kamu da cutar a ranar 110 ga Janairu, 2020) zuwa kashi 0.7% (ga wadanda suka kamu da cutar bayan ranar 1 ga Fabrairu, 2020). Sauran hanyoyin sun hada da tantance yawan mace-macen da ke haifar da cutar (CFR)  yawan marasa lafiya da aka gano da cutar da ke mutuwa daga cutar, da kuma yawan mace-macen kamuwa da cuta (IFR), wanda ke nuna yawan masu kamuwa da cutar (duka wadanda aka gano da wadanda ba a gano su ba) da ke mutuwa daga cutar.
Waɗannan ƙididdigar ba su da alaƙa da lokaci kuma suna nuna ƙididdigar wasu rukunin mutane daga lokacin kamuwa da cutar har zuwa ƙarshen cutar.
Wasu masana kimiyya sun yi ƙoƙari su ƙididdige waɗannan ƙididdigar a kan wasu mutane.
A cewar cibiyar binciken da aka yi a Jami'ar Oxford, yawan mace-mace da ke mutuwa daga cutar ya kai kashi 0.1 zuwa 0.39 cikin dari.
Adadin da ke sama ya yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus da kuma binciken da aka yi don nazarin tasirin gwajin akan ƙimar CFR.
Hukumar Lafiya ta Duniya ta ce za a iya sarrafa annobar.
Ba za a iya sanin ainihin lokacin da za a yi ɓarkewar ba kuma zai iya bambanta dangane da wurin da aka yi ɓarkewar.
Wani mai bincike a Jami'ar Pennsylvania, mai suna Boney, ya ce: "Abubuwan da ba a sarrafa su ba sukan soma ɓarkewa, kuma idan masu ɗauke da cutar suka ƙare, sai su soma ƙarewa.
Amma a yanzu, ba zai yiwu a yi wani kyakkyawan zato ba game da lokacin da hakan zai faru.
Babban mai ba da shawara kan harkokin lafiya na gwamnatin kasar Sin, Zhong Nansheng ya ce "za a iya kawo karshen cutar nan da watan Yuni" idan dukkan kasashen duniya suka yi aiki tare don bin shawarwarin WHO kan yadda za a dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Yankin Gishi na London ya ce SARS-CoV-2 zai yi yawo, wataƙila a cikin shekara ɗaya ko biyu.
A cewar wani bincike da kwalejin Imperial College ta gudanar karkashin jagorancin Neil Ferguson, "har sai an samar da allurar rigakafi (wataƙila watanni 18 ko sama da haka) " za a buƙaci kiyaye nesa da sauran matakan.
William Schaffner, wani ma'aikaci a Jami'ar Vanderbilt ya ce: "Ba na tsammanin wannan cutar za ta taɓa ɓacewa gaba ɗaya, domin tana da saukin yaduwa kuma tana iya zama cuta ta yanayi, tana ɓarkewa kowace shekara".
Yadda cutar za ta yi tsanani zai dangana ne a kan yadda mutane suke da rigakafi da kuma yadda suka kamu da cutar.
Alamomin COVID-19 na iya zama marasa ƙayyadaddun, kuma wasu mutane masu kamuwa da cutar na iya ɗaukar cutar ba tare da alamomi ba.
Alamun biyu da suka fi yawa sune zazzabi (88%) da tari mai bushe (68%).
Alamomin da ba a saba gani ba sun haɗa da gajiya, ƙwayoyin cuta a cikin hanyoyin numfashi (mucous), rashin wari, numfashi, ciwo a cikin tsokoki da haɗin gwiwa, ciwon makogwaro, ciwon kai, rawar jiki, amai, zubar da jini, zawo ko cyanosis.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ciwo mai ɗorewa ko jin matsi a kirji, kwatsam rashin fahimta, wahalar farkawa da launin shuɗi na fuska ko lebe. Idan akwai waɗannan alamun ya kamata a nemi taimakon likita nan da nan. Ci gaba da cutar na iya haifar da ciwon huhu mai tsanani, ciwon damuwa na numfashi mai tsanani, sepsis, septic shock da mutuwa.
Wasu mutane da suka kamu da cutar ba su da alamun cutar, amma sakamakon gwajin ya nuna cewa suna da cutar, saboda haka likitoci sun ba da shawarar sanya mutanen da ke kusanci da marasa lafiyar da aka tabbatar da cutar a ƙarƙashin kulawa mai tsanani da kuma bincika su don cutar.
Masana kimiyya na kasar Sin sun kiyasta cewa yawan mutanen da ba su nuna alamun cutar ba sun kai kashi 44 cikin dari.
Lokacin da aka saba da shi (lokacin da ke tsakanin kamuwa da cutar da bayyanar cututtuka) ya bambanta daga kwana ɗaya zuwa 14; yawanci kwanaki biyar ne. Har yanzu ba a bayyana cikakkiyar bayyanar cututtuka game da asarar ƙanshi ba: a ƙididdigar farko, yawan marasa lafiya na COVID-19 waɗanda suka sami wannan bayyanar cututtuka ya fara zama 30% sannan ya ragu zuwa 15%.
Har yanzu ba a san yadda cutar ke yaduwa ba.
Ana ganin cewa cutar tana yaduwa ne ta hanyar kusanci da kuma ta hanyar ƙananan ɗigon ruwa da ke fitowa cikin iska tare da tari, hancin ko yayin magana; kusanci yana nufin kusanci a cikin radius daga mita 1 zuwa 2 (daga ƙafa 3 zuwa 6).
Wasu bincike sun nuna cewa idan mutum ya yi tari a fili, zai iya yin hakan daga nisan mita 15 zuwa mita 8.2.
Akwai hasashe cewa kwayar cutar za ta iya yaduwa ta hanyar ƙananan ɗigon ruwa da aka fitar a cikin iska yayin magana, wanda zai iya kasancewa cikin iska na tsawon lokaci.
Sa'ad da mutane suke kusa da ku, za su iya samun ruwa a bakinsu ko kuma hancinsu.
Wasu hanyoyin magani kamar su intubation da CPR na iya haifar da yayyafa kayan numfashi kuma hakan yana haifar da yaduwar kwayar cutar a cikin iska.
Ƙari ga haka, zai iya shiga jiki idan mutum ya taɓa wani abu da ya ƙazantu, har da fatar jiki, sai ya taɓa idanunsa ko hancinsa ko bakinsa.
Akwai kuma tsoron cewa za a iya yada kwayar cutar ta hanyar bargo, amma ana ganin cewa wannan hanyar ba ta da haɗari.
Gwamnatin China ta musanta yiwuwar yaduwar SARS-CoV-2 ta baki da ƙura. Kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Akwai lokutan da gwajin ya nuna cewa mutum yana da cutar kafin ya fara nuna alamun cutar, kuma hakan ya nuna cewa mutum zai iya kamuwa da cutar kafin ya soma nuna alamun cutar.
Akwai rahotanni kaɗan kawai game da wasu lokuta da aka tabbatar da cutar ba tare da alamun cutar ba, amma binciken da aka yi a wasu ƙasashe ya nuna cewa akwai wasu mutane da ke da cutar.
Ma'aikatan Cibiyar Kula da Cututtuka ta Turai (ECDC) sun ce ba a san yadda cutar ke yaduwa ba, amma an san cewa mutum ɗaya da ke da cutar yakan kamu da mutane 2  3. Kwayar cutar na iya rayuwa a kan abubuwa na tsawon sa'o'i da yawa zuwa kwanaki da yawa.
Musamman, an gano cewa a kan filastik (polypropylene) da bakin karfe (304) kwayar cutar na iya rayuwa har zuwa kwanaki uku, a kan kwali  na tsawon rana guda, kuma a kan tagulla  har zuwa awanni 4.
Amma, waɗannan ƙididdigar sun bambanta dangane da yanayin zafi da zafi.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar ga mutane, ko da yake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun taɓa dabbobi, kamar yadda suke yi bayan sun taɓa wasu abubuwa da mutane masu cutar za su iya taɓa su.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin alamun sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin yanayi a cikin coronaviruses masu alaƙa. A waje da jikin mutum ana iya kashe kwayar cutar ta hanyar sabulu na gida wanda ke narkar da murfin kariya. SARS-CoV-2 yana da kamanceceniya da kwayar cutar SARS-CoV ta asali.
An ce ya fito ne daga dabbobi.
Binciken kwayoyin cutar coronavirus ya nuna cewa yana da nasaba da kwayoyin halitta tare da Betacoronavirus, wani nau'in Sarbecovirus (layin kwayar halitta B) tare da wasu nau'ikan ƙwayoyin cuta biyu na ƙwayoyin cuta.
A matakin kwayoyin halitta, ya kasance daidai da sauran samfuran kwayar cutar coronavirus na bat (BatCov RaTG13) da kashi 96%.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya kawai a cikin amino acid na wasu sassan tsarin kwayoyin halittar kwayar cutar pangolin da na mutum.
Kwatanta kwayoyin halittar mutum da kwayoyin halitta ya nuna cewa mafi yawan kamanceceniya (92%) tsakanin kwayar cutar ta coronavirus da SARS-CoV-2 amma wannan bai isa ya tabbatar da cewa pangolins sune masu karɓar kwayar cutar ba.
Ana iya gano kamuwa da cutar ta hanyar alamomi, amma a ƙarshe ana iya tabbatar da hakan ta hanyar nazarin ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ko ta hanyar kwamfuta.
Sakamakon binciken da ya kwatanta PCR da CT da aka yi amfani da su a Wuhan ya nuna cewa CT ya fi PCR hankali sosai, ko da yake ba shi da ƙayyadaddun bayani, saboda yawancin ayyukansa na gani sun dace da sauran cututtukan huhu da kuma cututtuka.
Tun daga watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar kada a yi amfani da CT don tantancewa ko a matsayin hanyar gwaji ta farko don gano COVID-19.
WHO ta wallafa wasu takardun gwajin RNA don SARS-CoV-2, kuma na farko an buga shi a ranar 17 ga Janairu.
Ana gwada gwajin polymerase a cikin lokaci na ainihi (RT-PCR).
Ana iya yin hakan ta wajen yin gwajin numfashi da kuma jini.
Sakamakon gwajin yakan kasance cikin sa'o'i da yawa ko kuma kwanaki.
Ana amfani da maganin shafawa daga hanci, ko da yake ana iya amfani da maganin shafawa daga zakara.
A ranar 6 ga Afrilu, 2020, babu wani daga cikinsu da ya isa ya sami amincewa don amfani da shi ko'ina.
A Amirka, an amince da gwajin ƙwayar cuta da Cellex ya yi don yin amfani da shi a cikin gaggawa kawai a cikin dakunan gwaje-gwaje masu ƙwarewa.
Abubuwan da ke nuna alamun bayyanar cututtuka a kan radiyo da kuma CT (CT) sune asymmetrical peripheral blurredness a cikin nau'in gilashin gilashi da kuma rashin ƙwayar pleural.
Ƙungiyar Radiology ta Italiya tana shirya bayanan hotuna na duniya na waɗanda suka kamu da cutar.
Saboda kamanceceniya da sauran cututtuka kamar adenovirus, hotunan da ba a tabbatar da su ta hanyar gwajin PCR ba suna da iyakantaccen takamaiman asibiti don gano COVID-19.
Wani babban bincike da aka yi a ƙasar Sin ya gwada sakamakon CT na kirji da na PCR, kuma ya nuna cewa ko da yake hotuna ba su da ƙayyadaddun cututtuka, amma suna da saurin ganewa, kuma suna da ƙwarewa sosai, saboda haka, ana iya yin amfani da wannan hanyar bincike don gano cututtuka a wuraren da suke da cutar.
An yi amfani da na'urar kwakwalwa don gano cutar ta hanyar yin amfani da hotuna na X-ray da na kwamfuta.
Dabaru na hana yaduwar cutar sun hada da kiyaye tsabtar jiki, wanke hannu, kauce wa taɓa idanu, hanci ko baki da hannuwan da ba su da tsabta, amfani da tawul lokacin tari ko hancin da ya kamata a zubar da shi nan da nan bayan amfani.
Ya kamata waɗanda suka kamu da cutar su sanya abin rufe fuska a wuraren da jama'a suke.
Don hana yaduwar cutar, an kuma ba da shawarar nisantawa da mutane. Gwamnatoci da yawa suna ba da shawarar guje wa duk wani balaguron da ba na gaggawa ba zuwa ƙasashe da yankuna da cutar ta shafa, kuma suna iyakance motsin jama'a.
Duk da haka, cutar ta yi nasara wajen yaɗuwa a yawancin yankuna na duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa tsakanin jama'a, wasu daga cikinsu ba su san inda ko yadda suka kamu ba. Ana ba da shawarar ma'aikatan kiwon lafiya da ke kula da marasa lafiya da za su iya kamuwa da cutar su yi amfani da matakan kariya na yau da kullun, da kuma matakan kariya na hulɗa da wasu mutane da kayan kariya na ido. Binciken hulɗa ma hanya ce mai mahimmanci da hukumomin kiwon lafiya ke amfani da ita don gano asalin kamuwa da cuta da hana ta ci gaba da yaduwa.
Amfani da gwamnatoci na amfani da bayanan wurin da mutane ke ciki ta hanyar wayoyin salula don wannan dalili ya haifar da damuwa game da tsare sirri, kuma kungiyoyi kamar Amnesty International da wasu kungiyoyi sama da 100 sun yi kira da a takaita wannan nau'in sa ido.
An tsara da kuma ba da aikace-aikacen wayoyin hannu daban-daban don amfani da son rai; kamar yadda na 7 ga Afrilu 2020 sama da ƙungiyoyin masana goma suna aiki kan samar da mafita don tabbatar da sirrin bayanan sirri  misali, yin rijistar kusanci ga mai amfani da wasu wayoyin hannu ta hanyar fasahar Bluetooth.
Idan mai amfani da wayar hannu ya kasance kusa da wanda ya gwada COVID-19 mai kyau, za a sanar da shi. Akwai kuma maganganu marasa tushe game da yadda za a hana kamuwa da cutar  kamar shafa hanci da baki, wanda a zahiri ba shi da tasiri.
A yanzu babu riga-kafin COVID-19, ko da yake ƙungiyoyi da yawa suna aiki a kan samar da ita.
Don hana yaduwar cutar, ana ba da shawarar wanke hannu.
Cibiyar Kula da Cututtuka ta Amirka (CDC) ta kuma ba da shawarar cewa a riƙa wanke hannuwanku da sabulu da ruwa aƙalla na dakika 20, musamman bayan kun je bayan gida ko kuma idan hannuwanku sun ƙazantu sosai, kafin ku ci abinci, bayan kun hũra, kuka ko kuma kun yi hancin jini.
Wannan yana da muhimmanci domin bayan ya fita daga jikin mutum, sabulu yana kashe shi kuma yana buɗe murfinsa.
Bugu da ƙari, idan sabulu da ruwa ba su da yawa, CDC ta ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu da ke da barasa da kashi 60 cikin ɗari.
Hukumar Lafiya ta Duniya ta ce kada mutane su taɓa idanunsu da hancinsu da bakinsu da hannuwan da suka ƙazantu.
Za a iya kashe kwayoyin cuta da dama (a kan farfajiyar da ba ta da tsatsa ba ta fara aiki bayan minti daya bayan an yi amfani da shi) tare da 6271% ethanol, 50100% isopropanol, 0,1% sodium hypochlorite, 0,5% hydrogen peroxide da 0,2 7,5% povidon-iod.
Wasu abubuwa kamar su benzalkonium chloride da chlorhexidine gluconate ba su da amfani sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko an tabbatar da cutar COVID a cikin wani wuri kamar ofis ko asibiti, duk wuraren da ke cikin irin wannan wurin, gami da dakunan aiki, dakunan wanka, wuraren amfani da jama'a, kayan aikin lantarki kamar su allunan kwamfuta, allon taɓawa, mabuɗan rubutu, na'urorin sarrafawa ta nesa da ATM da marasa lafiya ke amfani da su, su kashe ƙwayoyin cuta.
Ƙungiyoyin kiwon lafiya sun ce idan mutum yana tari ko hancinsa, ya rufe bakinsa da wuyansa da wuyan hannu ko kuma ya zubar da kayan tsabtace jiki da ya yi amfani da su nan da nan.
Ana ba da shawarar masu kamuwa da cutar su yi amfani da abin rufe fuska na likita saboda amfani da abin rufe fuska na iya iyakance yawan da kuma yaduwar abubuwan da ke cikin iska yayin magana, hancinsa da tari.
Hukumar Lafiya ta Duniya ta ba da umurni game da lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin kwayoyin cuta a Jami'ar Leeds, yin amfani da abin rufe fuska na iya rage sha'awar mutane su taɓa fuskokinsu, kuma taɓa fuska da hannayen datti  shine babbar hanyar kamuwa da cuta. Ana kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da mutanen da za su iya kamuwa da cutar.
WHO ta ba da shawarar cewa mutane masu lafiya su sa abin rufe fuska ne kawai idan suna cikin haɗari, kamar waɗanda ke kula da wanda ke da COVID-19, ko da yake ta kuma yarda cewa yin amfani da abin rufe fuska yana rage yawan taɓa fuska.
Kasashe da dama sun fara yin kira ga amfani da abin rufe fuska a wuraren jama'a.
Cibiyoyin CDC, Amurka, sun ba da shawarar sanya abin rufe fuska na masana'anta don dalilai marasa lafiya. China ta ba da mahimmanci game da mahimmancin amfani da abin rufe fuska na likita da lafiyayyu ke amfani da su, musamman idan suna cikin kusanci (mita 1 (ƙafa 3) ko ƙasa da haka) tare da wasu mutane.
A Hong Kong, ana ba da shawarar saka abin rufe fuska a cikin sufuri na jama'a ko wuraren da jama'a ke zaune.
Jami'an kiwon lafiya a Thailand sun bukaci mutane su yi abin rufe fuska a gida kuma su wanke su kowace rana.
A Jamhuriyar Czech da Slovakia, an hana mutane fita waje ba tare da rufe baki da hanci ba.
A ranar 16 ga watan Maris, gwamnatin Vietnam ta nemi dukkan 'yan kasar da su sanya takunkumin rufe fuska a wuraren da jama'a ke don kare kansu da kuma wasu.
Gwamnatin Austriya ta tilasta wa duk masu cin abinci su sanya abin rufe fuska.
Gwamnatin Isra'ila ta kuma nemi 'yan kasar da su sanya takunkumin rufe fuska a wuraren taruwar jama'a.
A ranar 1 ga Afrilu, Taiwan, inda aka samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta umurci duk fasinjojin jiragen kasa da na bas da su yi amfani da abin rufe fuska.
A Panama, an tilasta wa mazauna su sanya abin rufe fuska na likita idan sun fita waje; an shawarci mazauna da ba za su iya sayen abin rufe fuska ba su yi wa kansu a gida.
Hakanan ana amfani da masks na likita ta hanyar mazauna Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa tsakanin mutane (wanda aka fi sani da nisantar jiki)  wani mataki ne na hana kamuwa da cuta da ke nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Ƙuntatawa na tafiya, rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da kuma manyan shaguna suna cikin matakan tsaro.
Mutane za su iya yin amfani da matakan nisantar da kansu ta hanyar kasancewa a gida, ƙuntata tafiye-tafiye, guje wa wuraren da jama'a suke, yin gaisuwa ba tare da tuntuɓar juna ba da kuma nisantar da kansu daga wasu.
Gwamnatoci da yawa a yankuna da cutar ta fi shafa yanzu suna ba da umarni ko kuma ba da shawarar nisantar jama'a.
An rage yawan mutane da za su iya taruwa a wuri guda bisa ga shawarar hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka daga mutane 250 (a yankunan da babu rahoton yaduwar COVID-19), zuwa 50 kuma daga baya zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taruwa a cikin ƙungiyoyi da suka haɗa da mutane fiye da biyu. Tsofaffi da mutanen da ke fama da cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini da kuma raunana tsarin garkuwar jiki suna fuskantar haɗarin kamuwa da cutar a cikin mummunan yanayi. CDC ta ba su shawarar su zauna a gida har tsawon lokacin da zai yiwu idan akwai barkewar cutar a yankin. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar  nesa ta zamantakewa  da  nesa ta jiki , don haka suna bayyana manufar wannan matakin  don rage hulɗar jiki a cikin alaƙar zamantakewa, ko ta hanyar sadarwar kan layi ko ta hanyar nisantar jiki.
Amfani da kalmar "nisanci" an fahimci cewa mutane su yi wa kansu cikakken keɓewa ta zamantakewa maimakon kasancewa tare da wasu ta wasu hanyoyi. Wasu hukumomi sun buga jagororin kiwon lafiyar jima'i da za a yi amfani da su a lokacin annobar.
Wasu shawarwari da aka bayar su ne cewa ka yi jima'i da abokan zamanka kawai, waɗanda kake zama tare da su kuma ka tabbata cewa ba su da cutar da kuma alamun cutar.
Ana ba da shawarar cewa mutanen da ke da cutar COVID-19 da waɗanda ake zargi da kamuwa da cutar su keɓe kansu a gida.
Cibiyoyin kiwon lafiya sun wallafa cikakken bayani game da yadda za a ware kansu. Gwamnatocin ƙasashe da yawa sun kuma tilasta ko kuma sun ba da shawarar cewa dukan mutanen da ke yankunan da cutar ta shafa su ware kansu.
An ba da umarnin a keɓe mutanen da ke cikin rukunin masu haɗari sosai.
An shawarci mutanen da wataƙila sun taɓa yin hulɗa da waɗanda ke da cutar COVID-19, ko kuma waɗanda suka ziyarci wata ƙasa ko yanki da cutar ta shafa sosai, su keɓe kansu na kwanaki 14 daga lokacin da suka taɓa yin hulɗa.
Hanyoyin magance cutar sun haɗa da hana yaduwar cutar, hana ta ko kuma rage ta.
Ana hana yaduwar cutar a farkon matakan kuma yana da nufin bin diddigin da kewaye da masu cutar, kuma yana nufin wasu matakan kula da kamuwa da cuta da allurar rigakafi don dakatar da yaduwar cutar tsakanin sauran jama'a.
A lokacin da ba za a iya hana yaduwar cutar ba, ana ƙoƙarin rage tasirin: ana ɗaukar matakan da za su rage yaduwar cutar da kuma rage tasirin cutar a kan tsarin kiwon lafiya da al'umma.
Ana iya yin amfani da matakan hana yaduwar cutar da kuma rage tasirin cutar a lokaci guda.
Dakatar da kamuwa da cuta yana buƙatar ƙarin matakan gaggawa don juya cutar ta hanyar rage ƙimar ƙwayoyin cuta zuwa ƙasa da 1. Wani ɓangare na ƙoƙarin sarrafa ɓarkewar cutar mai saurin yaduwa yana nufin rage ƙimar cutar, wanda aka sani da daidaitawar cutar.
Irin wannan ƙoƙarin yana rage haɗarin cunkoson ayyukan kiwon lafiya kuma yana ba da ƙarin lokaci don samar da alluran rigakafi da hanyoyin magani.
Abubuwan da ba magunguna ba waɗanda za su iya taimakawa wajen magance barkewar cutar sun haɗa da matakan rigakafin mutum kamar tsabtace hannu, amfani da abin rufe fuska na likita da keɓewa; matakan zamantakewar da ke nufin nisantar da jiki kamar rufe makarantu da soke taron jama'a; samun al'umma don taimakawa da shiga cikin aiwatar da irin waɗannan matakan; da kuma matakan kare muhalli kamar tsabtace farfajiyoyi.
Sauran ƙasashe ma sun ɗauki wasu matakan da za su rage yaduwar cutar.
A Koriya ta Kudu, an kafa allurar rigakafi da kuma keɓewar wurare, kuma an kafa tsarin sanar da motsi na masu cutar.
A Singapore, an ba da tallafi na kuɗi ga waɗanda suka kamu da cutar da ke keɓe kansu kuma an ba da manyan tarar waɗanda ba su yi hakan ba.
A Taiwan, an kara samar da abin rufe fuska na likita kuma an ci tarar masu tara magunguna da yawa.Game da samfurin Burtaniya da Amurka, an nuna cewa akwai matsaloli masu tsanani game da ragewa (ragewa amma ba dakatar da yaduwar cutar ba) da kuma hanawa (dakatar da ci gaban cutar).
Manufofin da suka dace don rage yaduwar cutar za su iya rage yawan cutar da kashi biyu bisa uku, kuma mutuwar ta ninka, amma har yanzu yana iya haifar da dubban dubban mutuwar da kuma rushewar tsarin kiwon lafiya.
Za a iya yin amfani da maganin hana yaduwar cutar, amma ya kamata a yi amfani da shi har sai cutar ta yi yawo a cikin jama'a (ko kuma har sai an samar da allurar rigakafi, idan ta zo da wuri), in ba haka ba cutar za ta sake yaduwa da sauri idan an sassauta matakan.
Yin aiki na dogon lokaci don hana cutar yana haifar da farashi na zamantakewa da tattalin arziki.
A halin yanzu babu wasu magungunan rigakafin cutar da aka amince da su don maganin COVID-19, amma ana ƙoƙarin samar da su, gami da gwada magungunan da ake da su.
Yin amfani da magungunan sanyi da aka ba da takardar sayan magani, shan ruwa da yawa, da kuma hutawa sosai za su iya taimaka maka ka rage ciwon.
Bisa ga tsananin cutar, mai haƙuri zai bukaci shan iskar oxygen, shan ruwa cikin jijiya, da kuma taimakon numfashi.
Yin amfani da magungunan da ke hana shan taba zai iya jawo lahani.
Wasu mahaɗan da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta ana yin la'akari da su don maganin COVID-19.
WHO ta kuma ba da rahoton cewa wasu magungunan gargajiya da na gida na iya sauƙaƙa alamun da SARS-CoV-19 ke haifarwa.
WHO ta ɗauki haɓaka ƙarfin da daidaita lafiyar ga bukatun marasa lafiya da COVID-19 a matsayin babban matakin amsawa ga barkewar cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) da Hukumar Lafiya ta Duniya ta Yammacin Turai sun ba da jagororin ga asibitoci da sabis na kula da lafiya na farko don taimakawa wajen sake rarraba albarkatu a matakai da yawa, gami da mai da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, kawar da hanyoyin da ba na gaggawa ba idan ya yiwu, gano kwayar cutar da ke keɓe marasa lafiya tare da tabbataccen cutar COVID-19, da haɓaka damar kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan kayan aikin IVF da gadaje.
Akwai ra'ayoyi da yawa game da inda cutar ta fara, wanda ake kira "marasa lafiya".
Ana ganin cewa an fara samun sabon kamuwa da cutar korona a ranar 1 ga watan Disamba na shekarar 2019 a birnin Wuhan na lardin Hubei na kasar Sin.
A cikin wata guda, yawan masu kamuwa da cutar korona a lardin Hubei ya karu a hankali.
An danganta su da kasuwar sayar da kayan kifin na Huanan, wanda kuma ake sayar da dabbobi masu rai, kuma daya daga cikin ka'idojin shine cewa kwayar cutar ta shiga jikin mutum daga daya daga cikin wadannan dabbobi; a wasu kalmomin, kwayar cutar ta samo asali ne daga dabbobi.
A ranar 30 ga Disamba, wasu likitoci a asibitin Wuhan sun gargadi abokan aikinsu game da cutar korona mai kama da SARS.
Likitoci takwas daga cikin wadannan likitocin, ciki har da Li Wenliang, 'yan sanda sun yi musu gargadi game da alhakin yada jita-jita, kuma likitan, Ai Feng, ya sami tsawatawa daga shugabanninsa saboda tayar da firgici.
Daga baya, a ranar 31 ga Disamba, Hukumar Kiwon Lafiyar Wuhan ta ba da sanarwar jama'a kuma ta sanar da WHO game da halin da ake ciki.
Hukumomin kiwon lafiya na Wuhan sun ba da rahoton yawan mutanen da ke fama da cutar sankarar bargo, wanda ya isa ya fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan kasar Sin, wanda hutun Sabuwar Shekarar Sin da kuma kasancewar Wuhan babbar cibiyar sufuri da layin dogo ya taimaka.
A ranar 20 ga watan Janairu, kasar Sin ta samu sabbin mutane 140 da suka kamu da cutar a rana daya, ciki har da mutum biyu a birnin Beijing da kuma mutum daya a birnin Shenzhen.
A cewar bayanan hukuma na baya-bayan nan, a ranar 20 ga Janairun 2020, mutane 6,174 sun kamu da cutar. Ya zuwa ranar 26 ga Maris, Amurka ta zarce China da Italiya a cikin adadin mutane da suka kamu da cutar a duniya.
Kusan ƙasashe da yankuna 200 sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar, ƙasashen Turai da yawa na yankin Schengen sun ƙuntata motsi da kuma kafa iyakar.
Matakan mayar da martani na ƙasa sun haɗa da matakan hana yaduwar cutar kamar keɓewa (wanda aka sani da zama a gida, keɓewa a gida, ko keɓewa), da dokar hana fita. Kamar yadda yake a ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'ar Amurka, suna cikin wasu nau'ikan keɓewa, sama da mutane miliyan 50 suna cikin keɓewa a Philippines, kusan mutane miliyan 59 suna cikin keɓewa a Afirka ta Kudu, da mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kasance a cikin wani nau'i na keɓewa, kuma bayan kwana biyu, wannan adadi ya karu zuwa biliyan 2.6  kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An tabbatar da cutar COVID-19 ta farko a Wuhan a ranar 1 ga Disamba, 2019; a cewar wani rahoto wanda ba a tabbatar da ingancinsa ba, wannan ranar  17 ga Nuwamba.
A ranar 26 ga watan Disamba, likita Zhang Jiaxiang ta yi aiki da wani mummunan ciwo na ciwon huhu wanda ba a san irin sa ba, kuma a ranar 27 ga watan Disamba, asibitin ta ya sanar da Cibiyar Kula da Cututtuka da Rigakafin Cutar Jianghan a birnin Wuhan.
Gwajin kwayoyin halittar farko na marasa lafiya, wanda aka gudanar a ranar 27 ga Disamba, 2019, ya nuna cewa akwai kwayar cutar coronavirus mai kama da SARS.
A ranar 31 ga Disamba, Hukumar Kula da Lafiya ta Wuhan ta ba da sanarwar jama'a.
An sanar da WHO a ranar.
A sakamakon irin wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan da su dauki alhakin "fitar da jita-jita" game da barkewar cutar.
A farko Hukumar Lafiya ta Kasa ta kasar Sin ta ce babu wata hujja da ta nuna cewa sabon kwayar cutar na iya yaduwa daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na dakile yaduwar cutar, wanda daga bisani babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya kira "yaƙin mutane".
An fara aiwatar da abubuwan da suka faru a cikin tarihin 'yan adam, a ranar 23 ga Janairu an ba da sanarwar dokar hana fita da hana shiga Wuhan da dawowa, daga baya an faɗaɗa wannan matakin zuwa birane 15 na lardin Hubei kuma ya shafi mutane kusan miliyan 57.
An hana amfani da motocin mutane a birnin.
An soke bukukuwan bikin Sabuwar Shekarar kasar Sin a wurare da dama (Janairu 25).
Hukumomi sun kuma sanar da gina asibitin wucin gadi na Huoshenshan, wanda aka kammala a cikin kwanaki 10.
Daga baya, an gina wani asibiti, Leishengshan, wanda ya karɓi sauran marasa lafiya.
Baya ga sababbin asibitocin da aka gina, kasar Sin ta sake fasalin wasu cibiyoyi 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki karin matakan dakile barkewar COVID-19, ciki har da bayar da takardun kiwon lafiya ga matafiya da kuma tsawaita lokacin bikin Sabuwar Shekarar kasar Sin.
An rufe jami'o'i da makarantu a dukan ƙasar.
Yankunan Hong Kong da Macao sun kafa wasu matakan musamman ga makarantu da jami'o'i.
A wasu yankuna na kasar Sin, hukumomi sun fara aiki a nesa.
An saka takunkumin hana tafiya a lardin Hubei da kuma wasu yankuna.
An canja jadawalin sufuri na jama'a, kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin na ɗan lokaci.
An kafa tsarin kula da motsi a birane da dama, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumin motsi a waje.
Alal misali, an kafa dokar killace mutane na kwanaki 14 a birnin Beijing don duk matafiya na duniya da ke shiga birnin. Har zuwa ranar 23 ga watan Maris, an samu mutum guda ne kawai da ya kamu da cutar a cikin kasar, wanda ya faru kwanaki biyar kafin hakan, a wannan yanayin daga wani da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar cututtukan da ake yadawa a cikin kasar, kuma an shawo kan barkewar cutar a kasar Sin.
A ranar 26 ga watan Maris na shekarar 2020, Ma'aikatar Harkokin Wajen kasar Sin ta sanar da cewa daga ranar 28 ga watan Maris, za a dakatar da shiga ga mutanen da ke da biza ko izinin zama.
Masu son zuwa China za su nemi biza a ofisoshin jakadancin kasar Sin.
A ranar 30 ga watan Maris, gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu su dawo aiki, kuma ta samar wa kamfanoni da wasu matakan karfafa gwiwa. A ranar 4 ga watan Afrilu da karfe 10:00 na safe, an yi shiru na minti uku a kasar, wanda ya fara ranar makoki ga wadanda suka kamu da cutar coronavirus, wanda Majalisar Jiha ta bayyana kuma ya yi daidai da ranar Quocminh, amma gwamnatin tsakiya ta nemi 'yan kasa da su girmama wadanda suka mutu ta yanar gizo ta hanyar nisantar da kansu don kauce wa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
A ranar 20 ga watan Fabrairu, Ma'aikatar Lafiya ta Kasa ta ba da rahoton cewa an sami karuwar yawan mutanen da suka kamu da cutar, wanda ya faru ne saboda yawan mabiyan wata sabuwar kungiyar addini da aka sani da Church of Jesus Shinchhonji.
Mabiyan Shinchonj sun zo Taegu daga Wuhan, wanda ake zaton shine tushen fashewar.
A ranar 22 ga Fabrairu, daga cikin mabiya coci 9,336, 1,261 (kimanin 13%) sun ba da rahoton cewa suna da alamun cutar.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, kuma a ranar 29 ga watan Fabrairu, adadin ya kai 3,150.
An sanya dukkan sansanonin sojin Koriya ta Kudu cikin keɓewa bayan da aka tabbatar da cewa sojoji uku suna da cutar.
Cutar ta shafi yawan tafiye-tafiye, saboda haka an canza jadawalin jiragen jiragen sama.Koriya ta Kudu ta ƙaddamar da shirin tantance yawan jama'a don cutar, bin diddigin abokan hulɗa da kuma tsara matakan keɓewa ga masu hulɗa.Wannan shirin ana ɗaukarsa mafi girma kuma mafi kyau ta fuskar ƙungiyarsa a duk duniya.
Hanyoyin tantancewa sun haɗa da tilasta sanar da alamun cutar ta hanyar aikace-aikacen wayar hannu ga duk waɗanda suka zo daga ƙasashen waje, gwajin mutum don cutar, wanda sakamakon ya kasance a rana mai zuwa, da faɗaɗa damar gwaji, wanda ya ba da damar gwada mutane 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin mai nasara wajen magance cutar, duk da cewa ba a ware birane gaba ɗaya ba. Da farko, al'ummar Koriya ta Kudu sun rabu saboda yadda Shugaba Moon Jae-in ya amsa rikicin.
Mutane da yawa sun sanya hannu kan takardun neman izini da ke yaba wa shugaban kasar ko kuma kira ga tsige Mnu saboda rashin amsawa da suka ga gwamnati ta yi game da cutar.
A ranar 23 ga watan Maris, an ba da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin masu kamuwa da cutar a rana ɗaya cikin makonni huɗu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk waɗanda suka dawo daga ƙasashen waje za a sanya su cikin keɓewar mako biyu.
A cewar rahotannin kafofin yada labarai, a ranar 1 ga watan Afrilu, kasashe 121 sun nemi taimako a Koriya ta Kudu don gwajin cutar.
A ranar 19 ga watan Fabrairu, Iran ta sanar da cewa an samu mutum na farko da ya kamu da cutar SARS-CoV-2 a Kume, inda ma'aikatar lafiya da ilimin likitanci ta ce mutum biyu sun mutu a ranar.
Matakan farko da gwamnati ta ɗauka sun haɗa da soke kide kide da sauran abubuwan al'adu da wasanni, sallar Juma'a, da rufe jami'o'i, manyan makarantu da makarantu.
Iran ta kashe Riyal tiriliyan biyar wajen magance cutar.
Shugaban kasar Hassan Rouhani ya bayyana a ranar 26 ga Fabrairun 2020 cewa gwamnati ba ta shirin sanya dukkan yankunan da cutar ta shafa cikin keɓewa, amma za a sanya wasu mutane a keɓe.
A watan Maris an sanar da shirin rage tafiye-tafiye tsakanin biranen, amma an ci gaba da yawan zirga-zirga tsakanin biranen kafin Sabuwar Shekarar Farisa.
Wuraren ibada na Shi'a a Qum sun kasance a bude ga mahajjata har zuwa ranar 16 ga Maris, 2020.
A yayin da ake ta yin ikirarin cewa an boye yawan cutar a Iran, a ranar 28 ga watan Fabrairu, kasashe sama da goma sun danganta cutar da Iran, wanda ke nuna cewa cutar ta fi muni fiye da 388 da gwamnatin Iran ta samu a ranar.
Majalisar dokokin Iran ta rufe, kuma an bayar da rahoton cewa 23 daga cikin mambobi 290 na majalisar sun gwada cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta yi kira ga hukumomin kurkukun Iran da su saki masu kare hakkin dan Adam da aka tsare saboda rashin amincewarsu da zaman lafiya ba tare da wata takamaiman doka ba, da kuma sakin duk fursunonin da suka dace da wannan rukuni na 'yancin dan Adam.
Kungiyar ta ce akwai hadarin yaduwar cutar a wuraren da ba a iya shiga ba, kamar gidajen yari, inda ba a samun isasshen kiwon lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda  mafi yawan mutuwar da aka samu a kasar tun lokacin da barkewar cutar ta fara.
A ranar 17 ga watan Maris, aƙalla 'yan siyasa 12 na Iran da jami'an gwamnati sun mutu daga cutar.
A ranar 23 ga watan Maris, a kowace awa a Iran, ana samun sabbin mutane 50 da suka kamu da cutar korona, kuma a kowane minti goma, ana samun mutum daya da ke mutuwa sakamakon cutar.
A cewar wani jami'in hukumar lafiya ta duniya, yawan masu kamuwa da cutar a Iran zai iya zama sau biyar fiye da yadda aka bayyana a hukumance.
An kuma yi amannar cewa takunkumin da Amurka ta kakaba wa Iran na iya shafar karfin kudin kasar wajen kare kanta daga yaduwar cutar.
Babban kwamishinan kare hakkin bil adama na Majalisar Dinkin Duniya ya bukaci sassauta takunkumin tattalin arziki kan kasashen da cutar ta fi shafa, ciki har da Iran.
A ranar 31 ga watan Janairu, an tabbatar da cewa cutar ta shiga ƙasar Italiya lokacin da wasu 'yan yawon buɗe ido biyu daga China suka gwada SARS-CoV-2 a Roma kuma suka sami sakamako mai kyau.
Yawan masu kamuwa da cutar ya karu sosai, wanda ya sa gwamnatin Italiya ta dakatar da dukkan zirga-zirgar jiragen sama zuwa da daga China da kuma ayyana dokar ta baci.
Daga baya an gano tarin mutane da ba su da alaƙa da cutar COVID-19. An fara da samun mutane 16 da aka tabbatar da cutar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sabon doka don hana barkewar cutar, ta sanya mutane sama da 50,000 daga birane daban-daban 11 a arewacin Italiya a cikin keɓewa.
Firaministan kasar, Giuseppe Conte ya ce: "Za a dakatar da shiga da fita daga yankin da cutar ta bulla".
A cikin waɗannan yankuna an riga an ba da umarnin dakatar da ayyukan masana'antu da soke ayyukan wasanni. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe duk makarantu da jami'o'i a duk faɗin ƙasar, saboda a lokacin an riga an rubuta mutuwar mutane 100 a Italiya.
Duk manyan wasannin motsa jiki, gami da wasannin kwallon kafa na A, ya kamata a rufe su har zuwa Afrilu, amma a ranar 9 ga Maris an jinkirta duk wasannin motsa jiki aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci da rufe kamfanoni ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya na Anesthesia, Analgesia, Reanimation da Intensive Therapy (SIAARTI) ta buga shawarwarin ɗabi'ar likita game da ladabi na haƙuri don kula da marasa lafiya, wanda zai iya buƙatar amfani.
A ranar 19 ga watan Maris, Italiya ta zarce China a yawan masu kamuwa da cutar coronavirus, inda ta zama ta farko a duniya, bayan da aka sanar da mutuwar mutane 3,405.
A ranar 22 ga watan Maris ne aka sanar da cewa Rasha ta aika da jiragen sama tara da kayan aikin lafiya zuwa Italiya.
A ranar 5 ga Afrilu, Italiya ta samu mutum 128,948 da suka kamu da cutar, mutane 15,887 da suka mutu, da kuma mutane 21,815 da suka warke, kuma yawancin waɗannan mutane sun fi yawa a yankin Lombardy.
Wani rahoto na CNN ya ce wasu dalilai biyu ne da ke iya haifar da irin wannan yawan mutuwar a Italiya, wato yawan tsofaffi da kuma rashin iya yin gwajin duk wanda ya kamu da cutar.
Ƙasar Ingila ta fi kowanne ƙasa da cutar ta shafa yin shiru, kuma har zuwa 18 ga Maris, 2020, gwamnatin Birtaniya ba ta tilasta wa 'yan ƙasa su bi wani tsari na nisantawa da jama'a ko kuma keɓewa ba.
A sakamakon haka, an soki gwamnati saboda rashin amsawa cikin sauri da gaske ga barazanar da al'ummar kasar ke ciki. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar a guji duk tafiye-tafiye da hulɗar zamantakewar da ba ta da mahimmanci, yana ba mutane shawarar yin aiki daga gida idan za su iya kuma su guji wuraren jama'a kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren nishaɗi kamar mashaya da kulab ɗin wasanni dole ne su rufe da wuri-wuri, kuma ta yi alkawarin biyan 'yan ƙasa masu aiki har zuwa kashi 80% na albashi, amma ba fiye da fam 2,500 a wata ba a matsayin wani mataki na tallafawa jama'a a lokacin rikicin. A ranar 23 ga Maris, firaministan ya ba da sanarwar tsauraran matakan nisantar da jama'a, yana hana taruwa sama da mutane biyu da iyakance tafiya da hutu a waje kawai a lokuta masu matukar muhimmanci.
Ba kamar yadda aka saba ba, an yi amfani da 'yan sanda, da tarar mutane da kuma tara mutane.
An umarci rufe yawancin kamfanoni, ban da waɗanda ke ba da "rayuwar jama'a", ciki har da manyan kantuna, kantin magani, bankuna, shagunan kasuwanci, tashoshin mai da gareji.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da ya kamu da cutar COVID-19 a jihar Washington da ke arewa maso yammacin Pacific, wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga watan Janairu, an kafa wani rukunin aiki a fadar White House don yaki da cutar coronavirus.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci a fannin kiwon lafiya da kuma sanya takunkumin shiga kasar Sin.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Cututtuka, babbar ƙungiyar lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta haɓaka kayan gwajin kanta.
Duk da haka, ba a fara gwajin jama'a nan da nan a Amurka ba, kuma sakamakon haka, ainihin girman cutar a wannan lokacin ya ɓoye.
Gwajin ya kasance mai wahala saboda rashin ingancin gwajin da gwamnatin tarayya ta fitar a watan Fabrairu, rashin izinin gwamnatin tarayya har zuwa ƙarshen Fabrairu don amfani da gwajin gwaji na ƙasa wanda ƙungiyoyin kimiyya, kamfanoni daban-daban da asibitoci ke haɓaka, da kuma ƙuntatawa har zuwa farkon Maris wanda zai ba da izinin 'yan ƙasa su gwada (wannan za a iya yi ne kawai ta hanyar takardar izinin likita).
Jaridar Washington Post ta ruwaito cewa a ranar 27 ga watan Fabrairu, an yi gwajin ƙasa da 4,000 a Amurka.
Jaridar The Atlantic ta ruwaito cewa an yi gwaje-gwaje kasa da 14,000 a ranar 13 ga watan Maris.
A ranar 22 ga Maris, Associated Press ta ruwaito cewa: "Masu haƙuri da yawa, duk da alamun cututtuka da kuma ganawar likita, sun jira don gwaji na awanni ko kwanaki". Bayan da aka ba da rahoton mutuwar farko ta coronavirus a Amurka daga jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ba da sanarwar dokar ta baci, wanda wasu jihohi suka sanar nan ba da daɗewa ba.
A ranar 3 ga watan Maris, an soke makarantu a Seattle, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masanan cututtukan cututtuka na Imperial College, London, ta sanar da Amurka game da tsinkayen tasirin sabon coronavirus a ƙasar.
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Kuɗaɗen Shirye-shiryen Cutar Korona da kuma Amsawa, wanda ya ba hukumomin tarayya tallafin gaggawa na dala biliyan 8.3 don magance cutar.
Kamfanoni sun hana ma'aikata tafiya, sun soke taron taro kuma sun ce su yi aiki daga gida.
An soke wasannin motsa jiki da kuma kakar wasa. A ranar 11 ga Maris, Trump ya sanar da takunkumin hana tafiya zuwa yawancin Turai, ban da Burtaniya, na kwanaki 30, daga ranar 13 ga Maris.
Kashegari ya ƙara ƙuntatawa ga Burtaniya da Ireland.
A ranar 13 ga watan Maris, shugaban kasar ya ayyana dokar ta baci a kasar, wanda ya ba da damar amfani da kudaden tarayya don magance rikicin.
Tun daga ranar 15 ga watan Maris, kamfanoni da yawa sun rufe ko rage sa'o'i a duk faɗin Amurka don taimakawa wajen hana yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da barkewar cutar a duk jihohi 50 da gundumar Columbia. A ranar 23 ga watan Maris, an ba da rahoton cewa an sami kararraki 10,700 a New York a cikin yini ɗaya, wanda ya fi yawan adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nisantar da mutane daga juna zai iya zama matakin da ya dace, saboda ƙididdigar ninki biyu na yawan masu cutar ta ragu daga kwanaki 2.0 zuwa 4.7.
A ranar 28 ga watan Maris, an samu mutum 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu. An bayar da rahoton cewa a ranar 26 ga watan Maris, an samu karin mutane da suka kamu da cutar a Amurka fiye da kowace kasa a duniya, ciki har da China da Italiya. A ranar 8 ga watan Afrilu, an samu mutane 400,335 da suka kamu da cutar, kuma mutane 12,841 sun mutu.
Rahotanni a ranar 30 ga watan Maris sun nuna cewa shugaba Trump ya tsawaita dokar nisantar jama'a har zuwa ranar 30 ga watan Afrilu.
A wannan ranar, jirgin asibiti mai ɗauke da gadaje 1,000 mai suna USNS Comfort ya isa tashar jirgin ruwan New York.
A ranar 3 ga Afrilu, an samu mutuwar mutane 884 a Amurka a cikin sa'o'i 24 da suka gabata.
A jihar New York, adadin masu kamuwa da cutar ya zarce 100,000 a ranar 3 ga Afrilu.Fadar White House ta fuskanci suka saboda rashin fahimtar barazanar da kuma sanya takunkumi kan bayanan da ke fitowa a fili, ta hanyar sanya ido kan maganganun jama'a da wallafe-wallafen jami'an kiwon lafiya da masana kimiyya da ke da alaƙa da cutar, tare da taimakon ofishin Mataimakin Shugaban Amurka Mike Pence.
A cikin babban ra'ayi, magoya bayan shugaba Trump sun rabu da ra'ayi game da yadda ya yi nasara wajen magance rikicin.
Wasu jami'ai da masu sharhi sun soki dogaro da Amurka kan shigo da kayan masarufi, ciki har da kayan masarufi, daga China.
A tsakiyar Janairu 2020, mujallar Travel Medicine ta buga nazarin tsarin tafiye-tafiyen jirgin sama, wanda aka yi amfani da shi don zana taswira da hasashen yanayin yaduwar cutar.
Bisa ga bayanan kungiyar sufurin jiragen sama ta duniya a shekarar 2018, Bangkok, Hong Kong, Tokyo da Taipei sun karbi mafi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne ma sun kasance sanannun wuraren da masu yawon bude ido ke zuwa.
Daga cikin manyan wuraren shakatawa 20, Bali an kira shi mafi ƙarancin shirye-shiryen barkewar cutar, yayin da biranen Ostiraliya aka ɗauka mafi shirye. A ranar 7 ga Fabrairu, Ostiraliya ta ɗauki shirin ta na gaggawa game da sabon coronavirus (COVID-19).
A wannan yanayin, an ce akwai abubuwa da yawa da za a koya game da COVID-19, kuma cewa Ostiraliya za ta ba da hankali sosai ga kula da kan iyakoki da sadarwa a cikin yanayin barazanar.
A ranar 21 ga Maris, an sanar da dokar ta baci a Australia game da lafiyar ɗan adam.
Sakamakon ingantattun matakan killacewa da aka sanya a bangaren sufuri na jama'a a Wuhan da Hubei, wasu kasashe sun shirya kwashe 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen sama na kasashensu, wanda hukumomin kasar Sin suka ba da izinin.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus da Thailand sun kasance cikin na farko da suka shirya fitar da 'yan kasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasar ta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34/dangi na' yan Brazil, da 'yan Poland hudu, da wani dan kasar Sin da kuma dan kasar Indiya.
'Yan kasar Poland da China da Indiya sun sauka a Poland inda jirgin na Brazil ya tsaya kafin ya tashi zuwa Brazil.
An killace 'yan kasar Brazil da suka ziyarci birnin Wuhan a wani sansanin soji da ke kusa da birnin Brasilia.
A wannan ranar an kwashe 'yan kasar Canada 215 (mutane 176 daga jirgi na farko da 39 daga jirgin sama na biyu, wanda gwamnatin Amurka ta yi haya) daga Wuhan, aka kai su sansanin sojojin Kanada na Trenton kuma aka sanya su cikin keɓewa na tsawon makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama tare da 'yan Kanada 185 da aka fitar daga Wuhan ya sauka a CFB Trenton.
A ranar 3 da 4 ga watan Fabrairu, hukumomin Australia sun kwashe 'yan kasar 277 kuma suka sanya su a cibiyar zama na wucin gadi a tsibirin Kirsimeti, wanda aka sake fasalin shi zuwa cibiyar killacewa, inda suka zauna har tsawon kwanaki 14.
A ranar 5 ga Fabrairu, jirgin sama na New Zealand ya isa Auckland; fasinjojinsa (ciki har da wasu daga Ostiraliya da yankin Asiya da Fasifik) an sanya su cikin keɓewa a sansanin sojan ruwa a Vangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe 'yan ƙasar Amurka da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama mai dauke da fasinjojin Kanada 129 da aka kwashe daga "Diamond Princess" ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris, jirgin saman kamfanin jirgin sama na South African Airways, wanda gwamnatin Afirka ta Kudu ta yi haya, ya tashi tare da' yan Afirka ta Kudu 112 a cikin jirgin.
An yi wa fasinjojin gwajin lafiya kafin tashi, kuma an bar 'yan Afirka ta Kudu hudu da ke da alamun cutar coronavirus a China don rage haɗarin.
An kwashe 'yan Afirka ta Kudu ne kawai da suka kamu da cutar coronavirus.
An yi gwajin daga dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin agaji, kuma a matsayin kariya, duk sun kasance a karkashin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta sanar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun tura taimakon su zuwa kasar Sin.
Wasu daliban kasar Sin da ke karatu a jami'o'in Amurka sun hada kai don tarawa da kuma tura taimako zuwa yankunan da cutar ta shafa na kasar Sin, tare da wani rukuni daga Chicago da aka ruwaito sun aika da kayan aikin N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga Hukumar Lafiya ta Duniya don tallafawa samar da allurar rigakafi da maganin cutar coronavirus, da kuma kare mutanen Afirka da Kudancin Asiya daga barazanar cutar.
Interaksyon ta ruwaito cewa a ranar 6 ga watan Fabrairu, gwamnatin kasar Sin ta ba da gudummawar masks 200,000 ga kasar Philippines bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta aika da tallafin da ya kai dala miliyan 2.26 ga kasar Sin.
Japan ta kuma ba da gudummawar abin rufe fuska miliyan daya, Turkiyya ta aika da kayan aikin likita zuwa Wuhan, Rasha  sama da tan 13 na magunguna, Malaysia ta sanar da bayar da gudummawar safar hannu miliyan 18, Jamus ta aika da kayan aikin likita daban-daban, gami da kayan kariya 10,000, Amurka ta ba da gudummawar tan 17.8 na magunguna, tare da yin alkawarin ba da dala miliyan 100 a matsayin tallafin kuɗi ga ƙasashen da cutar ta shafa. Bayan halin da ake ciki a China ya daidaita, ƙasar ta kuma aika da taimako ga sauran ƙasashen da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun tura magunguna da masana zuwa Italiya don taimakawa mutane su magance cutar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya aika wa Kungiyar Tarayyar Afirka, Addis Ababa, Habasha, da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kuma riguna 60,000 don kungiyar ta rarraba su a kasashe mambobinta.
Daga baya kuma ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin shan magani guda biyar zuwa Panama.
Ma ya kuma ba da gudummawar magunguna ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwaji na kasar Sin.
Alal misali, Spain ta dawo da kayan gwajin cutar korona na kasar Sin 58,000 da ke da daidaito na kashi 30 cikin dari, kuma Netherlands ta dawo da abin rufe fuska na kasar Sin 600,000 da suka lalace.
Belgium ta kuma dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba: ana zaton an yi su ne a China, amma daga baya an gano cewa sun fito ne daga Colombia.
A wani bangare kuma, an yi maraba da taimakon da kasar Sin ta bayar a wasu sassan Latin Amurka da Afirka.
Hukumar lafiya ta duniya ta yaba wa kokarin da hukumomin kasar Sin ke yi na dakile yaduwar cutar.
Hukumar ta WHO ta lura da bambance-bambance tsakanin barkewar cutar sankarar bargo a shekarar 2002-2004, inda aka zargi hukumomin kasar Sin da boye bayanai, wanda ake zargin yana hana rigakafin cutar da kuma hana yaduwarta, da kuma rikicin yanzu, inda gwamnatin tsakiya ke ba da cikakken bayani game da yanayin don kauce wa firgici a jajibirin Sabuwar Shekarar Sin.
A ranar 23 ga watan Janairu, a mayar da martani ga matakin da hukumomin tsakiya suka dauka na hana zirga-zirgar ababen hawa a Wuhan, wakilin WHO, Goden Galea ya ce, ko da yake ba WHO ce ta ba da shawarar wannan matakin ba, amma kuma "babban tabbaci ne na cika alƙawarin da aka ɗauka na hana barkewar cutar a inda ta fi yaduwa", kuma ya kira ta "ba tare da misali ba a tarihin kiwon lafiyar jama'a". A ranar 30 ga Janairu, bayan da aka tabbatar da cewa kamuwa da cutar na iya yaduwa daga mutum zuwa mutum a wajen China da kuma karuwar masu kamuwa da cutar a wasu ƙasashe, WHO ta ayyana gaggawa ta kiwon lafiyar jama'a mai ma'ana ta duniya (PHEIC); wannan shine karo na shida tun daga 2009 da aka fara amfani da irin wannan matakin a lokacin annobar mura ta duniya.
Darakta Janar na WHO, Mr Tedros Adhanom ya ce sanarwar PHEIC ta shafi hadarin yaduwar cutar a duniya, musamman a kasashe masu karamin karfi da matsakaitan kudade da ba su da ingantaccen tsarin kiwon lafiya.
Da yake magana game da takunkumin tafiye-tafiye, Mista Tedros ya ce "babu wani dalili da zai sa a dauki matakan da za su hana zirga-zirgar kasa da kasa da cinikayya" kuma "WHO ba ta bayar da shawarar hana zirga-zirga da cinikayya".
A ranar 5 ga watan Fabrairu, WHO ta nemi al'ummar duniya da su ba da dala miliyan 675 don samar da shirye-shiryen da za a yi a ƙasashe masu karamin kuɗi, ta bayyana bukatar ba da taimako na gaggawa ga ƙasashen da ba su da tsarin gano mutanen da ke da cutar, duk da cewa cutar ba ta kai waɗannan ƙasashe ba tukuna.
Mista Tedros ya kuma ce "mai nuna shirye-shiryenmu" shine yadda muka shirya wa cutar a inda ta fi rauni, kuma ya bukaci al'ummar duniya su "yi zabi tsakanin saka hannun jari a yau ko biyan bashin nan gaba". A wani taron manema labarai da WHO ta yi a ranar 11 ga watan Fabrairu, ta sanya wa cutar sunan "COVID-19".
A wannan rana, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da samar da "dukan tsarin Majalisar Dinkin Duniya don amsa matsalar".
Sakamakon haka, an kafa kungiyar kula da rikicin Majalisar Dinkin Duniya don daidaita dukkan martani na Majalisar Dinkin Duniya; wadannan matakan, in ji WHO, za su ba da damar "mai da hankali kan amsawa a fannin kiwon lafiya, yayin da sauran hukumomi za su iya amfani da kwarewarsu don magance barkewar cutar a cikin yanayin zamantakewar da tattalin arziki".
A ranar 14 ga watan Fabrairu, WHO da China sun kafa wata ƙungiya ta musamman don samar da ƙwararrun ƙwararrun ƙasashen duniya da ma'aikatan WHO a cikin ƙasar Sin don taimakawa wajen magance matsalar cikin gida da kuma kimanta "tsananin cutar da kamuwa da ita", gudanar da bita da tarurruka tare da manyan hukumomin ƙasa, da kuma tafiye-tafiye don kimanta "inganta ayyukan mayar da martani a larduna da gundumomi, gami da birane da yankuna karkara". A ranar 25 ga Fabrairu, WHO ta ce duniya na bukatar yin ƙarin don shirya don yiwuwar cutar ta coronavirus, tana mai cewa "ba a fara kiran cutar da cutar ba tukuna, amma ƙasashe dole ne su kasance a shirye".
Lokacin da cutar ta barke a Iran, WHO ta tura wata ƙungiya ta musamman don tantance yanayin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ƙara yiwuwar yaduwar cutar coronavirus a duniya daga "mai girma" zuwa "mai girma sosai" zuwa matakin shiri da haɗari mafi girma.
Mike Ryan, darektan shirin gaggawa na lafiya na WHO, ya yi gargadin a cikin wata sanarwa: "Wannan gwaji ne ga kowace gwamnati a duniya don tabbatar da cewa ta shirya don gaskiyar: lokaci ya yi da za a yi aiki.
Wannan kwayar cutar na iya zuwa ƙasarku kuma kuna buƙatar kasancewa cikin shiri, kuma ya jaddada cewa matakan da suka dace na iya taimakawa duniya don kauce wa mafi munin yanayin da zai faru.
Ryan ya kuma ce bayanan da ake da su yanzu ba su ba da hujjar sanar da cutar ta duniya ba, kuma ya kara da cewa sanarwar cutar ta duniya za ta nuna cewa "muna amincewa da gaskiyar cewa kowane mutum a duniya yana cikin haɗarin kamuwa da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta bayyana cutar korona a matsayin annoba.
Darakta Janar na WHO ya ce WHO ta damu matuka game da yadda cutar ke yaduwa da kuma tsananin cutar, da kuma rashin aiki game da wannan matsalar. WHO tana fuskantar mummunan zargi saboda yadda ake ganin bai dace ba game da batun cutar, gami da sanar da gaggawa na kiwon lafiyar jama'a da kuma rarraba kwayar cutar a matsayin annoba.
A wani jawabi mai dadi, an aika da takardar neman murabus ga Darakta Janar na WHO, Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, masana da dama na Majalisar Dinkin Duniya kan hakkin dan adam sun jaddada muhimmancin girmama haƙƙin kowane mutum a lokacin annobar COVID-19.
Ƙungiyar ta ce kowa yana da 'yancin ya sami taimakon da zai ceci ransa, kuma gwamnati ce ke da hakkin yin hakan.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama hujja ba don nuna bambanci ga kowane rukuni na mutane.
Masana sun jaddada cewa kowa yana da hakkin ya sami lafiyar jiki, ciki har da nakasassu, 'yan tsiraru, tsofaffi, mutanen da aka kora daga gidajensu, marasa gida, marasa galihu, fursunoni, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana ba da ke bukatar tallafin gwamnati.
Ƙungiyoyin gwamnati na duniya suna nazarin tasirin tattalin arziki da zamantakewar da rikicin COVID-19 ya haifar.
Kungiyar hadin gwiwa ta tattalin arziki da ci gaba ta kafa wani dandamali da aka tsara don samar da cikakken bayani game da matakan siyasa a duk duniya, da kuma samar da shawarwari da shawarwari.
Cibiyar tana da bayanai game da matakan siyasa na ƙasashe (Country Policy Tracker) don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya, magance tasirin keɓewa da ƙuntatawa na balaguro don taimakawa ƙasashe su koya daga juna da kuma ba da gudummawa ga daidaitaccen martani na duniya game da coronavirus.
Gwamnatin kasar Sin ta fuskanci suka daga Amurka, Ministan Harkokin Wajen Burtaniya Michael Gove da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro, saboda yadda ta yi aiki don magance cutar da ta fara a lardin Hubei na kasar Sin.
An kori wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CCP) a larduna saboda matakan da suka dauka a tsakiyar kasar Sin, kuma wadannan korafe-korafen sun nuna rashin jin dadin yadda siyasa ta mayar da martani ga barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi amannar cewa an yi wannan matakin ne domin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun nuna rashin amincewarsu da wasu maganganun da aka yi a baya cewa cutar coronavirus ta fara ne a Wuhan, amma sun goyi bayan ka'idar maƙarƙashiya cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin shugaban Amurka Donald Trump ta kira coronavirus Cinese virus ko Wuhan virus, tana mai cewa sanarwar da ake yi a China tana kara tsananta cutar da ta zama annoba a duniya, kuma wasu masu sharhi sun soki wannan maganar, suna cewa irin wannan tsarin wariyar launin fata ne kuma yana janye hankali daga gazawar gwamnatin shugaban Amurka wajen dakile yaduwar cutar.
Jaridar Daily Beast ta samu damar amfani da sakon sakon gwamnatin Amurka wanda ya kunshi wata dabara ta sadarwa da ake ganin cewa Kwamitin Tsaro na kasa ne ya kirkira, tare da ambaton dabarun kamar haka: "Dukkanin abu a China ne.
An nemi mu yada wannan bayanin ta duk wata hanya da za mu iya, ciki har da taron manema labarai da kuma jawabai a talabijin. Ƙungiyoyi kamar su Politico, Foreign Policy da Bloomberg sun ce ƙoƙarin da China ke yi na taimaka wa ƙasashen da ke fama da cutar  wani ɓangare ne na  yunkurin yaɗa labarai  don samun tasiri a duniya.
Shugaban hukumar harkokin wajen EU, Josep Borrell ya yi gargadin cewa akwai wani bangare na siyasa da ya hada da fada da ake yi ta hanyar yada labarai da kuma siyasa ta karimci.
Borrell ya kuma ce, "Kasar Sin tana dagewa wajen ganin ta zama mai dogaro da alhakin da take da shi, sabanin Amurka".
Kasar Sin ta kuma bukaci Amurka ta soke takunkumin da ta kakaba wa kasashen Syria, Venezuela da Iran, inda ta ce ta tura tallafi ga kasashen biyu na karshe.
An dakatar da bayar da gudummawar Jack Ma na masks 100,000 zuwa Cuba saboda takunkumin da Amurka ta sanya a ranar 3 ga Afrilu.
An kuma zargi gwamnatin Amurka da karkatar da tallafin da aka yi niyyar bai wa wasu kasashe zuwa kasar ta.
Har ila yau, an yi jayayya game da abin rufe fuska tsakanin wasu ƙasashe kamar Jamus, Austria da Switzerland, Czech da Italiya.
Ƙari ga haka, Turkiyya ta ba da ɗaruruwan na'urorin iska na iska da aka yi niyya ga Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin goyon bayan Tarayyar Turai game da Italiya da ke fama da cutar coronavirus.
Maurizio Massari, jakadan Italiya a EU, ya ce China ce kadai ta amsa ta hanyar biyu.
Wannan ba ya nuna cewa akwai haɗin kai a Turai.
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya tura jami'an lafiya na Rasha zuwa Italiya, da motocin kashe kwayoyin cuta da sauran kayan aikin likita.
Jaridar La Stampa ta Italiya ta kawo wani "tushen siyasa mai zurfi" wanda bai bayyana sunansa ba, wanda ya ce kashi 80 cikin dari na taimakon da Rasha ta bayar "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Majiyar ta zargi Rasha da cewa tana neman yin kyakkyawan ra'ayi ga al'ummar duniya a matakin geopolitical da diplomasiyya.
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da hare-haren da kafofin yada labarai suka yi kuma sun nuna godiya ga taimakon da aka bayar.
Rasha ta kuma tura jirgin sama mai dauke da kayan aiki zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce "da yake ba da taimako ga abokan aikinsa na Amurka, [Putin] yana nuna cewa yayin da masana'antun Amurka na kayan aikin likita da kayan aiki suka kara yawan samarwa, su ma za su iya ba da taimako idan ya cancanta".
Aikin NATO na soja Defender-2020, wanda aka shirya a Jamus, Poland da ƙasashen Baltic  mafi girman horo na NATO tun bayan ƙarshen yakin sanyi  za a gudanar da shi a cikin gajeren tsari.
Babban sakataren Kamfen na Yaki da Nukiliya Kate Hudson ya soki atisayen Defender 2020: A cikin halin da ake ciki a yau na kiwon lafiyar jama'a, gudanar da wannan atisayen yana sanya rayuwar Amurka da sauran kasashen Turai da ke halartar taron cikin haɗari, har ma da mutanen da za a gudanar da irin waɗannan ayyukan. Gwamnatin Iran ta sha wahala sosai daga cutar.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wata wasika a bude ga shugabannin duniya don neman taimako, yana mai cewa kasarsa na fuskantar matsaloli wajen magance cutar saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin da Amurka ta sanya wa Iran. Cutar ta haifar da kira ga Amurka da ta dauki manufofin zamantakewar da aka saba a wasu kasashe masu arziki, gami da aiwatar da tsarin kiwon lafiya guda daya da kula da yara, hutun iyali da ake biya da kuma kara kudaden kiwon lafiyar jama'a.
Masana siyasa sun yi tsammanin hakan na iya shafar damar da Donald Trump ke da ita na sake zaɓar shugaban kasa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "matakan killacewa da rashin aiki" na Japan bayan da Japan ta sanar da cewa duk wani dan kasar da ya dawo daga Koriya ta Kudu za a killace shi na makonni biyu a wuraren da gwamnati ta kebe.
Da farko dai, jama'ar Koriya ta Kudu sun rabu saboda yadda Shugaba Moon Jae-in ya amsa wannan rikici.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman izini da ke yaba wa shugaban ko kuma suna kira da a tsige Mnu saboda abin da suka ce gwamnati ba ta dace ba game da barkewar cutar.
Wasu masu sharhi sun nuna damuwa cewa wannan matakin zai ba gwamnatoci damar karfafa ikonsu.
A Hungary, majalisar dokokin kasar ta amince da baiwa Firaminista Viktor Orban ikon yin mulki ta hanyar zartar da doka, dakatar da majalisar, gudanar da zabe da kuma hukunta wadanda ake zargi da yada labaran karya game da cutar da kuma matakan gwamnati na magance rikicin.
An ce cutar korona ta haifar da karancin kayayyaki da yawa saboda yawan amfani da kayan aiki a duniya, da kuma rashin aiki a masana'antu da kuma kayayyaki.
Hukumar kula da abinci da magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita, wanda ya taso ne saboda karuwar bukatar masu amfani da kuma gazawar masu samar da kayayyaki.
A wasu yankuna, an yi sayayya cikin tsoro; wannan ya haifar da yanayin da kayayyakin rayuwa kamar abinci, takarda na bayan gida da ruwan kwalba suka ɓace daga ɗakunan shaguna, wanda hakan ya haifar da karancin kayayyaki.
Musamman masana'antar fasaha suna faɗakarwa game da jinkirin samar da kayayyakin lantarki.
A cewar Darakta Janar na WHO, Tedros Adhanom, bukatar kayan kariya ta mutum ta ninka sau 100.
Wannan ya sa farashin kayayyaki ya ƙaru sau ashirin kuma ya hana kayayyakin kiwon lafiya zuwa ƙasar har tsawon watanni huɗu zuwa shida.
Ya kuma haifar da karancin kayan kariya a duniya, kuma Hukumar Lafiya ta Duniya ta yi gargadin cewa ma'aikatan lafiya za su fuskanci matsi saboda hakan.
A Ostareliya, saboda annobar, masu sayen daigoo sun sami sabuwar dama don sayar da kayayyakin Australiya zuwa China.
Wannan aikin ya haifar da karancin abinci ga yara a wasu manyan kantunan sayar da kayayyaki kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan adadin COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma yawan bukatar abinci, an sami nasarar kauce wa karancin abinci a yankuna biyu.
Matakan da China da Italiya suka ɗauka don hana tara kayayyaki da kuma cinikin kayayyaki da ba su da kyau sun taimaka wajen hana ƙarancin abinci da ake tsammani a Turai da kuma Amirka ta Arewa.
Arewacin Italiya, inda ake samar da kayan gona a kananan yankuna, ba ta sha wahala ba, amma masana'antun masana'antu sun ce farashin kayan gona na iya tashi.
Shaguna masu sayar da abinci sun kasance ba tare da komai ba, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka samar da kayan abinci na alade don ciyar da jama'a.
Ana bukatar masu sayar da abinci su adana abinci don gaggawa a ƙasar Italiya.
An yi tasiri a kan tattalin arzikin duniya a China: a cewar kafofin watsa labarai na ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don magance yaduwar cutar, wanda ya haifar da raguwar tallace-tallace da kashi 20.5%.
Babban yankin China  babban cibiyar tattalin arziki da masana'antu ne; saboda haka ana ganin barkewar cutar tana haifar da babbar barazana ga tattalin arzikin duniya.
Agatha Demarai, na Economist Intelligence Unit, ta yi hasashen cewa, har sai an fahimci sakamakon, za a ci gaba da samun koma baya a kasuwanni.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin annobar ta yanzu a cikin ci gaban duniya na iya wuce tasirin annobar cutar sankarar bargo ta 2002-2004.
Wani ƙwararre a Jami'ar Washington da ke St. Louis ya kimanta cewa, ana iya kashe dala biliyan 300 a kan kayayyakin da ake samarwa a faɗin duniya, kuma hakan zai iya ci gaba har na tsawon shekara biyu.
An ruwaito cewa kungiyar kasashen da ke fitar da man fetur (OPEC) ta dauki matakan gaggawa bayan da farashin man fetur ya fadi saboda faduwar bukatar da kasar Sin ke yi.
A ranar 24 ga watan Fabrairu, kasuwannin hannayen jari na duniya sun fadi saboda karuwar mutane da suka kamu da COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu saboda karuwar damuwa game da barkewar cutar coronavirus, alamun kasuwancin Amurka daban-daban, gami da NASDAQ-100, S&P 500 index da Dow Jones index don hannun jari na kamfanonin masana'antu, sun nuna raguwar da ta fi yawa tun 2008, tare da Dow index ya faɗi da maki 1191  mafi girman raguwar rana ɗaya tun bayan rikicin kuɗi na 2007-2008 .
A ƙarshen mako, duka alamun da aka ambata a cikin wannan talifin sun faɗi da kashi 10.
A ranar 28 ga watan Fabrairun, kamfanin Scope Ratings GmbH ya tabbatar da darajar darajar kasar Sin, amma ya ci gaba da yin mummunan hasashe.
Hannun jari sun sake faduwa saboda tsoron yaduwar cutar coronavirus, kuma mafi girman faduwar ya faru ne a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a iya samun koma bayan tattalin arziki.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa da manyan bankuna da gwamnatoci suka dauka.
Bankunan tsakiya suna amsawa da sauri fiye da lokacin matsalar kudi ta shekara ta 2008.
Yawon shakatawa  yana daya daga cikin bangarorin da suka fi fama da matsalar saboda dokar hana zirga-zirga, rufe wuraren taruwar jama'a, ciki har da wuraren shakatawa, da kuma shawarwarin gwamnatoci na hana yin balaguro.
Sakamakon duk waɗannan matakan, kamfanonin jiragen sama da yawa sun soke zirga-zirga saboda raguwar buƙatun tikiti, gami da British Airways, China Eastern Airlines da Qantas, kuma kamfanin jirgin sama na yankin Flybe na Burtaniya ya daina aiki.
Hakan ya shafi masana'antar jirgin ruwa sosai.
An rufe wasu tashoshin jirgin kasa da tashar jiragen ruwa.
Cutar ta zo daidai da Chong-yun, babban lokacin yawon shakatawa na bikin sabuwar shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da ke tattare da yawan jama'a, gami da bukukuwan Sabuwar Shekara na shekara-shekara; kamfanoni masu zaman kansu suma sun rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong da Shanghai Disneylands.
An soke yawancin bukukuwan Sabuwar Shekara kuma an rufe wuraren yawon bude ido don hana taron jama'a; alal misali, an rufe Haramtaccen Birni a Beijing kuma an soke bikin bikin haikalin gargajiya.
A larduna 24, da kananan hukumomi da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, inda suka umarci yawancin kamfanoni da kada su bude har zuwa wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin ɗari na GDP na ƙasar da kuma kashi 90 cikin ɗari na fitarwa.
Hukumomin Hong Kong sun kara yawan masu fama da cututtuka masu yaduwa zuwa matakin da ya fi girma kuma sun ayyana dokar ta baci, tare da rufe makarantu har zuwa watan Maris da kuma soke bikin Sabuwar Shekara.
Kasuwanci da ke Turai da Latin Amirka sun ragu da kashi 40 cikin ɗari.
Kasuwancin da ke Arewacin Amirka da Gabas ta Tsakiya sun rage yawan tallace-tallace da kashi 50 zuwa 60 cikin ɗari.
Sakamakon haka, yawan masu zuwa cibiyoyin kasuwanci ya ragu da kashi 33 zuwa 43 cikin dari a watan Maris.
Masu gudanar da cibiyoyin kasuwanci a duk duniya sun gabatar da ƙarin matakan kamar inganta tsaftacewa, sanya kayan aiki don bincika zafin jiki na baƙi da soke abubuwan da suka faru.A cewar kimantawar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki a Latin Amurka wanda cutar ta haifar na iya barin mutane miliyan 1422 a kan iyakar talauci fiye da yadda zai kasance a cikin irin wannan halin da ba tare da cutar ba.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta bulla a birnin Wuhan, mutane kusan miliyan biyar sun rasa ayyukansu a ƙasar Sin.
Yawancin 'yan aikin gona 'yan gudun hijira miliyan 300 na kasar Sin sun kasance a gida a lardunan kasarsu ko kuma a kulle a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimantawar Babban Bankin Tarayya na St. Louis, barkewar cutar coronavirus na iya rasa ayyukan yi miliyan 47 a Amurka, kuma yawan rashin aikin yi na iya kaiwa kashi 32%. Matakan killace kai da aka sanya a Indiya za su bar miliyoyin ma'aikatan Indiya da ke karɓar albashi na yau da kullun ba tare da aiki ba. Binciken da Cibiyar Angus Reid ta gudanar ya nuna cewa kashi 44% na gidajen Kanada sun fuskanci rashin aikin yi ta wata hanyar. Kusan ma'aikata 900,000 na Spain suma sun rasa ayyukansu tun lokacin da aka fara killacewa a Spain a tsakiyar Maris 2020.
A watan Maris, ma'aikata miliyan hudu a Faransa sun nemi tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan daya a Birtaniya sun nemi tallafin biyan albashi guda daya.
An kuma kafa tsarin biyan albashi na ɗan lokaci a Faransa da kuma Ingila.
Har ila yau, al'amuran fasaha da al'adun gargajiya sun sha wahala sosai daga cutar, wanda ya shafi ayyukan ƙungiyoyi da mutane, ko suna aiki ko ba su da aiki, a duk duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙarin tallafawa aikin su (wanda galibi gwamnati ke ba da kuɗi) na samar da damar shiga al'adun al'adu ga jama'a, ta hanyar tabbatar da amincin ma'aikatansu da jama'a, da kuma tallafawa masu fasaha idan ya yiwu.
A watan Maris na 2020, gidajen tarihi, dakunan karatu, dakunan kide kide da wake-wake da sauran cibiyoyin al'adu sun rufe a duk duniya har abada, ko kuma an hana su shiga, kuma an soke ko kuma an sake shirya nune-nunen, abubuwan da aka yi da kuma wasan kwaikwayo.
A maimakon haka, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da ke karuwa na yaduwar kwayar cutar shine soke ayyukan addini, manyan wasanni da sauran abubuwan da ke faruwa a cikin jama'a kamar bukukuwa da kide kide da wake-wake, taron fasaha da nunin kayan kwalliya.
A cikin fim din, akwai wasu matsaloli, kuma Vatican ta sanar da soke taron mako mai tsarki a Roma, wanda aka gudanar a makon karshe na lokacin tuba na Kirista  Azumi Mai Girma.
Da yawa daga cikin majami'un coci sun umurci Kiristoci tsofaffi su zauna a gidajensu kuma kada su halarci ibada a ranar Lahadi; wasu majami'u sun fara watsa wa'azin coci a rediyo, kai tsaye ko talabijin, yayin da shugabannin wasu majami'u suka ba da shawarar gudanar da ibada a waje.
Cocin Roman Katolika na Roma ya rufe majami'unsu, ɗakin sujada da filin St. Peter, inda har yanzu ba a sake ganin mahajjata na Kirista ba, kuma daga baya wasu kungiyoyin addini sun soke ayyukan ibada kuma sun takaita damar yin ibada a cikin majami'u, masallatai, majami'u, temples da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma daga baya aka rufe wuraren ibada; Saudiyya ta hana masu aikin hajji na kasashen waje da mazauna cikin gida shiga wuraren alfarma na Makka da Madina.
Cutar ta kawo gagarumin canji a kalandar wasannin duniya tun bayan Yaƙin Duniya na Biyu.
Yawancin manyan abubuwan wasanni an soke su ko an sake su, gami da gasar zakarun Turai ta 201920, gasar Premier ta 201920, UEFA Euro-2020, kakar NBA ta 201920 da kakar NHL ta 201920.
Cutar kwayar cutar coronavirus ta kuma lalata shirye-shiryen gudanar da wasannin Olympics na bazara na 2020, wanda ya kamata ya fara a ƙarshen Yuli; a ranar 24 ga Maris, Kwamitin Wasannin Olympics na Duniya ya ba da sanarwar cewa za a "jarumtar taron zuwa bayan 2020 amma ba daga baya ba a lokacin bazara na 2021".
Wannan ya haifar da yawancin 'yan wasa sun koma kan layi, kuma yawancin rukunin yanar gizon caca suna ba da rahoton ƙaruwar sabbin masu biyan kuɗi.
Manyan gidajen wasan kwaikwayo da yawa, kamar Broadway, sun soke duk wasan kwaikwayon su.
A matsayin madadin ayyukan gargajiya na waje, wasu masu fasaha da mawaƙa sun fara nazarin zaɓuɓɓukan ci gaba da ayyukansu da raba sakamakon su ta hanyar Intanet, shirya watsa shirye-shiryen raye-raye na kan layi ko bukukuwa na yanar gizo; wannan yana taimaka wa masu fasaha su ci gaba da yin aiki, fitarwa ko buga ayyukansu.
Akwai wasu abubuwan da ke faruwa a yanar gizo da ke da alaƙa da cutar korona, da yawa daga cikinsu suna da ban dariya kuma suna sa mutane su ji daɗin rayuwa a lokacin da babu tabbas.
Tun bayan barkewar cutar COVID-19, an samu karuwar nuna bambanci, nuna kyamar baki da nuna wariyar launin fata ga 'yan kasar Sin da mutanen da ke da asalin gabashin Asiya da kuma mutanen da ke cikin kasashen Turai da Amurka da sauran ƙasashe.
An samu tashin hankali na tsoro, tuhuma da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka da kuma yankin Asiya da Fasifik.
Rahotanni a watan Fabrairu (lokacin da yawancin cututtukan ke cikin kasar Sin) sun nuna wariyar launin fata da aka nuna a kungiyoyi daban-daban a duniya game da 'yan kasar Sin da suka ce sun cancanci cutar ko kuma sun sami sakamako mai kyau.
A wasu kasashen Afirka ma, ana samun karuwar nuna adawa da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci saboda asalin yankin su.
An ba da tallafi ga 'yan kasar Sin da kuma mazauna yankunan da cutar ta shafa, a layi da kuma kan layi.
Cutar ta fara yaduwa a wasu sabbin kasashe, musamman a Italiya  ƙasa ta farko a Turai da ta fuskanci mummunar barkewar COVID-19; saboda haka, 'yan ƙasa a waɗannan yankuna na iya fara fuskantar tasirin tuhuma da ƙiyayya. 'Yan ƙasa kamar Malaysia, New Zealand, Singapore da Koriya ta Kudu a farkon matakin sun sanya hannu kan takarda kai don nace hana' yan ƙasar Sin shiga ƙasashensu don hana cutar.
A Japan, hashtag #ChineseDontComeToJapan (#Sinanci Kada Ku Zo Japan) ya kasance a kan Twitter.
'Yan kasar Sin da sauran mutanen Asiya da ke zaune a Birtaniya da Amurka sun ba da rahoton karuwar nuna wariyar launin fata da harin.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ya kira coronavirus virus na kasar Sin; masu sukar sun ce wannan ra'ayi na wariyar launin fata ne da kuma adawa da kasar Sin.
A Ukraine masu zanga-zanga sun kai hari kan motocin bas da ke jigilar 'yan kasar Ukraine da na kasashen waje da aka kwashe daga Wuhan zuwa New Sanjar.
Daliban da ke zuwa daga arewa maso gabashin Indiya da ke da iyaka da China da kuma manyan biranen Indiya sun ba da rahoton cewa an tsananta musu saboda cutar coronavirus.
Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata a jihar Bengal, ya ce kasar Sin ta lalata muhalli kuma "don haka Allah ya rama musu".
Daga baya, ofishin jakadancin kasar Sin a Calcutta ya yi tir da wannan furucin, yana mai cewa "kurakurai ne". A China, saboda annobar, wariyar launin fata da wariyar launin fata sun sake barkewa ga mazauna da ba 'yan kasar Sin ba: an fara kiran baƙi "sharar gida" da kuma abubuwan da za a yi amfani da su.
Yawancin jaridu masu ba da labarai da aka biya sun kawar da waɗannan ƙuntatawa ga wasu ko duk yankunan da cutar ta shafa.
Yawancin masu wallafa littattafai sun ba da labaransu game da cutar korona.
Wasu masana kimiyya sun yanke shawarar ba da damar gajeren lokaci ga sakamakon binciken su a kan sabobin wallafe-wallafen kamar bioRxiv.
Cutar cututtuka mai yaduwa  Cutar cututtuka daga mai cutar da ke dawowa, wanda ba a san yawan yaduwar ko hanyar watsawa ba
Duniya da cututtuka  Binciken duniya da yaduwar cuta
Jerin cututtuka da cututtuka  Jerin wadanda suka mutu daga cutar kamuwa da cuta
 Kasuwancin dabbobi masu banƙyama yana da lahani ga lafiyar mutane.
Gwajin dakin gwaje-gwaje na coronavirus na numfashi na 2019 (COVID-19) da kuma SARS-CoV-2 mai alaƙa da shi ya haɗa da hanyoyin gano cutar da hanyoyin gano ƙwayoyin cuta da aka samar don amsa kamuwa da cuta.
Ana tabbatar da cutar a cikin samfurin ta hanyar OTC-PCR, wanda ke gane RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne kawai don gano RNA na kwayar SARS-CoV-2.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko masu aiki.
Ana iya amfani da gano kwayoyin cutar (serology) don ganewar asali da kuma manufar sarrafa yawan jama'a.
Ana gwada ƙwayoyin rigakafin don a ga yawan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar da za su iya kai su asibiti ko kuma waɗanda ba su da cutar.
Za a iya sanin ainihin adadin waɗanda suke mutuwa daga wannan cutar da kuma yawan waɗanda suke da rigakafin cutar ta hanyar yin wannan gwajin.
A watan Maris na 2020, babu wata ƙasa da ke da tabbataccen bayani game da yaduwar cutar a cikin jama'a saboda iyakancewar gwajin.
A ranar 23 ga watan Maris, babu wata kasa da ta yi gwajin fiye da kashi uku na al'ummarta, kuma akwai bambancin ra'ayi game da yawan gwajin da aka yi a ƙasashe daban-daban.
Wataƙila, irin wannan bambancin yana shafan yawan mutuwar da ake yi a wasu ƙasashe.
Ana iya yin gwajin ta hanyar amfani da maganin polymerase chain reaction (rRT-PCR) a cikin hanyoyi daban-daban, ciki har da samfurin hanci ko samfurin kumburi.
Ana samun sakamakon a cikin sa'o'i da yawa zuwa kwanaki biyu.
Ana iya yin gwajin PCR na jini a cikin mako na farko na cutar.
Daga baya, ƙwayar za ta iya fita daga makogwaro, amma ta ci gaba da ƙaruwa a cikin huhu.
A cikin marasa lafiya da ke da cutar, ana iya gwada su a mako na biyu na cutar, a matsayin madadin, ana iya ɗaukar abu daga ƙananan hanyoyin numfashi ta hanyar mai tsotsa, ko kuma ana iya amfani da kayan ƙura (scum).
An tsara ɗayan gwajin PCR na farko a asibitin Sharite, Berlin, a cikin Janairu 2020 ta amfani da sake fasalin sarkar polymerase a ainihin lokacin (rRT-PCR) kuma ya zama tushen kayan aiki 250,000 waɗanda daga baya Hukumar Lafiya ta Duniya (WHO) ta rarraba.
A ranar 23 ga Janairun 2020, Burtaniya ta kuma samar da gwajin ta. A ranar 28 ga Janairun 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan aiki don gano SARS-CoV-2 bisa PCR na matakin asibiti (PowerChek Coronavirus).
Yana gano kwayar halitta E, wacce ta zama gama gari ga dukkan beta-coronavirus, da kwayar halitta RdRp, wacce ta dace da SARS-CoV-2. Kamfanin BGI Group na kasar Sin ya zama daya daga cikin kamfanoni na farko da suka sami izinin Hukumar Kula da Magunguna ta kasar Sin don amfani da kayan gaggawa don gano SARS-CoV-2 bisa PCR. A Amurka Cibiyoyin Kula da Cututtuka (CDC) suna rarraba kwamiti na ganowa don yin RT-PCR na ainihi (2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel) a dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar International Reagent Resource.
Ɗaya daga cikin gwaje-gwaje uku na kwayoyin halitta daga tsofaffin nau'ikan gwajin gwajin ya ba da sakamako mara kyau saboda rashin ingantattun abubuwa da kuma ƙarancin yankin gwaji da CDC ke gudanarwa a Atlanta; sakamakon haka a cikin watan Fabrairun 2020 gaba ɗaya, a matsakaita an sami nasarar sarrafa ƙasa da samfuran 100 a kowace rana.
Ba a amince da gwaje-gwaje da ke amfani da abubuwa biyu ba har zuwa 28 ga Fabrairun 2020, kuma bayan wannan ranar ne aka ba da izinin gwaje-gwaje na jihohi da na gida don fara gwaji.
Hukumar Kula da Abinci da Magunguna ta amince da gwajin a matsayin wani ɓangare na izinin gaggawa don amfani. Dakunan gwaje-gwaje na kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da yiwuwar gwajin COVID-19 bisa tushen RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ta fara gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu takunkumin yawa; dole ne a tattara da sarrafa gwaje-gwajen daidai da bukatun CDC.
Cibiyar Nazarin Kimiyya da Kimiyyar Kwayoyin Cutar da Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar Kimiyyar
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta haɓaka gwajin don gano kamuwa da cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don amfani da gwajin wanda za a iya gudanarwa a cikin awanni 3.5 a kan manyan samfuran, yana ba da damar inji ɗaya don sarrafa kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani (EUA) ga dakunan gwaje-gwaje na Abbott don yin gwajin tsarin Abbott m2000; a baya FDA ta ba da irin wannan izinin ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid kuma ta sami EUA daga FDA don gwajin da ke ɗaukar kimanin minti 45.
FDA ta kuma amince da gwajin da ke amfani da fasahar ƙara isothermal nucleic acid maimakon PCR.
Tun da yake ba a bukatar jerin zafin jiki da ke juyawa don yin wannan gwajin, wannan hanyar tana iya nuna sakamako mai kyau cikin minti biyar kawai, kuma mummunan sakamako cikin minti 13.
A halin yanzu akwai kimanin 18,000 na irin waɗannan na'urori a Amurka, kuma Abbott na shirin haɓaka samarwa zuwa gwaje-gwaje 50,000 a kowace rana. A halin yanzu ana haɓaka gwajin a Taiwan ta amfani da kwayar cutar monoclonal, wanda ke ɗaure da furotin nucleocapsid (N-furotin) na sabon coronavirus ta hanyar takamaiman hanya, kuma akwai fatan samun sakamako a cikin mintuna 15-20, kamar gwajin hanzari don mura.
Binciken wallafe-wallafen da aka yi a watan Maris na 2020 ya nuna cewa hotunan X-ray na kirji ba su da ƙimar ganewar asali a farkon matakan, yayin da sakamakon CT [komputa na tomography] na iya samun ƙimar cutar har ma kafin bayyanar cututtuka.
Alamun da aka gano a lokacin CT sun haɗa da ƙwayoyin subpleural masu yawa na biyu da ke da nau'in gilashi mai mahimmanci tare da rarrabawa na gefe, asymmetrical da posterior.
Ƙarƙashin ƙwayar cuta, alamar ƙwayar cuta da kuma ƙarfafawa suna ci gaba yayin da cutar ta ci gaba.
Sakamakon binciken da ya kwatanta hanyoyin PCR da CT da aka yi amfani da su a Wuhan a lokacin da annobar ta barke, ya nuna cewa CT ya fi PCR hankali sosai, kodayake ba shi da takamaiman bayani, saboda yawancin ayyukan gani sun dace da sauran hanyoyin cutar huhu da sauran cututtuka.
Tun daga watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar kada a yi amfani da CT don tantancewa ko a matsayin hanyar gwaji ta farko don gano COVID-19.
Amsar rigakafi ga kamuwa da cuta tana nunawa ta hanyar samar da ƙwayoyin cuta, ciki har da IgM da IgG.
Ana iya amfani da waɗannan ƙwayoyin don gano kamuwa da cuta a cikin mutane bayan kwana 7 na bayyanar cututtuka, don ƙayyade rigakafi da kuma don gudanar da kulawar jama'a. Ana iya yin bincike a cikin cibiyoyin bincike na tsakiya (CLT) ko ta hanyar gano wuri (PoCT).
A yawancin dakunan gwaje-gwaje na asibiti, za a iya yin waɗannan gwaje-gwajen ta hanyar tsarin sarrafa kansa mai ƙarfi, amma samunsu zai dogara da saurin samar da kowane irin wannan tsarin.
A CLT, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfurori na jerin don lura da amsawar rigakafi.
A lokacin PoCT, ana ɗaukan jini guda ɗaya ta hanyar huda fatar jiki.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin ɗaukar jini don ɗaukar gwajin gwaji. A ranar 26 ga Maris, 2020, FDA ta ambaci ƙungiyoyi 29 waɗanda suka bi duk hanyoyin rajista da ake buƙata kuma yanzu za su iya rarraba gwaje-gwajen su don ƙwayoyin cuta.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai don izinin gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don amfani da kayan gwajin su, waɗanda za su iya gano IgG da IgA antibodies a cikin samfuran jini waɗanda ke da ikon yaƙar cutar.
Ana iya yin gwajin a kan ɗaruruwan samfurori a cikin sa'o'i da yawa, kuma hakan yana sa gwajin ya fi saurin yin amfani da PCR.
Ana iya gano kwayoyin cutar bayan kwana 14 da kamuwa da cutar.A farkon watan Afrilu, Burtaniya ta gano cewa babu wani kayan gwajin kwayoyin cutar da ta saya da ya ba da sakamako mai gamsarwa.
A Hong Kong, an tsara wani tsari don barin marasa lafiya da ake zargi da cutar a gida: ma'aikatan sashen gaggawa suna ba da gwajin ga mai haƙuri don samfurin, mai haƙuri ya tofa a ciki, ya mayar da shi kuma bayan ɗan lokaci ya sami sakamakon gwajin. NHS na Burtaniya ta sanar da ƙaddamar da shirin gwajin gwaji na marasa lafiya a gida, wanda ke kawar da haɗarin kamuwa da cutar daga mai haƙuri ga sauran masu zuwa asibiti, ko buƙatar kashe ƙwayoyin cuta na motar gaggawa idan an yi amfani da ita don jigilar mai haƙuri. A lokacin gwajin gaggawa don COVID-19, a cikin yanayin da ake zargi, ma'aikacin kiwon lafiya yana yin gwaji ta amfani da duk matakan kariya da suka dace.
Cibiyoyin gwajin gaggawa sun taimaka wa Koriya ta Kudu ta shirya ɗayan hanyoyin gwaji mafi sauri da girma fiye da kowace ƙasa.A ranar 2 ga Maris a Jamus, Kungiyar Likitocin Kula da Lafiya ta Kasa ta ce a shirye take ta gudanar da gwaje-gwaje kusan 12,000 a rana a cikin yanayin asibiti, yayin da mako guda da suka gabata za su iya yin gwaje-gwaje 10,700 a mako.
Idan likita ne ya rubuta maka wannan jarrabawar, inshorar lafiya za ta biya maka kuɗin.
Shugaban Cibiyar Robert Koch ya ce, Jamus tana yin gwaji 160,000 a mako.
A ranar 19 ga Maris, an ba da shawarar yin gwajin gaggawa a manyan birane da yawa.
A ranar 26 ga Maris, 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda sakamakon da aka samu kawai tabbatacce ne.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a cikin mako na kalandar 12/2020, an ɗauki aƙalla gwaje-gwaje 483,295 don SARS-CoV-2 har zuwa mako na 12/2020, kuma a cikin samfurin 33,491 (6.9%) sakamakon ya kasance tabbatacce. Masu bincike a asibitocin Technion da Rambam Hospital na Isra'ila sun haɓaka da gwada hanyar gwajin samfuran da aka ɗauka daga marasa lafiya 64 a lokaci guda, haɗa samfuran kuma kawai yin ƙarin gwaji idan samfurin haɗin ya nuna sakamako mai kyau. A Wuhan, a ranar 5 ga Fabrairu, 2020, Kamfanin BGI ya buɗe dakin gwaje-gwaje na wucin gadi na murabba'in mita 2000 mai suna  Hu-Yuan (Chinese Fire-Eye or Ocular Eye), wanda zai iya sarrafa sama da samfuran 10,000 a rana.
Wanda ya kafa BGI, Wang Jian, ya shirya gina wannan dakin gwaje-gwaje kuma an kammala shi cikin kwanaki 5 kawai; ƙirar ta nuna cewa idan ba a ba da wannan dakin gwaje-gwaje ba a cikin irin wannan saurin, cututtukan cutar a Hubei za su karu da kashi 47%, kuma, bisa ga haka, farashin keɓewa zai ninka sau biyu.
Bayan an buɗe dakin gwaje-gwaje a Wuhan, nan da nan aka buɗe dakin gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing da Shanghai  a cikin birane 12 na kasar Sin.
A ranar 4 ga Maris, 2020, yawan gwajin yau da kullun ya kai 50,000 a kowace rana. An saki tsarin Origami Assays na buɗewa wanda zai iya gwada har zuwa gwaje-gwaje 1,122 na marasa lafiya don COVID19 ta amfani da allunan 93 kawai. Irin waɗannan ƙirar daidaitaccen tsari na iya aiki a cikin ƙananan dakunan gwaje-gwaje, ba tare da buƙatar amfani da masu sarrafa ruwa na robotic ba.
A watan Maris, saboda ƙarancin magungunan, gwajin mutane da yawa a EU, Birtaniya da Amurka ya zama matsala.
Sakamakon haka, wasu marubuta sun juya zuwa ga tsarin sarrafa samfurin gwaji, wanda ke ba da damar dumama samfuran a 98 ° C (208 ° F) na tsawon minti 5 don sakin kwayoyin halittar RNA don ƙarin gwaji.A ranar 31 ga Maris, an ba da sanarwar cewa gwajin coronavirus da Hadaddiyar Daular Larabawa ke yi a kan kowane mutum a halin yanzu ya fi na kowace ƙasa, kuma ba da daɗewa ba za a gwada yawancin jama'a.
Wannan ya faru ne saboda damar yin gwajin gaggawa, tare da siyan dakin gwaje-gwaje na yawan jama'a daga Group 42 da BGI (wanda aka kirkira bisa ga dakin gwaje-gwajen gaggawa na Huo-Yan a China).
Wannan dakin gwaje-gwaje da aka gina a cikin kwanaki 14 yana iya yin dubban gwaje-gwaje na PCR a kowace rana kuma shi ne na farko a duniya da aka gina a wannan babban filin waje da kasar Sin.
An samar da gwaje-gwaje daban-daban da ke nuna sassa daban-daban na kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da tsarin gwajin da Jamus ta yi, kuma ana turawa ƙasashe masu ƙarancin kuɗi da ba su da isashen kuɗi don yin gwajin.
An buga sigar Jamusanci a ranar 17 ga Janairun 2020; yarjejeniyar da cibiyoyin cututtukan cututtukan cututtukan Amurka suka tsara ba ta samuwa har zuwa 28 ga Janairu, wanda ya haifar da rashin kayan gwaji a Amurka. A farkon barkewar cutar, China da Amurka sun fuskanci matsalolin amincin kayan gwajin, kuma waɗannan ƙasashe, da Australiya, ba su iya samar da isasshen kayan aikin da masana kiwon lafiya suka ba da shawarar ba.
A Koriya ta Kudu, masana sun ce, yin gwajin ya taimaka wajen rage yaduwar cutar.
A cikin shekaru da dama, gwamnatin Koriya ta Kudu ta yi aiki don samar da damar yin gwaji, galibi a dakunan gwaje-gwaje masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau ta rage yaduwar cutar COVID-19. Sakamakon karuwar bukatar gwaji da yaduwar cutar ta haifar, dakunan gwaje-gwaje masu zaman kansu da yawa na Amurka da ke karɓar ɗaruruwan dubban samfuran gwaje-gwaje sun cika, kuma kayan adana kayan shafawa da masu sarrafa sinadarai suna saurin ƙarewa.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton matsalolin da ke tattare da daidaito na kayan gwajin ta.
Kayan gwajin Amurka da CDC ta haɓaka suna da "rauni", kuma saboda wannan dalili gwamnati ta kawar da shingen hukuma wanda ke hana haɓaka gwaje-gwaje na masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya zama sakamakon rashin samfurori ko kuma rashin amfani da samfurori.
Ma'aikatar ta Spain ta ce za ta dawo da kayan aikin da ke ba da sakamako mara kyau kuma za ta maye gurbinsu da wasu kayan aikin  na kamfanin Shenzhen Bioeasy. 80% na kayan gwajin da Czech ta saya daga China sun ba da sakamako mara kyau.
Firayim Minista Matović ya ba da shawarar zubar da su a cikin Danube. Atesh Kara, wani ma'aikacin Ma'aikatar Lafiya ta Turkiyya, ya yi iƙirarin cewa kayan gwajin da aka saya daga China suna da "manyan kurakurai" kuma Ma'aikatar "ba ta amfani da su ba".
Matakan keɓewa ga mutanen da gwajin su ya nuna sun kamu da SARS-CoV-2, da kuma lura da mutanen da suka yi hulɗa da irin waɗannan marasa lafiya, sun sami sakamako mai kyau.
Masu bincike da ke aiki a birnin Vauxhall na Italiya, inda mutum ya fara mutuwa daga COVID-19 a Italiya, sun yi gwaje-gwaje biyu na mutane 3,400 a tsakanin kwanaki goma.
Kimanin rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an killace duk marasa lafiyar da suka kamu da cutar.
An rufe hanyar shiga yankin kuma an dakatar da yaduwar cutar gaba daya.
A cikin yanayin sa ido kan hulɗa, ƙuntatawa na shiga, gwaji da matakan keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta kasance mai sauƙi fiye da sauran ƙasashe masu tasowa, kuma ba a buƙatar sanya ƙuntatawa masu tsanani kamar tilasta rufe gidajen abinci da shaguna.
An soke ayyuka da yawa a can, kuma a ranar 28 ga Maris, Singapore ta fara ba da shawarar mazauna su zauna a gida, amma makarantun da suka ƙare a ranar 23 ga Maris sun sake buɗewa kamar yadda aka tsara.
Wasu ƙasashe kamar Iceland da Koriya ta Kudu sun shawo kan annobar ta hanyar bin diddigin lamba, ƙuntatawa, gwaji da kuma keɓewa, amma ba su da ƙarfi sosai.
Binciken ya nuna cewa a ƙasashen da aka yi gwaje-gwaje da yawa fiye da waɗanda suka mutu, yawan mutuwar ya ragu sosai, wataƙila domin waɗannan ƙasashe sun sami ƙarin marasa lafiya da ba su da alamun cutar ko kuma ba su da alamun cutar.
WHO ta ba da shawarar ƙasashe da ba su da albarkatun gwaji da yawa, da kuma dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙarancin ƙwarewa a cikin COVID-19, su aika da sakamakon gwajin COVID-19 biyar na farko da farkon sakamako mara kyau goma zuwa ɗayan dakunan gwaje-gwaje na 16 na WHO don tabbatarwa.
7 daga cikin 16 na gwajin suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka, 1 kuma a Ostiraliya.
A cikin zane mai zuwa, kashi % na sakamakon da aka samu ya dogara da tsarin gwajin da aka yi a wata ƙasa.
Ƙasar da ke gwada marasa lafiya a asibiti kawai za ta sami sakamako mafi kyau idan aka kwatanta da ƙasar da ke gwada dukan 'yan ƙasa, ko da suna da alamun cutar ko a'a, a ƙarƙashin yanayi iri ɗaya.
Wanke hannu, wanda aka fi sani da higiene  , tsari ne na tsabtace hannu don kawar da gurɓataccen abu, mai, ƙwayoyin cuta ko wasu abubuwa masu cutarwa.
Wanke hannuwanmu da sabulu a wasu lokatai na musamman a rana yana hana yaduwar cututtuka da yawa, kamar zawo da kwalara, waɗanda ke yaduwa ta hanyar ƙazanta.
Mutum zai iya kamuwa da cututtukan numfashi kamar mura ko sanyi idan ya taɓa idanunsa, hancinsa ko bakinsa da hannunsa da ba a wanke ba.
Abubuwa biyar masu muhimmanci da ya kamata a yi a wanke hannu da sabulu a rana su ne: kafin da kuma bayan yin fitsari, bayan wanke bayanwar jariri ko canja diapers, kafin ciyar da jariri, kafin cin abinci, kafin da kuma bayan dafa abinci ko sarrafa nama, kifi da kuma kaji.
Idan ba a sami sabulu da ruwa ba, za ka iya wanke hannuwanka da toka.
Kafin, sa'ad da, da kuma bayan ka dafa abinci.
Kafin da kuma bayan kula da marar lafiya.
Bayan an canja diaper ko kuma bayan an wanke yaro bayan ya je bayan gida.
Bayan da ka yi hanzari, tari ko hancin ƙanƙara.
Bayan ka taɓa dabbobi ko abincin dabbobi ko kuma ƙwayoyin da suka ɓace.
Lafiyar hannu ta likita tana nufin aikin tsabtace jiki da ke tattare da aikin likita.
Wanke hannu kafin shan magani ko kuma yin jinya zai taimaka wajen hana ko kuma rage yaduwar cutar.
Babban manufar wanke hannu a fannin kiwon lafiya shi ne a tsabtace hannaye daga ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da ke iya haifar da cuta), da kuma daga sinadarai da za su iya zama masu cutarwa ko kuma su haifar da wasu cututtuka.
Wannan yana da muhimmanci musamman ga waɗanda suke dafa abinci ko kuma waɗanda suke aikin kiwon lafiya, amma yana da muhimmanci ga kowa.
Wanke hannu yana da amfani ga lafiyar jiki, kamar rage yaduwar mura da korona da sauran cututtuka masu yaduwa, hana cututtukan gudawa, rage yaduwar cututtukan numfashi,
kuma yana rage yawan mutuwar jarirai a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu da kyau zai iya sa yara su yi girma da sauri kafin su kai shekara biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da na zawo ta wajen yin ayyuka masu sauƙi kamar wanke hannu da sabulu.
Wannan hanya ce mai sauƙi da za ta iya rage mutuwar waɗannan cututtuka da kusan kashi hamsin cikin ɗari.
Tunatarwa game da amfanin wanke hannu a kai a kai zai iya rage yawan masu zazzaɓin jini da kashi ɗaya cikin uku, kuma hakan zai iya zama kamar yadda samun ruwa mai tsafta a yankunan da ba su da kuɗi sosai zai iya taimaka.
Rage yawan masu zazzabin jini da kashi 48 cikin dari na iya kasancewa ne ta hanyar wanke hannu da sabulu. Wanke hannu da sabulu  hanya ce guda mafi inganci da tsada don hana zazzabin jini da cututtukan numfashi masu saurin kamuwa da su (SARS) idan aka kafa halaye masu dacewa a kowane gida, makaranta da sauran wuraren jama'a a duniya.
Ciwon huhu, wanda shi ne babban ciwo da ke tattare da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Cutar gudawa da ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
Hukumar Kula da Yara ta Majalisar Ɗinkin Duniya ta ce wanke hannu da sabulu kafin cin abinci da kuma bayan bayan gida zai iya ceton rayuka fiye da allurar riga-kafi ko kuma magani, kuma zai rage mutuwar masu zazzaɓin jini kusan rabin, kuma zai rage mutuwar masu kamuwa da cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana yawanci haɗa wanke hannu da wasu ayyukan tsabtace jiki da ake yi a cikin shirin samar da ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana hana kamuwa da cutar impetigo , wadda ke yaduwa ta hanyar saduwa da mutum kai tsaye.
Wani mummunar sakamako da wanke hannu sau da yawa yake da shi shi ne, zai iya sa fata ta bushe kuma ta lalace.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu yana iya sa mutum ya yi ƙaiƙayi da kuma yin fata  wata cuta da ake kira eczema ko kuma cututtukan fata na hannu, wadda ta fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa zai iya zama alamar rashin lafiyar jiki.
Akwai abubuwa biyar da ake kira matsalar lokaci a cikin rana inda wanke hannu da sabulu yana da mahimmanci don rage haɗarin kamuwa da cutar ta hanyar fitsari: bayan zubar da ciki (yin fitsari, zubar da ciki), bayan wanke ƙashin jariri (canza diapers), kafin ciyar da jariri, kafin cin abinci da kafin / bayan dafa abinci ko sarrafa nama, kifi ko kaji.
Wasu lokatai da ya kamata a wanke hannu don hana kamuwa da cuta su ne kafin ko bayan an yi aiki da rauni ko rauni, bayan yin atishawa, tari ko hancinsa, bayan an taɓa shara ko dabbobi, bayan an taɓa shara.
A ƙasashe da yawa, wanke hannu da sabulu ba a yi amfani da shi sosai ba.
Binciken wanke hannu da aka gudanar a shekarar 2015 a kasashe 54 ya nuna cewa a matsakaita kashi 38.7% na iyalai suna wanke hannu da sabulu  al'ada ce da aka yarda da ita. Binciken na 2014 ya nuna cewa mafi girman adadin, kashi 97%, an samu a Saudiyya; Amurka a cikin wannan jerin tana kusa da tsakiyar, da kashi 77%; mafi ƙarancin adadin an samu a China  23%. A halin yanzu akwai wasu hanyoyin canza halaye da haɓaka al'adun wanke hannu da sabulu a cikin mawuyacin yanayi. A cikin ƙasashe masu tasowa, wanke hannun ɗalibai a cikin rukuni a lokacin da aka tsara na rana  ɗayan hanyoyin ne da ke taimaka wa yara su koya wa irin wannan aikin.
Shirye-shiryen Kula da Lafiya na gaggawa na Ma'aikatar Ilimi ta Philippines  misali ne na manyan ayyuka na inganta lafiyar yara da kuma inganta ilimin yara.
Wannan shirin na ƙasa ya ƙunshi wanke hannuwanku da sabulu da kuma goge haƙoranku da ruwa sau biyu a shekara.
An yi irin wannan shirin a ƙasar Indonesia.
Ana iya kawar da ƙwayoyin cuta daga fata idan aka ƙara sabulu ko kuma kayan wanki.
Babban aikin sabulu da kayan wanki shine kawar da shinge don narkewa da kuma ƙara yawanta.
Ba a ɗaukan ruwa da kansa a matsayin mai tsabtace fata mai kyau domin kitse da furotin da ke cikin ƙazantar ƙwayoyin halitta ba sa narkewa sosai.
Amma idan akwai ruwa sosai, zai taimaka wajen wanke jikin.
Sabulu mai tauri, saboda ana amfani da shi sau da yawa, zai iya ƙunsar ƙwayoyin cuta da za su iya shiga cikin sa idan aka yi amfani da shi a baya.
Ƙananan bincike da aka yi game da ƙwayoyin cuta da ke cikin fata da ke cikin sabulu mai ƙazantawa sun nuna cewa ba za su iya shiga cikin fata ba domin ana wanke su da kumfa.
Cibiyar Kula da Lafiya ta Duniya ta ce sabulu mai ruwa da ke dauke da ruwan hannu ne ya fi dacewa wajen wanke hannu.
Ana yin tallace-tallace sosai don sabulu na ƙwayoyin cuta a cikin al'ummomin da suke kula da lafiyarsu.
A yau, babu wata shaida da ta nuna cewa maganin kashe ƙwayoyin cuta da ake ba da shawarar yana shafar ƙwayoyin cuta da ke da ƙarancin ƙwayoyin cuta.
Amma sabulu na ƙwayoyin cuta yana ɗauke da magungunan ƙwayoyin cuta kamar su triclosan, wanda ƙwayoyin cuta da yawa suke jurewa.
Saboda haka, ko da kwayoyin da ba su da ƙwayoyin cuta ba su da kyau a kan sabulu na ƙwayoyin cuta, amma ba su da tasiri kamar yadda aka yi talla.
Baya ga kayan aiki na farfajiya da kayan kare fata, mahadi masu rikitarwa na iya ƙunsar acid (acetic acid, ascorbic, madara) a matsayin mai daidaita pH, da kuma maganin antimicrobial aiki benzoic acid da sauran abubuwan shaƙatawa (aloe vera, bitamin, menthol, tsire-tsire masu tsire-tsire).
Ruwa mai zafi da ke da kyau ga fatar mutum ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin cuta suna yawaita da sauri a zafin jiki na 37 ° C.
Amma, ruwan sabulu mai ɗumi ya fi ruwan sanyi amfani wajen kawar da kitse na halitta da ke hana ƙazantawa da ƙwayoyin cuta.
Akasin abin da mutane da yawa suke tsammani, bincike ya nuna cewa shan ruwan zafi ba ya rage ƙwayoyin cuta a hannuwanmu.
Maganin kashe ƙwayoyin cuta na hannu (sanitizer) ko maganin kashe ƙwayoyin cuta na hannu  kayan aikin tsabtace hannu ne, ba tare da ruwa ba.
A ƙarshen shekarun 1990 da farkon karni na 21, kayan aikin tsabtace hannu na giya da ba su da ruwa sun zama sananne (wanda aka fi sani da kayan aikin kashe ƙwayoyin cuta na giya, maganin kashe ƙwayoyin cuta na hannu ko masu tsabtace jiki).
Yawancin waɗannan kayan aikin an yi su ne bisa tushen isopropyl alcohol ko ethanol tare da ƙara kayan ƙyama kamar carbomer (polymer na acrylic acid) a cikin gel, ko moisturizers kamar glycerin a cikin ruwa ko kumfa, wanda ke ba da damar amfani da waɗannan kayan aikin kuma yana rage tasirin bushewar fata da barasa.
Ƙara hydrogen peroxide mai narkewa yana ƙara ƙwayar cuta. Magungunan kashe ƙwayoyin cuta da ke da kashi 60 zuwa 95 cikin ɗari na barasa suna kashe ƙwayoyin cuta.
Magungunan kashe ƙwayoyin cuta na barasa suna kashe ƙwayoyin cuta, ciki har da ƙwayoyin cuta masu jurewa da yawa (MRSA da VRE), ƙwayar tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis) da fungi.
Magungunan kashe ƙwayoyin cuta da ke dauke da kashi 70% na barasa suna kashe kashi 99.97% na ƙwayoyin cuta (ƙarancin logarithm na 3.5 daidai yake da raguwa da decibel 35) a hannaye bayan daƙiƙa 30 bayan amfani da su da kuma kashi 99.99%  99.999% na ƙwayoyin cuta (ƙarancin logarithm 45) a hannaye bayan minti 1 bayan amfani da su.
Magungunan kashe ƙwayoyin cuta na tushen giya kusan ba su da tasiri a kan ƙwayoyin cuta na Norovirus (ko Norwalk), wanda shine mafi yawan sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ana shafa fuska da bayan hannu biyu da kuma tsakanin yatsunsu a tsawon sa'o'i 30 har sai ruwan ya sha ko kuma ya sha ko kuma ya yi sanyi.
Ƙarfin yatsun hannu a hannaye biyu ma ya kamata a wanke sosai. Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar yin wanke hannu maimakon amfani da maganin kashe ƙwayoyin cuta, musamman idan hannuwan suna da ƙazanta sosai.
An san waɗannan magungunan da amfani da su da sauri kuma suna kashe ƙwayoyin cuta, amma ba za su iya maye gurbin wanke hannu ba idan akwai ruwa da sabulu.
Yin amfani da kayan kashe ƙwayoyin cuta na hannu da yawa a kan barasa zai iya haifar da bushewar fata, idan sun ƙunshi kayan shafawa da (ko) moisturizers na fata.
Za a iya rage ko kawar da tasirin bushewar fata da barasa ta hanyar ƙara glycerin da (ko) wasu abubuwa masu laushi a cikin kayan aiki.
A gwaji na asibiti, maganin kashe ƙwayoyin cuta na hannu da ke ɗauke da barasa da ke ɗauke da abubuwa masu saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin
Ba a yawan samun cututtukan fata na haɗuwa da haɗari, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ƙananan yiwuwar cutar cututtukan fata na haɗuwa ya zama dalilin da ya sa za a zabi kayan shafawa fiye da sabulu da ruwa.
Ko da yake waɗannan kayan aikin suna da amfani sosai, amma ba sa wanke hannuwanku daga ƙwayoyin cuta.
Saboda haka, maganin kashe ƙwayoyin cuta na hannu ba ya hana ƙwayoyin cuta yawaita yaduwa kamar sabulu da ruwa, domin idan aka yi amfani da su, ƙwayoyin cuta suna ci gaba da kasancewa a hannu.
Amfani da maganin kashe ƙwayoyin cuta na hannu wanda ba ya dauke da barasa ya dogara da abubuwan da ke ciki da kuma abun da ke ciki, kuma a tarihi ya kasance ƙasa da ƙasa fiye da barasa ko kayan maye.
A kwanan nan, an nuna cewa magunguna da ke ɗauke da benzalkonium chloride suna da tasiri mai ƙarfi da kuma ƙwayar cuta, amma barasa yana da lahani idan aka yi amfani da shi sau da yawa, wataƙila don ci gaba da cutar fata.
Mutane da yawa a cikin ƙananan al'ummomi ba za su iya sayen sabulu ba kuma suna amfani da yumbu ko yumɓu a madadinsa.
Ƙura ko yumɓu suna iya yin aiki fiye da ruwa, amma ba su da amfani kamar sabulu.
Amma, wata matsala da wannan hanyar take da ita ita ce, idan laka ko toka tana da ƙwayoyin cuta, hakan zai iya sa cutar ta yaɗu.
Kamar sabulu, toka tana kashe ƙwayoyin cuta domin tana sa ruwa ya zama ruwan gishiri.
Idan ba a samun sabulu, Hukumar Lafiya ta Duniya ta ce a yi amfani da toka ko yashi.
Cibiyar Kula da Cututtuka ta Amirka ta ce yin wanke hannu yana da muhimmanci don hana kamuwa da cutar.
Ka wanke hannuwanka da ruwan sanyi ko mai ɗumi.
Ana ba da shawarar ruwan da ke gudana domin yana iya gurɓata ruwa, amma yawan zafin ruwan ba shi da muhimmanci.
Ka wanke hannayenka da sabulu mai yawa, har da bayan hannu, tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa idan mutane suka yi amfani da sabulu (maimakon ruwa kawai) suna iya wanke hannayensu sosai.
Ka shafa hannayenka na akalla dakika 20.
Rubbing yana taimaka wajen kawar da ƙwayoyin cuta daga fata, kuma idan ka riƙa shafa hannunka, za ka iya kawar da ƙwayoyin cuta.
Ka wanke hannayenka sosai da ruwan da ke gudana.
Rage hannuwanku cikin ruwa mai ɗumi zai iya sa ku sake kamuwa da cutar.
Ka goge hannayenka da tawul mai tsabta ko kuma ka bar su su bushe da kansu.
Hannun da suke da rigar suna da saukin kamuwa da cutar, kuma mutane sukan manta da su a wurare kamar babban yatsa, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusoshin ƙafafunsu.
Ƙwaƙwalwar da aka yi da ƙusa da kuma ruwan ƙusa da aka yi da ƙusa zai iya ɗauke da ƙwayoyin cuta da yawa.
Ana yawan ba da shawarar yin amfani da ruwan shafa don hana bushewar fata na hannu, wanda zai iya haifar da lalacewar fata da kuma ƙara haɗarin kamuwa da cuta.
Idan ruwa mai gudana da sabulu ba su da yawa, akwai hanyoyi daban-daban masu rahusa don wanke hannu: zubar da ruwa daga kwalban da ke rataye ko kwalbar kwalba tare da ramuka da aka yi, da / ko amfani da toka idan ya cancanta, kamar yadda ake yi a ƙasashe masu tasowa.
Faucet tare da ƙafafun ƙafa  tsari ne mai sauƙi, wanda ya ƙunshi wani akwati da aka rataye a kan igiya, da kuma ƙafafun kafa, wanda ya kamata a danna don ruwa ya zuba a hannunka; a wannan yanayin ya kamata a yi amfani da sabulu.
Drying hannaye  wani ɓangare ne na aikin tsabtace hannu, amma akwai wasu muhawara game da mafi kyawun bushewa a cikin gidan wanka.
Bincike da yawa sun nuna cewa takarda da aka yi amfani da ita tana da tsabta fiye da na'urar busar hannu da ake amfani da ita a gidajen wanka.
A shekara ta 2008, Jami'ar Westminster a London ta gudanar da bincike, wanda aka tallafawa ta hanyar taron Turai game da samar da takarda takarda da tawul; batun wannan binciken shine kwatanta matakan tsabtace takarda, bushewar hannu tare da iska mai dumi da kuma kayan bushewa na hannu na zamani.
An gano cewa bayan an wanke hannuwanku kuma an bushe su a cikin na'urar busar da iska mai dumi, adadin ƙwayoyin cuta a kan yatsunsu ya ƙaru da kashi 194 cikin ɗari, kuma a kan hannayen hannu ya ƙaru da kashi 254 cikin ɗari.
An kuma gano cewa bayan an wanke hannuwanku kuma an bushe su a cikin na'urar busar da iska, adadin ƙwayoyin cuta a kan yatsunsu ya ƙaru da kashi 42 cikin ɗari, kuma a kan hannayenku ya ƙaru da kashi 15 cikin ɗari.
Bayan wankewa da kuma bushe hannuwanku da tawul ɗin takarda, yawan ƙwayoyin cuta a kan yatsunsu ya ragu da kashi 76 cikin ɗari, kuma a kan hannayen hannu ya ragu da kashi 77 cikin ɗari.
Wannan na'urar busar da iska da ke fitar da iska a saurin da aka ce tana zuwa mita 180 a kowane lokaci (kilomita 650 a awa daya, mil 400 a awa daya) tana iya fitar da kwayoyin cuta daga hannayenmu da kuma daga cikin ɗakinmu kuma tana iya cutar da wasu masu amfani da gidan wanka da kuma gidan wanka a cikin radius na mita biyu.
Yin amfani da na'urar busar hannu da iska mai ɗumi yana sa ƙwayoyin cuta su yadu a nisan mita 0.25 daga wurin busar.
A shekara ta 2005, kamfanin TÜV Produkt und Umwelt ya gudanar da bincike don kimanta hanyoyin bushewa na hannu.
Ana ganin waɗannan canje-canje a cikin adadin kwayoyin cuta dangane da hanyar bushe hannu:
Akwai masana'antun busar hannu da yawa, kuma ana kwatanta busar hannu da busar takarda.
Tsabtace hannu da kayan wanke hannu zai iya zama wata hanya ta musamman a lokacin da ba ku da sabulu da ruwa.
Ya kamata maganin kashe ƙwayoyin cuta na hannu da ke da barasa ya ƙunshi giya aƙalla kashi 60 cikin ɗari.
Hanyar wanke hannu ta zama dole tun da daɗewa bayan likitan Hungary Ignaz Zemmelweis ya gano ingancinsa (a shekara ta 1846) a cikin rigakafin cututtuka a cikin yanayin asibiti.
Akwai na'urorin lantarki da ke tunasar da ma'aikatan asibiti cewa idan sun manta su wanke hannayensu, suna bukatar su yi hakan.
Wani bincike ya nuna cewa yin amfani da waɗannan na'urorin yana taimaka wa mutane su rage kamuwa da cutar.
Wanke hannu na likita yana da tsawon akalla dakika 15, kuma ana amfani da sabulu da ruwa da kuma gel da yawa don wankewa da kuma goge kowane sashi na hannu.
Ya kamata a shafa hannayenku sosai, a haɗa yatsunsu.
Idan akwai datti a ƙarƙashin ƙusa, za ka iya cire shi da goga.
Tun da yake ƙwayoyin cuta za su iya kasancewa a cikin ruwa da ke hannayenku, yana da muhimmanci ku wanke su sosai kuma ku goge su da tawul mai tsabta.
Bayan ka bushe hannuwanka, ka rufe famfo da kuma kofar idan ya cancanta, ka yi amfani da tawul na takarda.
Hakan zai taimaka wajen hana hannuwanku sake ƙazantar da su.
Manufar wanke hannu a cibiyoyin kiwon lafiya  kawar da ƙwayoyin cuta (microbes) da hana yaduwar su.
Jaridar New England Journal of Medicine ta ce, a yawancin wuraren kiwon lafiya, ana ci gaba da yin rashin tsabta ta wajen manta da wanke hannu kafin a taɓa marasa lafiya, kuma hakan yana sa mutane su riƙa samun ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka na yau da kullum za su iya rage yawan kamuwa da cututtukan jini da ke tattare da amfani da bututun ruwa da kashi 66 cikin ɗari.
Ana kuma iya samun littafin WHO game da tsabtace hannu a shafin yanar gizon ta kuma ana iya tattauna shi a fili.
Whitby ya yi bita mai dacewa tare da marubuci.
Idan ana bukatar a tabbatar da cewa an cika dokokin, za a iya amfani da na'urorin kasuwanci don auna ƙimar da kuma bincika tsabtace hannu.
Ƙungiyar Lafiya ta Duniya ta bayyana abubuwa biyar da ya kamata a yi wanka a kai:
bayan haɗuwa da jini ko ruwa mai narkewa,
kafin amfani da maganin kashe ƙwari, da
Bayan kula da marasa lafiya, ƙara sinadarai masu hana ƙwayoyin cuta a sabulu da ake wanke hannu (sabon magani ko sabulu mai hana ƙwayoyin cuta) zai taimaka wajen kashe ƙwayoyin cuta.
Irin wannan kayan maganin antibacterial na iya zama dole kafin gudanar da tiyata ko a cikin yanayin da ke da ƙwayoyin cuta masu jurewa. Don tsabtace hannayenka kafin tiyata, ana buƙatar famfo wanda za a iya kunnawa da kashewa ba tare da taɓa hannayenka ba; Hakanan ya kamata a yi amfani da ɗan chlorhexidine ko ruwan iodine don goge hannayenka, tawul ɗin tsabta don bushe hannayenka bayan wanka, goga mai tsabta don shafawa da wani kayan aikin tsabta don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Wannan aikin yana bukatar wanke hannu da kuma gwiwoyi har zuwa gwiwar hannu a cikin minti 2 zuwa 6.
Ba ka bukatar ka shafe tsawon lokaci, kamar minti goma.
Sa'ad da kake wankewa, kada ruwan da ke cikin hannayenka ya koma cikin hannayenka.
Bayan an gama wankewa, ana bushe hannaye da zane mai tsabta kuma ana saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da mai ciwo.
Don magance cututtukan staph a asibitoci, an gano cewa kashi 20 cikin dari na wanke hannu ne ke kawo amfanin wanke hannu, kuma ba a sami ƙarin fa'idodi ba idan aka ƙara yawan wanke hannu da kashi 35 cikin ɗari.
Idan aka kwatanta da wanke hannu da sabulu mai hana kwayar cuta, wanke hannu da sabulu na yau da kullun yana haifar da karuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Koyaya, sabulu da ruwa har yanzu sun fi maganin hannu na giya tasiri wajen rage yawan cutar mura A H1N1 da cutar Clostridium difficile a hannayenku. Ayyukan haɓaka tsabtace hannu a cibiyoyin kiwon lafiya na iya haɗawa da horar da ma'aikata kan wanke hannu, haɓaka wadatar maganin hannu mai shan giya, da kuma tunatar da ma'aikata a rubuce da magana game da buƙatar wanke hannu.
Ana bukatar ƙarin bincike a kan hanyoyin da suka fi dacewa a wasu wuraren kiwon lafiya.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai sauƙi da kuma muhimmanci don inganta lafiyar jiki har ma da narkewa.
Amma, rashin ruwa da sabulu da kuma kayan wanke hannu a gida, makaranta, da kuma wuraren aiki yana hana mutum yin wanke hannu a kai a kai.
Alal misali, a yawancin yankunan karkara na Afirka, ba kowane bayan gida ko gidan wanka na jama'a ba ne ke da famfunan wanke hannu, ko da yake akwai hanyoyi masu sauƙi na yin hakan.
Amma, rashin tsabtace hannu yana iya zama sanadin ƙarancin sabulu da ruwa ba.
Tallafawa da ƙarfafa wanke hannu da sabulu na iya shafar yanke shawara na siyasa, haɓaka wayar da kan jama'a game da amfanin wanke hannu da haifar da canje-canje na dogon lokaci a cikin halayen jama'a.
Don tabbatar da ingancin irin waɗannan matakan, dole ne a gudanar da sa ido da kimanta sakamakon.
A cikin nazarin bincike na bincike 70, an gano cewa kula da cututtukan cututtuka a matakin al'umma yana da tasiri don inganta yanayin tsabtace hannu a ƙasashe masu matsakaicin kuɗi, yayin da kamfen ɗin tallan jama'a ba shi da tasiri. Misali ɗaya na tallatawa game da wanke hannu a makarantu shine tsarin UNICEF na Three Star Approach: yana ba da shawarar aiwatar da matakan tattalin arziki masu sauƙi a makarantu don ƙarfafa ɗalibai su wanke hannayensu da sabulu da kuma bin wasu buƙatun tsabta.
Bayan sun bi ƙa'idodin ƙa'idodi, za su iya ƙara darajarsu daga tauraro ɗaya zuwa uku.
 Ɗaya daga cikin hanyoyin da za a iya amfani da su wajen sanar da mutane game da tsabtace hannu don rage yawan yara da ke mutuwa.
Ranar Wanke Hannun Duniya (Global Hand Washing Day)  wani misali ne na kamfen na wayar da kan jama'a da ke nufin sauya dabi'u. Sakamakon annobar cutar coronavirus ta 2019-20, Asusun Yara na Majalisar Dinkin Duniya yana tallata amfani da emojis da ke nuna wanke hannu.
Wasu bincike sun yi la'akari da yadda wanke hannu yake da amfani a ƙasashe masu tasowa idan aka kwatanta da shekarun da aka adana na rashin nakasa.
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu  yana da amfani sosai idan aka kwatanta da wasu hanyoyin tsabtace jiki.
Muhimmancin wanke hannu ga lafiyar mutum  musamman ga mutane masu rauni kamar matasa mata ko sojoji da aka ji rauni a asibitoci  an fara gane su ne a tsakiyar karni na 19 da sababbin sababbin abubuwa a fannin tsabtace hannu: likitan Hungary Ignaz Semmelweis, wanda ke aiki a Vienna (Austria), da Florence Nightingale, wata ma'aikaciyar jinya 'yar Ingila kuma mai kafa kulawar marasa lafiya ta zamani.
A lokacin, mutane da yawa suna ganin cewa ƙwayoyin cuta suna zuwa ne daga ƙamshi mai ƙanshi da ake kira miasma.
A cikin shekarun 1980, sakamakon ɓarkewar cututtukan da ke yaduwa ta hanyar narkewa da cututtukan da ke tattare da kula da lafiya, Cibiyoyin Kula da Cututtuka da Cututtuka a Amurka sun fara ba da shawarar tsabtace hannu a matsayin muhimmin mataki na hana yaduwar kamuwa da cuta.
Sakamakon barkewar cutar mura ta alade a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020, mutane a ƙasashe da yawa sun ƙara fahimtar mahimmancin wanke hannu da sabulu don kare jiki daga irin waɗannan cututtukan.
Alal misali, a ƙasar Jamus, ana saka takardu da ke nuna yadda za a wanke hannu a bayan gida a wuraren wanka na jama'a da kuma a wuraren wanka na ofisoshi da kuma filayen jirgin sama.
Wannan furcin "wanke hannuwanku" yana nufin cewa ba ku son ku ɗauki wani hakki ko ku kasance cikin wani abu.
An samo shi daga Littafi Mai Tsarki, Linjilar Matta: Bilatus Ba-Bunti ya wanke hannunsa lokacin da ya yanke shawarar gicciye Yesu Kristi; daga baya wannan magana ta sami amfani a wasu yankunan Ingila.
A cikin wasan Shakespeare, Lady Macbeth ta fara wanke hannayenta ba tare da son rai ba don ta kawar da wani abu da ke nuna cewa tana da laifi game da laifin da ta yi da mijinta.
An kuma gano cewa mutanen da suka tuna ko suka lura da wani abin da bai dace ba sun fi yawan wanke hannayensu fiye da sauran mutane, kuma suna ganin wanke hannu yana da muhimmanci.
Hakanan, mutanen da suka sami damar wanke hannayensu bayan ganin abin da suka gani ba su da wataƙila su shiga cikin wasu ayyukan "tsabtace" kamar aikin sa kai.
A cikin addinai, wanke hannu yana da ma'anar tsabta da ma'ana. Wanke hannu da ruwa, amma ba tare da sabulu ba, wani ɓangare ne na al'ada da aka tsara a addinai da yawa, ciki har da Baha'i, Hindu, tevilah da netilat yadayim a Yahudanci, Lavabo a Kristanci da Wudhu a Musulunci. Addinai kuma suna ba da umarnin wanke hannuwan tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci, da Islama sun umurci mutum ya wanke hannu bayan ya je bayan gida.
A addinin Hindu, Buddha, Sikh, da Islama, ana bukatar a wanke hannu kafin da kuma bayan kowane cin abinci.
Kula da abubuwan samarwa dangane da COVID-19
Kula da abubuwan samarwa dangane da COVID-19 yana nufin amfani da hanyoyin tabbatar da lafiyar aiki da kiyaye lafiya don sarrafa haɗari da yaƙi da cutar coronavirus ta 2019 (COVID-19).
Kula da haɗarin da ya dace a wurin aiki ya dogara da wuri da aikin, yana dogara da kimanta haɗarin, tsananin cutar a cikin al'umma da abubuwan haɗari ga ma'aikata na musamman waɗanda zasu iya zama masu rauni saboda COVID-19.
Hukumar Kula da Lafiya da Kiwon Lafiyar Aiki ta Amurka (OSHA) ta ba da rahoton cewa ayyuka masu haɗari suna da iyakantaccen hulɗa da jama'a da abokan aiki, kuma a irin waɗannan lokuta ana buƙatar matakan kula da kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan sun kamu da rashin lafiya, bin ƙa'idodin numfashi, da tsaftacewa da kuma tsabtace wuraren aiki kowace rana.
Matsakaicin haɗarin aiki yana buƙatar hulɗa da mutane da yawa ko kusanci da waɗanda ba su da tabbacin ko zargin cutar COVID-19 amma suna iya kamuwa da cutar saboda yaduwar cutar a cikin al'umma ko yayin balaguron ƙasa da ƙasa.
Waɗannan sun haɗa da ma'aikatan da suke aiki tare da jama'a, kamar a makarantu, wuraren aiki da ke da yawan jama'a da kuma manyan shaguna.
Matakan kula da haɗari ga irin wannan rukunin, ban da matakan hana kamuwa da cuta na asali sun haɗa da iska mai ƙarfi ta amfani da matattarar iska, amfani da allon kariya da kayan kariya na mutum idan sun haɗu da mutumin da ke da cutar COVID-19.
OSHA ta yi imanin cewa ma'aikatan kiwon lafiya da ma'aikatan gidan gawa da suka taɓa saduwa da mutumin da aka tabbatar da cutar ko kuma ake zargin yana da cutar COVID-19 suna cikin haɗarin haɗari; tare da haɗarin da ke ƙaruwa sosai yayin da irin waɗannan ma'aikatan ke yin ayyukan da ke tattare da samar da iska ko tattara / sarrafa samfuran daga mutumin da aka tabbatar da cutar ko kuma ake zargin yana da COVID-19.
Matakan kula da haɗari da suka dace da irin waɗannan ma'aikata sun haɗa da amfani da kayan aikin injiniya na aminci, kamar ɗakunan da ke da iska mai ƙarfi, da kuma kayan kariya na sirri da suka dace da aikin.
Cutar COVID-19 na iya shafar wurin aiki a hanyoyi da yawa.
Ma'aikata za su iya yin rashin aiki domin rashin lafiyarsu, ko kuma don kula da wasu ko kuma don tsoron kamuwa da cutar.
Hanyoyin kasuwanci na iya canzawa dangane da nau'ikan kayan da ake buƙata da kuma hanyoyin siyan waɗannan kayan (misali, yin sayayya a lokutan da ba a kai ba tare da fitar da mota ko sabis).
A ƙarshe, ana iya samun katsewar jigilar kayayyaki daga yankunan da COVID-19 ta shafa.
Shirye-shiryen sun shafi batutuwan haɗari da ke tattare da wurare da ayyuka daban-daban, ciki har da tushen kamuwa da cuta, abubuwan haɗari da ke faruwa a gida da kuma cikin al'umma, da kuma abubuwan haɗari na ma'aikata na musamman, kamar tsofaffi ko rashin lafiya.
Waɗannan tsare-tsaren suna kuma nuna hanyoyin da ake bukata don magance waɗannan haɗarin da kuma yadda za a magance matsalar gaggawa da za ta iya tasowa.
Shirye-shiryen shirye-shiryen annobar da kuma matakan da za a ɗauka za su iya zama bisa ga shawarwarin da aka bayar a matakin ƙasa ko na jihar.
Wasu daga cikin manufofin da aka tsara don magance cutar: rage yaduwar cutar ga ma'aikata, kare mutanen da ke da haɗarin kamuwa da cutar, ci gaba da ayyukan kasuwanci da rage tasirin tasirin ga sauran ƙungiyoyi a cikin sarkar samar da su.
Yadda ake magance cutar ya dangana ga yadda cutar take da tsanani a yankin da ake kasuwanci.
Tsarin tsarin kula da haɗari  tsari ne da aka yi amfani dashi a cikin tabbatar da lafiya da kiwon lafiya na aiki, don rukuni irin waɗannan kayan aiki dangane da inganci.
Idan ba za a iya kawar da haɗarin kamuwa da COVID-19 ba, kayan aikin injiniya da na fasaha na tsaro sune mafi inganci, sannan  matakan gudanarwa, kuma a ƙarshe  kayan kariya na mutum.
Za a iya yin amfani da kayan aikin injiniya don a kāre ma'aikata daga haɗarin da ke tattare da aikin kuma ba za a dogara da halayyar ma'aikaci ba.
Matakan gwamnati suna nufin canje-canje a cikin manufofin aiki ko hanyoyin aiki da ke buƙatar aiki daga ma'aikaci ko ma'aikaci.
Ana ganin cewa kayan kariya na mutum (PPE) ba su da tasiri sosai kamar na injiniya ko na gwamnati, amma suna iya taimaka wa mutane su guji wasu haɗari.
Dukkanin kayan kariya na mutum dole ne a zaɓa bisa ga barazanar ma'aikaci, ya dace da girmansa (misali, masu numfashi), a yi amfani da shi koyaushe kuma yadda ya kamata, a bincika shi a kai a kai, a kiyaye shi a cikin yanayin da ya dace kuma a maye gurbinsa idan ya cancanta, kuma a cire shi, a tsabtace shi kuma a adana shi ko kuma a yi amfani da shi yadda ya kamata don kauce wa kamuwa da cutar.
Hukumar Kula da Lafiya da Kiwon Lafiyar Aiki ta Amirka (OSHA) ta ce ayyuka da ke da haɗari sosai ba sa saɓa wa jama'a da kuma abokan aikinsu.
Matakan farko na yaki da annobar da aka ba da shawarar ga dukkan wuraren aiki sun haɗa da wanke hannu da yawa da kyau, shawarwari ga ma'aikata masu rashin lafiya su zauna a gida, bin ƙa'idodin numfashi, gami da rufe baki da hannu lokacin tari da hancin, samar da tawul da kwantena don shara, kasancewa a shirye don aiki mai nisa ko sauyawa, idan ya cancanta, shawarwari ga ma'aikata don guje wa amfani da wasu kayan aiki da kayan aiki, da kuma tsabtace da kuma kashe ƙwayoyin cuta a cikin aikin yau da kullun.
Gano da kuma ware mutanen da ke da cutar da wuri  mataki ne mai muhimmanci don kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar ma'aikata da ke da alamun cututtukan numfashi na gaggawa su kasance a gida har sai zafin jiki ya ƙare, babu zazzabi da sauran alamun aƙalla awanni 24 ba tare da amfani da maganin zazzabi ko wasu magunguna masu magance alamun ba, kuma sun ba da umarnin samar da sassauƙan manufofin kan takardun asibiti, ba ma'aikata damar zama a gida don kula da wani dangin da ke rashin lafiya, da kuma tabbatar da cewa ma'aikata sun san irin waɗannan manufofin.
A cewar OSHA, matsakaitan haɗarin aiki suna buƙatar hulɗa da yawa da kusanci a nesa da ƙafa shida (1.8 m) tare da mutanen da ba a tabbatar da su ko kuma ake zargin sun kamu da COVID-19 ba, amma akwai yiwuwar kamuwa da SARS-CoV-2 saboda yaduwar cutar a cikin al'umma a yankin da kasuwancin yake, ko kuma saboda ziyarar kwanan nan da irin wannan mutumin ya yi zuwa wuraren da COVID-19 ke yaduwa.
Irin waɗannan rukunin sun haɗa da ma'aikata waɗanda ke da hulɗa da jama'a, kamar a makarantu, wuraren aiki masu yawan jama'a, da wasu manyan shagunan sayarwa. Ayyukan injiniya da na fasaha don waɗannan rukunin masu haɗari sun haɗa da buƙatar ma'aikata marasa lafiya su zauna a gida, maye gurbin ganawa da kai tare da kayan aikin kama-da-wane, saita jadawalin aiki, ba tare da dakatar da jadawalin tafiya ba a cikin wuraren da ke da haɗarin COVID-19, haɓaka kayan aikin sadarwa na yau da kullun, gami da samar da kayan aikin kariya na sirri, ko kuma samar da horo na musamman ga ma'aikata da abokan ciniki, amma ba za mu iya ba da takamaiman bayani game da COVID-19 ba.
A wasu lokatai, ma'aikata da ke cikin wannan rukunin suna iya bukatar su sa kayan numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, don tabbatar da lafiyar ma'aikata da sauran fasinjoji, ana buƙatar matakan kamar ware mutum mai rashin lafiya daga sauran mutane a nisan ƙafa 6, sanya wani memba na ma'aikatan jirgin don kula da mutumin mara lafiya, samar da abin rufe fuska ga mutumin mara lafiya, ko kuma tambayar irin wannan mutumin ya rufe hanci da baki da tawul lokacin da yake tari ko hancinsa.
Ya kamata ma'aikatan jirgin su sa safar hannu na yau da kullum idan sun kusanci matafiyi mai ciwo ko kuma idan sun taɓa ruwa ko kuma wasu abubuwa da za su iya kamuwa da cutar, kuma wataƙila su sa wasu kayan kariya idan mai ciwon yana da zazzabi, tari ko kuma yana da wahalar numfashi.
Ya kamata a sanya safar hannu da sauran kayan da ake amfani da su a cikin jaka mai lafiya, kuma ya kamata a tsabtace da kuma kashe ƙwayoyin cuta a bayan haka.A cikin yanayin jirgin ruwa na kasuwanci, gami da jiragen ruwa da sauran jiragen ruwa masu fasinja, matakan tsaro sun haɗa da jinkirta tafiya idan akwai rashin lafiya, keɓe kai da sanar da cibiyar kiwon lafiya a jirgin nan da nan idan akwai zazzabi ko wasu alamun a cikin jirgin.
A cikin yanayin makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsabtace ko kashe ƙwayoyin cuta idan mutumin da ke da cutar yana cikin makarantar, ba tare da la'akari da yaduwar cutar a cikin al'umma ba.
Idan akwai ƙananan ko matsakaicin yaduwar kamuwa da cuta a cikin al'umma, ana iya aiwatar da dabarun nisantar da jama'a, kamar soke fita don tarurruka na mutum, tarurruka da sauran abubuwan da suka shafi jama'a kamar motsa jiki ko waƙar mawaƙa, cin abinci a gidajen abinci, ƙara nesa tsakanin tebur, daidaita lokacin isowa da kulawa, ƙuntata ziyarar da ba ta da mahimmanci, amfani da wuraren kiwon lafiya daban don yara masu alamun mura.
Idan akwai yawan yaduwar cutar a cikin al'umma, ban da dabarun nisantar da jama'a, ana iya yin la'akari da matakan da za su iya hana su zuwa makaranta na dogon lokaci. Ga ma'aikatan tsaro da ke yin ayyukansu na yau da kullun, an yi la'akari da haɗarin lafiyar kai tsaye a matsayin ƙasa, a cewar CDC.
Ma'aikatan tsaro da ke da alhakin hulɗa da mutanen da aka tabbatar da cutar ko kuma waɗanda ake zargi da kamuwa da COVID-19, ana ba su shawarar su bi umarnin da aka ba likitocin gaggawa, gami da amfani da kayan kariya na sirri.
Idan ma'aikata sun yi hulɗa da juna a lokacin da aka tsare su, dole ne su tsabtace da kuma kashe ƙwayoyin cuta kafin su sake amfani da belinsu da kayan aiki tare da kayan tsabtace gida ko ta hanyar shafawa, su bi ka'idodin aikin aiki na yau da kullum don hana yaduwar cutar da kuma kawar da kayan kare kansu da aka yi amfani da su, da kuma amfani da wanke tufafi.
OSHA ta ce wasu ma'aikatan kiwon lafiya da kuma ma'aikatan asibiti suna cikin haɗari sosai.
Matsayi mai haɗari ya haɗa da ma'aikatan kiwon lafiya, masu ba da tallafi, ma'aikatan dakin gwaje-gwaje da masu jigilar kayayyakin kiwon lafiya waɗanda ke hulɗa da marasa lafiya da aka tabbatar da cutar ko kuma ana tsammanin suna da cutar COVID-19.
Suna da haɗarin kamuwa da cutar idan suna yin aikin da ke haifar da aerosol ko tattara / sarrafa samfuran daga mutanen da aka tabbatar da cutar ko kuma ana tsammanin suna da cutar COVID-19.
Hanyoyin da ke haifar da aerosol sun haɗa da bincike, hanyoyin da ke haifar da tari, bronchoscopy, wasu hanyoyin ilimin hakori da kuma bincike ko tattara samfurori ta hanyar hanyoyin da ba a sani ba.
Ma'aikatan gidan gawawwaki masu haɗari sun haɗa da ma'aikatan da ke kula da gawawwakin mutanen da ke da tabbacin cutar ko ana zargin sun kamu da COVID-19 a lokacin mutuwarsu; idan irin waɗannan ma'aikatan suna yin autopsy, to, sun shiga cikin babban haɗari. Ƙarin kayan aikin injiniya don waɗannan rukunin haɗarin sun haɗa da amfani da ɗakunan keɓewa don marasa lafiya da aka tabbatar da cutar ko ana zargin suna da COVID-19, gami da aiwatar da hanyoyin da ke tattare da samar da aerosol.
A wasu wuraren kiwon lafiya da kuma asibitocin gawa, ana iya yin amfani da iska mai sanyaya iska.
Ya kamata a yi amfani da samfurori tare da kiyaye matakan kariya na matakin 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar sanya marasa lafiya masu zuwa cikin yankunan jira dangane da yiwuwar kamuwa da COVID-19. Baya ga sauran kayan kariya na mutum, OSHA ta ba da shawarar yin amfani da na'urar numfashi ga ma'aikatan da ke hulɗa da nesa da ƙafa 6 daga marasa lafiya da ke da tabbataccen cutar ko ana tsammanin kamuwa da SARS-CoV-2, da kuma waɗanda ke gudanar da ayyukan da ke haifar da aerosol.
A Amurka, ana buƙatar amfani da na'urar numfashi ta NIOSH da ke da N95 ko mafi girma a matsayin ɓangare na rubutaccen shirin kariya na numfashi wanda ke ba da takamaiman buƙatun zaɓi da bincike na likita.
Sauran nau'ikan kayan numfashi na iya samar da kariya da jin daɗi ga ma'aikaci. WHO ba ta ba da shawarar yin amfani da tufafi na musamman ba saboda COVID-19  cuta ce da ake ɗauka ta hanyar numfashi, ba ta ruwa na jiki ba.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa masu aikin tiyata da ke yin gwajin a wuraren da ake kula da marasa lafiya ne kawai su riƙa sanya abin rufe fuska.
WHO ta ba da shawarar cewa mutanen da ke karɓar samfurin numfashi daga marasa lafiya da ke da COVID-19 ko masu ɗaukar cutar ba tare da yin aikin da ke haifar da iska ba, su sa abin rufe fuska, tabarau ko allon fuska, riguna da safar hannu.
A lokacin da ake yin aikin da ke haifar da ƙwayoyin cuta, ya kamata a sa kayan N95 ko FFP2 maimakon abin rufe fuska.
Ganin rashin wadatar kayan kariya na mutum a duk duniya, WHO ta ba da shawarar rage bukatar irin waɗannan kayan kariya ta hanyar amfani da damar nesa, shinge na zahiri kamar windows masu haske, samar da damar zuwa ga mai cutar COVID-19, kawai waɗanda ke kula da kai tsaye, amfani da kayan kariya na mutum waɗanda suka dace da takamaiman aikin, amfani da injin guda ɗaya na dogon lokaci ba tare da cirewa ba, yayin aiki tare da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da kayan kariya na mutum, da kuma shawarar kada a yi amfani da abin rufe fuska ga waɗanda ba su da alamomi.
MAI SHAHADA: Katherine Maher, Babban Daraktan Kamfanin Wikimedia Foundation
MAI SHAHADA: Dukan ma'aikatan Wikimedia Foundation
MAI TAMBAYA: [Covid-19] Sauƙaƙa Nauyin da ke tattare da Shirye-shiryen Nan Gaba
RANAR/Lokacin aikawa: 14 ga Maris, 2020, 00:24 UTC
CC0: Babu haƙƙoƙin da aka kiyaye
Muna cikin yanayi na musamman a wannan watan.
Cutar COVID-19  wani abu ne da ya nuna yadda mutane a duniya suke da alaƙa da juna da kuma yadda muke da alhakin juna.
Ba mu taɓa fuskantar irin wannan matsalar ba, amma mun san cewa yadda muke aiki ya dogara ne da jinƙai, haɗin kai da kuma ci gaban al'ummomi a duk faɗin duniya, wanda shine tushen wannan ƙungiyar.
Mun ga yadda abokan aikinmu suke nuna ƙauna da kuma kula da juna, kuma hakan ya bayyana a wasiƙun da muke aikawa da kuma yadda muke tattaunawa da mutane a kan waya. Hakan ya nuna cewa muna da mutane masu ban mamaki da muke aiki da su.
Ina alfahari da ku sosai kuma ina godiya da ku sosai don ku abokan aikina ne.
A makon da ya gabata, na ji cewa an yaba mana sosai.
Na tuna yadda muhimmancin samun damar shiga Wikipedia a duniya a yanzu, da kuma yadda amfani yake ga kowa ya sami damar shiga wannan muhimmin kayan aiki a yanar gizo.
Kuma hakan na yiwuwa ne saboda aikinku, ko dai don ci gaba da gudanar da shafukanmu, biyan abokan aikinmu, ko kare lafiyar al'ummominmu.
Duniya tana bukatar bayanan da ke cikin Wikipedia, kuma wannan ya fi muhimmanci a yau.
A wannan lokaci, don samun sakamako mai ma'ana ga duniya, ba abin da muke yi kawai ba ne, amma yadda muke yi.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa a wannan aiki, za mu kawo wasu muhimman canje-canje ga yadda muke aiki tare, daga mako mai zuwa.
Gyara Tsarin Ayyukanmu da jadawalinmu
Kamar yadda Robin ya fada a baya, ƙungiyar c-team ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A lokacin tattaunawar, mun tattauna yadda za mu yi aiki da kyau a wannan yanayin da kuma yadda za mu ci gaba da kasancewa da aminci a wannan lokacin.
Yawancinmu muna son mu rage damuwa kuma mu ci gaba da aikinmu na dogon lokaci.
Idan kuna son ku ja da baya, to, ku yi haka.
Ga dukan ma'aikata, 'yan kwangila da kuma ma'aikatan da ba sa aiki:
Mun yi hasashen cewa za a yi aiki na sa'o'i hudu a rana ko kuma sa'o'i 20 a mako kafin a ba da umarni na gaba.
Ba ma yin hutu, idan za ku iya yin aiki na tsawon sa'o'i, za mu iya yin hakan don manufarmu.
Amma, duniya ba ta da tabbas, kuma ko da mene ne bukatunku, ko kula da danginku, sayen abinci ko zuwa asibiti, lafiyarku ita ce kan gaba a rayuwarmu.
Ba ma saka idanu a kan lokacin aikinku.
Idan kana rashin lafiya, kada ka yi aiki.
Wannan abu ne da babu shakka, amma mun ambata shi.
Ba ka bukatar ka yi rajistar rashin lafiya ko kuma ka bar wurin aiki, amma ka gaya wa shugabanka kuma ka taimaka wa ƙungiyarka ta sake duba kalandar da kuma jadawalin aiki don ka tabbata cewa an yi amfani da su a wurare da suka dace.
(Idan an tabbatar da cutar COVID-19, sanar da Brian a T&C Ops don T&C ta iya ba da tallafi da kulawa daga jagora ga halin da kuke ciki).
Za a biya kuɗin awa ɗaya.
Mun riga mun sanar kuma mun tabbatar da niyyarmu na cika alkawuranmu ga masu aikinmu da ma'aikatanmu a kan farashin sa'a.
Kowane mutum zai sami kuɗin da ake biya a kowane sa'a.
Wannan ya haɗa da lokutan da ba za ka iya aiki ba domin rashin lafiya.
Idan kana son ka yi aiki, za mu tallafa maka.
Mutane da yawa suna amfani da aikinsu don su mai da hankali ga abin da ke faruwa a duniya.
Abubuwan da muke yi za su iya kawo sakamako mai ban mamaki, musamman a irin wannan lokacin.
Kuma wannan ma batun taimakon kai ne.
Muna roƙonku ku tuntuɓi shugabanku don mu san abin da za ku yi tsammani kuma mu daidaita ayyukanmu yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Ya kamata mu riƙa tallafa wa irin waɗannan ayyukan a koyaushe.
Ƙungiyoyin SRE, HR Ops, Trust&Safety, da kuma Fundraising (da sauransu) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin tallafi.
Muna saita tsarin aiki ga dukkan sassanmu don tantance manufofinmu na yanzu da kuma mayar da hankali kan samar da tallafi, wanda yake da mahimmanci ga aikinmu.
Akwai ayyuka da yawa da kowannenmu zai yi, kuma muna mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Idan muka yi jinkiri a yau, hakan ba ya nufin cewa za mu sha wahala a nan gaba.
Ba mu da niyyar yin aiki sau biyu don yin abin da muka rasa bayan annobar ta ƙare.
Ba za ka yi aiki fiye da lokacin da aka ba ka don ka bi wani lokaci da ba ka so ba.
Mun fahimci cewa yanayi ya canja kuma za mu yi aiki don kafa sababbin maƙasudai da kuma lokacin da za mu iya cim ma hakan.
Menene ke faruwa da APP (shirin shekara-shekara)?
Don daidaitawa da sabon yanayin da tsammanin yawan lokacin aiki na yau da kullun, muna da niyyar daidaita lokacin aiwatar da Tsarin Shekararmu na 2020-2021.
Muna da niyyar bayar da shawarar tsawaita lokacin shirinmu na 2019-2020, don haka samar da karin lokaci don tsara kasafin kuɗi, wanda zai ba ma'aikata damar ba da fifiko ga aiki mai mahimmanci, taimakon kansu da kula da ƙaunatattun su, yayin da duk waɗanda suke buƙatar ko suke son yin aiki za a ba su gajarta jadawalin na makonni masu zuwa.
Wannan zai taimaka wajen rage yawan aiki da kuma damuwa a ƙungiyar.
Za mu gabatar da shawarwarinmu ga majalisar a mako mai zuwa, kuma za mu sanar da wakilanmu da kuma kungiyoyinmu game da matakan da za su bi nan da nan bayan an tabbatar da hakan.
Na gode wa APP don jagorantar wannan aikin.
Yanayin ofishin, haɗari da kuma tsabtace shi
A makon da ya gabata ne muka sami labarin cewa wani abokin aikinmu a San Francisco yana iya kamuwa da cutar COVID-19.
Amma, ban da wasu matakan tsaro, mun ɗauki ƙungiyar tsabtace ƙwayoyin cuta don su tsabtace dukkan wuraren da ke ofishinmu a San Francisco.
Sun yi amfani da maganin rigakafin cutar don kashe ƙwayoyin cuta a duk wuraren da muke da su da kuma ɗakunan shiga da hawa da ke da hanyar shiga bene.
Ginin yana da dokoki na musamman da suka shafi yin hankali da kuma amfani da kayayyakin da za su sa masu haya su kasance da aminci.
Muna jin cewa za a shirya ofishin sosai a lokacin da muka koma.
Ofishinmu a D.C. yana cikin hanyar sadarwar WeWork, wadda ta sanar da mu da kuma ma'aikatanmu a D.C. game da dokokin COVID-19.
A makon da ya gabata, ofishinmu a D.C. ya koma aiki a nesa kamar yadda San Francisco ta umurce mu.
Kamar yadda wasu abokan aikinmu a New York suka sani, mun tattauna batun hayar wani gida a Brooklyn.
Ana ci gaba da wannan tattaunawar, amma za a iya jinkirta ta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dā da suke aiki daga nesa sun san cewa za mu iya yin gyara kuma za su so su ba ku wasu shawarwari:
Ana ba da shawarar cewa a rage tsawon taron zuwa awa ɗaya ko biyu.
Idan kuna bukatar ƙarin lokaci, ku yi la'akari da raba zaman zuwa kwanaki da yawa.
Ka bayyana manufar taron da kuma abin da za ka tattauna, kuma ka tura wa mutane abin da za ka tattauna da su.
Ka yi amfani da bidiyo ta hanyar tsoho, kuma ka yi amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe hulɗa da sadarwa.
Don saukakawa, ka naɗa mai kula  wanda zai lura da yadda ake amsa tambayoyin da ake yi a cikin hira da kuma wanda zai kula da jerin masu magana da kuma wanda zai riƙa yin rubutu (ko kuma yin nazari tare).
Idan kana bukatar ka yi amfani da lasifika mai amfani, ka tuntuɓi sashen taimakon fasaha ta imel.
Ka yi amfani da amfanin shirin Wellness Reimbursement a lokacin da kake sayen abinci.
Ku shiga Slack ta hanyar #remoties don tattaunawa da abokan aikinku game da aiki mai rarrabawa.
Ƙungiyar HR Operations tana nazarin jagororin ergonomics da aka ba su a cikin yanar gizo don taimakawa wajen inganta aikin da aka rarraba a cikin kungiyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafin al'umma da su soke duk wani taron Wikimedia da aka tallafawa, kamar editathons, har sai WHO ta sanar da cewa annobar ta ƙare.
Mun fahimci kuma mun sanar da cewa buƙatunmu na irin wannan ƙuntatawa da sauran ƙuntatawa na iya haifar da rashin yiwuwar aiwatar da ayyukan tallafin da aka tsara, kuma ba za a hukunta kowa ba saboda jinkirin tilas ko canza waɗannan manufofin.
Za mu ci gaba da gudanar da wasu ayyuka a mako mai zuwa don ƙarin bayani game da Wikimania, da sauran taron yanki da taron al'umma.
Yanayin da ya zama ruwan dare tsakanin al'ummomin duniya  ba kawai baƙin ciki ne game da dakatarwar ba, amma kuma wani sauƙi game da fahimtar juna da kuma damar da za a mayar da hankali ga al'ummomin su, Wikimedia da sauransu.
Game da hangen nesa, CRT yana aiki akan shafi a Meta-Wiki wanda zai samar da sarari ga al'umma don lura da tasiri da sadarwa.
Muna ci gaba da tuntuɓarku game da COVID-19
Za mu tura muku gayyata zuwa kalandarku don taron ma'aikata na musamman da za a yi a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
A wannan karon za mu yi amfani da wannan dama don mu raba ƙarin bayanai, mu amsa tambayoyinku kuma mu yi amfani da lokaci tare, muna haɗa juna.
Muna cikin wannan yanayin tare kuma muna shirye mu taimaka da duk abin da za mu iya.
Duk da haka, za ka iya ci gaba da samun bayanai daga wannan imel ɗin, da kuma sauran muhimman bayanai game da COVID-19  daga Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka, kuma za ta tattara duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatanmu a ƙasashen da wannan ya shafi su sosai.
Idan kana da tambayoyi game da tafiye-tafiye, ayyuka, muhimman ayyuka, ko kuma idan kana bukatar taimako, ka tuntuɓi CRT.
Muna shirye mu ba da taimako da kuma sadarwa idan da bukata.
Idan kana da wata matsala game da sirrinka, ka tuntuɓi Brian Judan, darektan HR International Global Operations.
Ba za a ɗauki irin wannan canjin a matsayin yin watsi da aikinmu da kuma alkawuranmu ba.
Akasin haka, yana nufin cewa muna bukatar mu daidaita ayyukanmu da kuma alkawuranmu.
Mun yi imanin cewa irin waɗannan matakai suna da muhimmanci don tallafawa juna da kuma samar da damar ci gaba da aiki, don ba da goyon baya ga motsinmu da kuma duniya ta hanyar sabis na gaskiya.
Za mu ci gaba da aikinmu har sai lokacin da ya dace.
Yanzu lokaci ne da za mu tallafa wa juna kuma mu samar da sarari don aiki mai muhimmanci da za a yi a makonni masu zuwa, wataƙila ma watanni.
Don wannan ya faru, muna bukatar taimakon kowannenku, kuma muna bukatar ku kula da kanku da iyalanku kuma ku yi aiki da kyau idan bukatar ta taso.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, Tony S), da sauran membobin ƙungiyar Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Angiotensin-converting enzyme 2 (ACE2) wani enzyme ne wanda aka haɗa da ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, kodan da hanji.
ACE2 yana hana aikin enzyme mai canza angiotensin (ACE) mai dacewa, yana rage abun ciki na angiotensin-II da haɓaka Ang (1-7), yana mai da shi kyakkyawan mafita don magance cututtukan zuciya. AC2 kuma yana aiki a matsayin hanyar shiga cikin sel don wasu coronavirus.
An kira nau'in enzyme na mutum da hACE2.
Angiotensin-converting enzyme 2  wani sinadarin zinc ne wanda ke cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
ACE2 yana dauke da N-karshen peptidase yankin M2 da kuma C-karshen sufuri yankin na koda amino acid collectrin.
ACE2 shine furotin membrane mai wucewa guda ɗaya na nau'in I, yankin aikinsa yana shiga cikin ƙwayoyin huhu da sauran kyallen takarda.
Ana cire yankin ACE2 daga cikin ƙwayar cuta ta hanyar wani enzyme da aka sani da sheddaze, kuma an saki furotin mai narkewa cikin jini kuma a ƙarshe an fitar da shi tare da fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana haɗe da ƙwayoyin ƙwayoyin ƙwayoyin alveolar na yawancin ƙwayoyin huhu na nau'in II, ƙwayoyin hanji na ƙananan hanji, ƙwayoyin jini da ƙwayoyin ƙwayoyin jini da ƙwayoyin tsoka masu laushi na yawancin gabobin jiki.
Ana kuma samun sinadarin ACE2 da RNA a cikin ƙwaƙwalwar ƙwaƙwalwa, ƙwaƙwalwar ƙwaƙwalwa, hypothalamus, da kuma ƙwaƙwalwar ƙwaƙwalwa.
Babban aikin ACE2 shine ya zama mai daidaitawa ga ACE.
ACE yana raba hormone angiotensin I zuwa angiotensin II mai ɗauke da jijiyoyi.
ACE2, a nasa bangaren, ya rabu da amino acid na ƙarshe na phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya canza shi zuwa angiotensin (1-7), (H-Asp-Arg Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya rarraba wasu peptides, ciki har da [des-Arg9] -bradikinin, apelin, neurotensin, dinorphin A da ghrelin.
ACE2 kuma yana daidaita jigilar jigilar amino acid mai tsaka tsaki SLC6A19 kuma yana cikin cututtukan Hartnup.
A matsayin furotin mai ƙarancin ƙwayoyin cuta, ACE2 shine babban hanyar shiga ƙwayoyin cuta don wasu coronavirus, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
A takaice dai, haɗawar furotin S1 na SARS-CoV da SARS-CoV2 tare da yankin enzymatic ACE2 a saman ƙwayoyin halitta yana haifar da endocytosis da fassarar kwayar cutar da enzyme zuwa cikin endosomes a cikin ƙwayoyin halitta.
Wannan aikin shigarwa kuma yana buƙatar furotin S na serine protease mai ɗaukar TMPRSS2, wanda hana shi a halin yanzu ana nazarin shi azaman magani mai yuwuwa. Wannan ya haifar da wasu tunani cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Duk da haka, yawancin ƙwararrun masana da hukumomi suna ba da shawarar ci gaba da maganin rigakafin APF da BRAS.
A cewar wani nazari da kuma nazarin da aka buga a ranar 11 ga Yuli, 2012, amfani da masu hana APF ya kasance da alaƙa da raguwar haɗarin ciwon huhu da kashi 34% idan aka kwatanta da ƙungiyar kulawa.
Bugu da ƙari, haɗarin ciwon huhu ya ragu a cikin marasa lafiya da ke shan maganin hana hana ƙwayoyin cuta na APF, waɗanda ke da haɗarin kamuwa da ciwon huhu, musamman marasa lafiya da ke fama da bugun jini da rashin ƙarfi.
Hakanan an haɗa amfani da masu hana APF tare da rage mutuwar huhu, kodayake sakamakon bai da tabbaci sosai kamar na marasa lafiya da ke da haɗarin cutar huhu gaba ɗaya.
Ana tsammanin cewa sake haɗuwa da ɗan adam ACE2 (rhACE2) sabon abu ne a cikin maganin cutar cututtukan huhu kuma yana da alama yana inganta haɓakar jini da kuma iskar oxygen a cikin aladu tare da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututut
Lokacin da rhACE2 ya rabu da mutane yana da sa'o'i 10 kuma yana da minti 30 kafin ya fara aiki, ban da tsawon sa'o'i 24.
Wasu bayanai sun nuna cewa rhACE2 na iya zama mai alkawari ga mutanen da ba su da haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtukan da ke da ƙaruwa a cikin angiotensin II. An gwada rhACE2 a cikin gwaji a cikin maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu da aka tsara don taimakawa a cikin binciken annoba a cikin annobar cutar coronavirus ta 2019-20, wato, gano mutanen da zasu iya tuntuɓar mutum mai cutar.
A wasu yankuna, an samar da aikace-aikace da yawa da aka amince da su a hukumance.
An yi amfani da wasu aikace-aikace don saka idanu kan lambobin sadarwa.
Wannan ya haifar da muhawara game da matsalolin sirri, musamman game da tsarin da ke dogara da bin diddigin wurin da masu amfani da aikace-aikacen suke.
Zaɓuɓɓuka masu laushi a wannan batun sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun ba da sanarwar cewa za su haɗa haɗin gwiwa don haɗa haɗin ayyukan tallafi na irin waɗannan aikace-aikacen da ke da tushen Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A China, gwamnati tare da Alipay sun ƙaddamar da wata manhaja da ke ba 'yan ƙasa damar bincika ko sun taɓa yin hulɗa da mutanen da ke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin, kuma a Singapore akwai wata manhaja da ake kira TraceTogether.
An samar da manhajar ne ta kamfanonin IT na cikin gida, kuma an bude ta kuma za a mika ta ga gwamnati.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya sun haɗa kai don tsara manhajar.
A ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran rajista a cikin Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce aikace-aikacen bin diddigin lamba yana kan matakin karshe na ci gaba kuma zai kasance a shirye don turawa a cikin 'yan makonni.
Australia da New Zealand suna nazarin amfani da aikace-aikacen da ke da tushe a kan aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha tana da niyyar amfani da aikace-aikacen da ke da fasalin yanki wanda ke da niyyar  lura da cewa marasa lafiya da ke da cutar COVID-19 da ke zaune a Moscow ba su bar gidajensu.
Ross Anderson, Farfesa a Tsaro, Jami'ar Cambridge, ya nuna wasu matsalolin da za su iya faruwa tare da tsarin aikace-aikacen, ciki har da kuskure da kuma yiwuwar rashin amfani idan ƙananan mutane suna amfani da aikace-aikacen.
Dangane da damuwa game da yaduwar ɓatarwa ko aikace-aikacen cutar coronavirus, Apple ya iyakance jerin nau'ikan ƙungiyoyin da za su iya ba da aikace-aikacen da ke da alaƙa da cutar coronavirus a cikin App Store, suna haɗa da a'idar ko wasu ƙungiyoyi masu aminci a cikin wannan jerin.
Google da Amazon sun kafa irin wannan dokar.
Masu fafutukar kare sirrin jama'a sun nuna damuwa game da tasirin sa ido kan jama'a ta hanyar aikace-aikacen da ke da alaƙa da cutar coronavirus; musamman, an yi tambaya ko za a rushe tsarin sa ido da aka gina don magance cutar coronavirus lokacin da barazanar ta ɓace.
Ƙungiyar Amnesty International da wasu ƙungiyoyi sama da 100 sun wallafa wata sanarwa da ke kira da a rage irin wannan sa ido.
Kungiyoyin sun sanar da sharudda takwas da suke gabatar wa ayyukan gwamnati:
Dole ne a yi sa ido a kan abin da ya dace da doka, dole ne kuma daidai gwargwado.
fadada sa ido da lura dole ne ya kasance tare da sharhi game da iyakance lokacin aiki;
amfani da bayanai ya kamata ya kasance ne kawai don magance yaduwar COVID-19;
Dole ne a kare tsaro da rashin sani na bayanai kuma dole ne a ba da tabbacin wannan kariya;
digital lura kamata kauce wa sharudda nuna bambanci da kuma marginalization;
duk wani musayar bayanai tare da ɓangarorin uku dole ne a ƙayyade a matakin doka;
Dole ne a tabbatar da kariya daga cin zarafi, da kuma hakkin 'yan ƙasa na amsawa ga cin zarafi;
Ya kamata a samar da mahimman bayanai  daga dukkan masu ruwa da tsaki , ciki har da masana kiwon lafiya da wakilan kungiyoyi masu zaman kansu.
Google da Apple sun gabatar da shirin haɗin gwiwa don magance matsalar sa ido na dindindin, wanda ke nufin cire tsarin sa ido daga tsarin aiki na na'urorin su da zarar ba a buƙatar hakan.
A wasu ƙasashe, ana amfani da hanyar sadarwar wurin zama maimakon aikace-aikace, wanda ke kawar da buƙatar saukar da aikace-aikacen da kuma yiwuwar kauce wa sa ido.
An amince da bin sawun mutane a Isra'ila.
Hanyoyin sadarwa waɗanda ke da damar yin amfani da bayanan wuri na asali suna da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da sabobin tsakiya ba ne ya kamata su sami damar yin amfani da bayanan sirri game da wurin zama; an tsara wasu tsarin tare da tsare sirri wanda ke amfani da sabobin tsakiya kawai don sadarwa (duba sashe na ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba ya amfani da manhajar a matsayin tushen bin diddigin lambobin sadarwa.
Maimakon amfani da aikace-aikacen musamman, tsarin ya tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na na'urorin hannu da ma'amalar katin, sannan ya haɗa su don ƙirƙirar sanarwa a cikin saƙonnin rubutu waɗanda aka aika wa mutanen da ke da yiwuwar kamuwa da cutar.
Gwamnati ba wai kawai ta yi amfani da wannan bayanin don faɗakar da 'yan ƙasa game da yiwuwar hulɗa da mutanen da ke da cutar ba, amma kuma ta ba da bayanin wurin zama ga jama'a, wanda ya yiwu saboda canje-canje masu mahimmanci a cikin dokokin kariya na bayanai da aka yi bayan barkewar MERS a wannan ƙasar.
Ana iya samun wannan bayanin ta hanyar wasu manhajoji da shafukan yanar gizo. Kasashe, ciki har da Jamus, suna la'akari da yiwuwar amfani da tsarin tsakiya da kuma tsarin tsare sirri.
A ranar 6 ga Afrilu, 2020 ba a sanar da cikakken bayani ba.
Binciken tuntuɓar sirri  tsari ne mai kyau wanda yawancin wallafe-wallafen bincike suka fara aƙalla 2013. Kamar yadda yake a ranar 7 ga Afrilu, 2020, sama da ƙungiyoyin masana goma suna aiki kan hanyoyin magance sirri kamar amfani da Bluetooth Low Energy (BLE) don yin rajistar kusanci mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT samfurin haɗin gwiwar ne wanda ya haɗa da hanyoyin tsakiya da na rarraba, kuma ba yarjejeniya ɗaya ba.
Waɗannan hanyoyin sun tabbatar da cewa bayanan da aka gano ba su fita daga na'urar ba, amma duk abubuwan da aka yi a ciki.
The Privacy Group, MIT Media Lab tana haɓaka SafePaths, dandamali don tabbatar da sirrin sirri yayin tattarawa da amfani da bayanan wuri ko ƙetare hanya don bin diddigin yaduwar COVID-19.
Wannan aikin ya dogara ne akan binciken da aka bayar a cikin takaddar Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic (Aikace-aikacen ɓarna: yadda za a kiyaye sirrinka a lokacin annobar), wanda aka buga a watan Maris na 2020. Wani irin wannan aikin shine dandalin SafeTrace wanda Enigma MPC ya haɓaka, kamfanin da ke haɓaka fasahar tabbatar da sirrin, wanda kuma MIT Media Lab ta kafa shi.
SafeTrace yana amfani da ingantaccen fasahar kayan aiki wanda ke ba masu amfani damar musayar bayanan wuri da lafiyarsu tare da sauran masu amfani da jami'ai ba tare da yin haɗari ga sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi masu ra'ayi ɗaya da amfani da ladabi iri ɗaya sun kafa haɗin gwiwar TCN na duniya, wanda ke da niyyar  rage rarrabuwa da tabbatar da jituwa ta duniya don aikace-aikacen sa ido da faɗakarwa, wanda shine mabuɗin don yaduwar su.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe lambar asalin BlueTrace da ake amfani da ita don aikin aikace-aikacen hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da ayyukan dandamali na Android da iOS, sun ba da sanarwar shirin bin diddigin lambobin sadarwa, wanda suka ce zai ba da sirri, kuma yana da haɗin haɗin fasahar Bluetooth Low Energy da ɓoyewa don kiyaye sirrin.
Sun kuma wallafa fasahar fasahar da ake amfani da ita wajen sarrafa tsarin.
A cewar Apple da Google, tsarin ya kamata a shimfida shi cikin matakai uku:
samar da kayan aiki da ke ba gwamnatoci damar samar da aikace-aikacen hukuma don bin diddigin motsin 'yan ƙasa da ke fama da cutar coronavirus, amma tare da kiyaye sirrin bayanai
Ta hanyar haɗa wannan aikin kai tsaye cikin iOS da Android, Google da Apple suna shirin magance matsalolin sa ido na yau da kullun, da farko ta hanyar shigar da tsarin ta hanyar sabunta tsarin aiki, sannan cire shi ta wannan hanyar bayan barazanar ta ɓace.
Sake sanya magani (wanda aka fi sani da sake fasalin, sake juyawa, canza manufa ko sake fasalin magunguna)  shine sake fasalin magani da aka amince da shi don magance cuta ko yanayin kiwon lafiya daban da cutar da aka tsara tun asali.
Wannan shine ɗayan fannonin bincike na kimiyya wanda ake amfani dashi yanzu don haɓaka ingantattun hanyoyin magani na COVID-19.
Sauran hanyoyin bincike sun haɗa da samar da allurar rigakafin COVID-19 da kuma ƙarin jini. SARS-CoV-2 yana da ƙwayoyin cuta 66 masu jurewa, kowannensu yana da yankuna masu ɗaure ligand da yawa.
Binciken waɗannan wuraren haɗin yana ba da tushe mai kyau don haɓaka ingantaccen maganin rigakafin ƙwayoyin cuta na COVID-19.
Muhimman sunadarai masu mahimmanci don SARS-CoV-2  papain-like protease, RNA-dependent RNA-polymerase, helix, S protein da ADF-ribophosphataze.
Hussain AA da abokan aikinsa a cikin binciken da suka yi kafin gwaji sun bincika wasu mahaɗan ɗan takara waɗanda aka inganta su kuma suka bincika kamaninsu da magungunan da aka amince da su don hanzarta haɓaka magani mai tasiri sosai akan SARS-CoV-2 wanda za a ba da shawarar don gwaji na asibiti.
Chloroquine magani ne na zazzabin cizon sauro, kuma ana amfani da shi wajen magance wasu cututtuka na autoimmune.
A ranar 18 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chlorokhin da kuma hydroxychloroquine da ke da alaƙa da shi za su kasance cikin magunguna huɗu da ake gwadawa a cikin gwajin asibiti na "Solidarity".
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa gwajin chlorokhin da hydroxychloroquine za su fara a jihar New York a ranar 24 ga Maris. A ranar 28 ga Maris FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chlorokhin phosphate a ƙarƙashin izinin amfani da gaggawa (EUA).
Ba a amince da tsarin maganin ba yayin aikin gwaji na FDA kuma an ba da izinin EUA kawai a matsayin gwaji don kula da gaggawa ga marasa lafiya waɗanda ke asibiti amma ba za su iya samun magani a cikin tsarin gwajin asibiti ba.
CDC ta ce ba a riga an gano yadda za a yi amfani da shi ba, ko yawan adadinsa ko tsawon lokacin da za a yi amfani da shi don hana ko magance kamuwa da cutar SARS-CoV-2 ba.
Likitoci sun ce suna amfani da maganin ne kawai idan ba su da wata hanyar da za su bi.
Wata ƙungiyar bincike a Turkiyya a Istanbul tana yin wani ɗan bincike game da amfani da chlorokhinin tare da zinc da bitamin A, C da D.
Ana yin bincike mai zurfi a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar kiwon lafiya ta Jami'ar New York a Langon tana nazarin lafiyar da kuma ingancin amfani da maganin hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun nuna favipiravir yana da tasiri sosai.
A Shenzhen, marasa lafiya 35 da suka sha maganin sun kamu da cutar bayan kwana hudu, yayin da marasa lafiya 45 da ba su sha maganin ba suka kamu da cutar bayan kwana 11.
Wani bincike da aka yi a birnin Wuhan ya yi da ya shafi mutane 240 da ke fama da ciwon huhu, rabin su suna shan favipiravir, rabin kuma suna shan umifenvir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa sakamakon da ke nuna tasirin maganin ba shi da yawa kuma bai kamata a ɗauka cewa tabbatacce ne ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don sake cika kayanta, kuma za ta yi amfani da albarkatun soja don isar da shi zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya da COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya sanar da gwamnatin Trump cewa zai iya sayen maganin, wanda zai iya zama da illa ga cututtukan da suka fara.
Yin amfani da shi ba shi da lafiya ga marasa lafiya masu ciki ko marasa lafiya da ke ƙoƙarin yin ciki.
Wani bincike da aka yi a kan magungunan ƙwayoyin cuta na lopinavir da ritonavir (Kaletra) ya nuna cewa ba a taɓa samun sakamako mai kyau ba.
An tsara magungunan ne don hana kwayar cutar HIV ta hanyar ɗaure ta da ƙwayar protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magunguna don nemo mahaɗin da zai haɗa da SARS-CoV-2 protease.
Hukumar Lafiya ta Duniya ta haɗa haɗin lopinavir da ritonavir a cikin gwajin haɗin kai na duniya.
Gilead Sciences ne ya kirkiro da kuma samar da remdesivir don maganin cutar Ebola da cututtukan Marburg. Daga baya, ma'aikatan Gilead Sciences sun gano cewa remdesivir yana da tasirin cutar a cikin in vitro ga yawancin kwayoyin halitta, huhu, paramyxoviruses da coronaviruses.
Wata matsala da ke tattare da maganin cutar ita ce, ta hanyar maye gurbin kwayoyin halitta, cutar ta iya zama mai jurewa, kuma hakan na iya haifar da cututtuka masu tsanani da kuma yaduwar su.
Wasu binciken farko na farko sun nuna cewa remdesivir na iya samun babban shinge na asali don juriya. A halin yanzu ana gudanar da gwaji na asibiti da yawa, gami da biyu da Jami'ar Cleveland ke gudanarwa; ɗayan ana gudanar da shi ne a kan marasa lafiya da ke da matsakaiciyar cutar, ɗayan kuma a kan marasa lafiya da ke da matsananciyar cutar.
A halin yanzu ana gudanar da gwaji uku na asibiti don amfani da bitamin C a cikin jijiyoyin jini ga mutanen da ke asibiti da mummunan cutar COVID-19: gwaji biyu na sarrafawa (China, Kanada) da kuma gwaji ɗaya ba tare da amfani da placebo ba (Italiya).
A ranar 24 ga Maris, 2020, an fara gwajin maganin azithromycin a jihar New York.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin gudanar da gwajin asibiti na Alvesco (cyclesonide) Teijin, corticosteroid na inhalation don maganin asma, don amfani da shi don magance marasa lafiya da ke fama da sabon coronavirus.
An yi gwajin mataki na biyu, wani nau'i na enzyme mai canza angiotensin 2, a kan marasa lafiya 200 daga Denmark, Jamus da Austria da ke cikin asibiti da ciwo mai tsanani don a san ko magani yana da tasiri.
Masu bincike daga Cibiyar cututtukan zuciya da jijiyoyin jini ta Montreal, Kanada, a halin yanzu suna nazarin rawar da colchicine ke takawa wajen rage kumburi da matsalolin huhu a cikin marasa lafiya da ke da alamun COVID-19 marasa ƙarfi.
An gayyaci manya 6,000 masu shekaru 40 zuwa sama da suka kamu da COVID-19 da ke nuna alamun rashin lafiya da ba sa bukatar a kwantar da su a asibiti don binciken da ake kira COLCORONA.
Mata masu ciki, masu shayarwa da kuma waɗanda ba sa amfani da maganin hana ɗaukar ciki ba za su iya shiga cikin wannan binciken ba.
A ƙasar Italiya, ana gwada wasu magunguna da za su taimaka wajen hana jini yaduwa.
Ana amfani da ƙananan ƙwayar heparin sosai wajen kula da marasa lafiya, kuma hakan ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa shawarwari game da amfani da wannan magani.
A ranar 14 ga Afrilu, an sanar da wani bincike da aka yi a Italiya da ya shafi marasa lafiya 300 da ke nazarin amfani da sodium enoxaparin a cikin maganin rigakafi da magani.
Tun da SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga sake fasalin magungunan da aka amince da su don cutar da aka riga aka yi amfani da ita kamar MERS, SARS da West Nile virus.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 bisa ga bugawa ta 7 na shawarwarin kasar Sin.
Umifenovir: an ba da shawarar Umifenovir don maganin COVID-19 bisa ga bugawa ta 7 na shawarwarin China
Wasu magungunan rigakafi da aka gano cewa suna da amfani don maganin COVID-19:
Tocilizumab (mai karɓar IL-6): an amince da shi a China.
Ka kuma duba gwaji a Italiya da China, duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19  allurar rigakafin cutar coronavirus ta 2019 (COVID-19) ce.
Ko da yake babu wani rigakafi da aka gwada a asibiti, ana ci gaba da yin ƙoƙari da yawa don yin irin wannan rigakafin.
A ƙarshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a samu allurar rigakafin cutar SARS-CoV-2 ba kafin watanni 18.
A watan Afrilu, an yi gwajin aminci na mataki na farko a kan alluran rigakafi biyar.
An gano cutar COVID-19 a watan Disamba na 2019.
A shekara ta 2020, wata babbar annobar cutar ta bazu a duniya, wanda ya haifar da saka hannun jari sosai a cikin samar da allurar rigakafi da ayyukan bincike.
Kungiyoyi da yawa suna amfani da kwayoyin halittar da aka buga don samar da alluran rigakafin SARS-CoV-2.
Kamar yadda aka sanar a watan Afrilu, manyan manufofin shirin samar da alluran rigakafin CEPI  shine samar da saurin da ake buƙata, ƙarfin samarwa, turawa da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa a farkon shekarar 2020, akwai dandamali daban-daban na fasaha 10 da ke cikin bincike da haɓaka don ƙirƙirar ingantaccen allurar rigakafin COVID-19.
Wasu manyan manufofin dandamali da aka haɗa a cikin binciken tsaro na mataki na 1:
nucleic acid (DNA da RNA) (mai haɓaka mataki na I da kuma samfurin-mai neman rigakafi: Moderna, iRNA-1273)
kwayar cutar (mai haɓaka mataki na I da kuma takarar rigakafin: CanSino Biologics, kwayar cutar adenovirus nau'in 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, alluran rigakafi 115 masu yuwuwa suna cikin matakan farko na haɓakawa, 78 daga cikinsu ana amfani da su a cikin ayyukan da aka amince da su (79, a cewar Cibiyar Milken); an kuma bayyana wasu alluran rigakafi 37 masu neman, amma akwai bayanai kaɗan game da su (wanda ake tsammani suna cikin shirin ko haɓakawa).
A matakai na I-II, ana yin gwajin farko don aminci da rigakafi, yawanci bazuwar, sarrafawa da wuribo da kuma wurare da yawa tare da tantance mafi daidai da tasiri a lokaci guda.
Mataki na uku na gwaji yawanci ya ƙunshi mahalarta da yawa, ciki har da ƙungiyar kulawa; a wannan matakin ana gwada magunguna don ingancin rigakafin cutar kuma a lokaci guda ana lura da tasirin sakamako a cikin mafi kyawun allurai.
Daga cikin alluran rigakafi 79 da ke cikin aiki (an tabbatar da su a farkon Afrilu 2020), 74 ba su riga sun yi gwaji a kan ɗan adam ba (har yanzu suna cikin gwajin gwaji).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland, Ostiraliya, ta sanar da cewa tana nazarin yiwuwar allurar rigakafin kwayar halitta, wanda ke canza kwayoyin halitta na ƙwayoyin cuta don motsa amsar rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar allurar rigakafin ƙasa da ƙasa (VIDO-InterVac) a Jami'ar Saskatchewan, Kanada, ta sanar da cewa ta fara aiki a kan allurar rigakafin kanta da nufin fara gwajin mutane a 2021.
An kuma sanar da fara ayyukan samar da alluran rigakafi a Cibiyar Kula da Cututtuka ta China a ranar 26 ga Janairu, 2020 da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, kamfanonin magunguna na Janssen karkashin jagorancin Hanneke Shuitmaker sun sanar da fara aikin samar da allurar rigakafin su.
Janssen da abokin aikinsa Vaxart suna yin allurar rigakafi da za a iya sha.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar samarwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairun 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga takarda game da haɓaka allurar rigakafi ta hanyar fasaha mai kama da wacce ake amfani da ita don allurar rigakafin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar bincike ya sanar da kammala aikin samar da allurar rigakafi da kuma fara gwaji.
A ranar 27 ga Fabrairun 2020, wani kamfani na Generex, NuGenerex Immuno-Oncology, ya sanar da cewa ya fara aikin samar da allurar rigakafin peptide Ii-Key akan COVID-19.
Manufarsu ita ce su samar da maganin da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Kwamitin Kula da Kiwon Lafiya da Kayan Aiki na Sojojin Amurka, Fort Detrick, da Cibiyar Nazarin Sojojin Walter Reed, Silver Spring, waɗanda ke yammacin jihar Maryland, sun ba da sanarwar cewa suna haɓaka allurar rigakafin su.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta shiga cikin haɗin gwiwa tare da Novavax Inc.
don samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da shirye-shiryen gudanar da gwajin gwaji da gwajin gwaji na farko a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar cewa suna nazarin marasa lafiya 11 da aka ware, kuma ko da a cikin saurin aiki, zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere-kere, Quebec, ya ba da rahoton cewa tare da tallafin kuɗi daga Cibiyar Nazarin Kiwon Lafiyar Kanada, sun ƙirƙiri wani abu mai kama da coronavirus.
Ana gudanar da gwajin gwaji a cikin dakin gwaje-gwaje, kuma an shirya gwajin mutum a watan Yuli ko Agusta na 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac dimbin kuɗi don samun damar yin allurar rigakafin COVID-19, wanda gwamnatin Jamus ta nuna rashin amincewar ta.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da kulla kawance da kamfanin BioNTech na Jamus don haɓaka allurar rigakafi tare bisa tushen iRNA.
BNT162 shine ɗan takarar rigakafin da ke da tushen iRNA; a halin yanzu ana yin gwajin rigakafin rigakafin, kuma za a fara gwajin asibiti a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020, kamfanin fasahar halittu na Italiya Takis Biotech ya sanar da cewa zai sami sakamakon gwajin farko a watan Afrilu na 2020, kuma za a iya fara gwajin maganin na ƙarshe a kan mutane a kaka.
A ranar 19 ga Maris, 2020, Ƙungiyar Innovation for Epidemic Preparedness (CEPI), Faransa, ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar don haɓaka allurar rigakafin COVID-19 tare da halartar Cibiyar Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh. Jimlar saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 ya kai dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI a cikin samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'o'in Hong Kong, Oxford da Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin wasu magunguna shida daban-daban a kan dabbobi.
Masu bincike a kwalejin Imperial College, London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da allurar rigakafin RNA mai karawa kanta COVID-19.
An samar da maganin rigakafin a cikin kwanaki 14 bayan an samu jerin daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da ba da dala miliyan 275 na Kanada don tallafawa ayyukan bincike 96 kan maganin COVID-19, gami da haɓaka takwarorin allurar rigakafi da yawa a kamfanonin Kanada da jami'o'i kamar Medicago da Jami'ar Saskatchewan.
A kusan wannan lokacin, gwamnatin Kanada ta sanar da ba da dala miliyan 192 na Kanada musamman don samar da allurar rigakafin COVID-19, da kuma shirin kafa bankin allurar rigakafin ƙasa wanda zai haɗa da sabbin alluran rigakafi da yawa da za a iya amfani da su idan aka sake barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike daga Makarantar Kiwon Lafiya ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna cewa MNA ta ba da alluran rigakafin SARS-CoV-2 S1 na ƙananan rukuni, yana haifar da martani mai ƙarfi na ƙwayoyin rigakafi na antigen-takamaiman [a cikin beraye] waɗanda suka bayyana makonni 2 bayan allurar rigakafi.
A ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo ta Kanada ta sanar da samar da yiwuwar allurar rigakafin DNA, wanda wataƙila za a samar da shi a cikin hanyar fesa hanci.
Ta hanyar bacteriophages, DNA za ta ninka a cikin kwayoyin cuta na mutum kuma ta samar da ƙwayoyin cuta marasa lahani waɗanda za su iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta da ke kan kwayar SARS-CoV-2.
A watan Maris na 2020, gwamnati, masana'antu da jami'o'i uku na Amurka sun haɗa albarkatun manyan kwamfutocin IBM tare da albarkatun girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran suna da sakamako na al'ada, wanda ake kira sakamako mara kyau.
Wannan yana nufin cewa suna iya samun wasu amfani ban da rigakafin cututtuka.
Wani bincike kuma da aka yi a ƙasar Ostareliya ya haɗa da ma'aikatan kiwon lafiya 4,170.
Zai yiwu cewa alluran da ake samarwa ba su da lafiya ko kuma ba su da amfani.
Binciken farko don kimanta ingancin alluran rigakafi ta amfani da samfuran dabbobi waɗanda ke da COVID-19, kamar ACE2-transgenic mice, sauran dabbobin gwaji, da ƙananan dabbobi masu mahimmanci, suna nuna buƙatar matakan hana kamuwa da cuta tare da matakin aminci na 3 yayin sarrafa ƙwayoyin cuta masu rai, da kuma daidaitaccen tsarin aminci na duniya.
An gwada alluran rigakafin SARS da MERS a kan dabbobi.
A shekarar 2020, babu wani magani ko allurar rigakafi da ke da lafiya da kuma tasiri ga mutane don magance SARS.
A cewar binciken da aka buga a cikin 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don maganin cutar huhu ya kasance fifiko ga gwamnatoci da cibiyoyin kiwon lafiya a duk duniya.
Lokacin da MERS ya fara yaduwa, an yi imanin cewa binciken SARS da ake yi a lokacin zai iya zama mizani don haɓaka alluran rigakafi da magunguna don kamuwa da cutar MERS-CoV.
A watan Maris na 2020, akwai rigakafin MERS guda ɗaya (wanda ya dogara da DNA) wanda ya wuce matakin gwaji na farko a kan mutane, da wasu alluran rigakafi guda uku, dukansu alluran rigakafi ne na kwayar cutar kuma suna cikin aikin haɓakawa, biyu  adenovirus (ChAdOx1-MERS, BVRS-GamVac) da ɗaya  MVA-vector (MVA-MERS-S).
An yi ta yada ka'idar ƙulla makirci a shafukan sada zumunta, da ke cewa cutar COVID-19 ba sabuwar ba ce, kuma riga-kafin ta riga ta wanzu.
Shafukan sada zumunta sun ambaci wasu marasa lafiya da suka yi ikirarin cewa akwai takardun shaida na kwayoyin halittar wasu nau'ikan coronavirus, kamar SARS coronavirus, da kuma alluran rigakafi don waɗannan nau'ikan.
Cutar coronavirus  cuta ce da aka gano a cikin 2019 (COVID-19), cuta ce mai saurin kamuwa da cuta ta hanyar cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Alamun da aka fi gani a cikin wannan yanayin su ne zazzabi, tari, da kuma numfashi cikin wuya.
Sauran alamun za su iya kasancewa gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙamshi, da ciwon ciki.
Lokaci daga farkon bayyanar cututtuka zuwa lokacin da cutar ta kai matsakaicin lokaci yawanci kwanaki biyar ne, amma kuma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Yawancin lokaci, cututtukan suna da sauƙi, amma a wasu lokatai suna iya zama cututtukan cututtukan cututtuka da kuma rashin ƙarfi.
A ranar 17 ga Afrilu, 2020, an samu sama da mutane miliyan 2.24 da suka kamu da cutar a kasashe 210 da yankuna, kuma sama da mutane 153,000 ne suka mutu sakamakon cutar.
Fiye da mutane 568,000 sun warke, kuma ana yada cutar ne ta hanyar kusanci da mutane, sau da yawa ta hanyar ƙananan ruwa da ke fitowa daga iska yayin tari, hancin baki ko magana.
Ko da yake ana fitar da waɗannan ɗigon sa'ad da ake numfashi, suna da haɗari idan suka fāɗi ƙasa ko kuma a ƙasa, amma ba sa wucewa nesa.
Mutane suna kuma kamuwa da cutar ta wurin taɓa gurɓataccen abu da idanunsu da hancinsu da kuma bakinsu.
Kwayar cutar na iya rayuwa a farfajiya na tsawon sa'o'i 72.
Yana da mafi kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakai na gaba.
Ana ba da shawarar yin amfani da abin rufe fuska ga marasa lafiya da ake zargi da cutar da kuma masu kula da su.
Shawarwarin da aka bayar game da amfani da abin rufe fuska na likita ya bambanta: wasu hukumomi suna ba da shawarar kada su yi amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna buƙatar hakan.
A halin yanzu babu allurar rigakafi ko magani na musamman don cutar COVID-19.
An samu yaduwar cutar a yawancin ƙasashe a dukan yankuna shida na WHO.
Wadanda suka kamu da cutar suna iya rashin alamun cutar ko kuma su sami alamun mura kamar zazzabi, tari, gajiya da kuma numfashi.
Alamun gaggawa sun haɗa da numfashi cikin wahala, ciwo ko kuma matsi a kirji, rikicewa, wahalar farkawa, fuska ko lebe sun yi ruwan kasa. Idan ka ga waɗannan alamun, ka nemi taimako na likita nan da nan.
Ba a yawan samun alamun cututtukan numfashi na sama kamar yin hancin baki, sanyi ko ciwon makogwaro.
Ƙari ga haka, ana samun cututtuka dabam-dabam a cikin hanji, kamar su tashin zuciya, amai da gudawa.
Wasu cututtuka da aka samu a ƙasar Sin, a farko suna nuna cewa zuciyarsu tana bugun jini kuma suna jin kamar an matsa su.
A wasu lokatai, cutar tana iya ci gaba zuwa ciwon huhu, rashin aiki na gabobin jiki, kuma a ƙarshe mutuwa.
Wannan shi ake kira lokacin ƙwanƙwasawa.
Lokacin kwantar da hankali na COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya bambanta daga kwana biyu zuwa 14.
A cikin mutane 97.5%, alamun cutar sun fara bayyana a cikin kwanaki 11.5 bayan kamuwa da cutar.
Ba a san ainihin yadda waɗannan ƙwayoyin cuta suke sa mutane kamuwa da cutar ba, amma wasu bayanai sun nuna cewa suna iya sa mutane su kamu da cutar.
Ba a san yawan mutanen da ke dauke da cutar ba tare da alamun cutar ba a halin yanzu, ana nazarin su ne kawai; tare da cibiyoyin kula da cututtuka da rigakafin cututtuka na KCDC sun ba da rahoton cewa kashi 20 cikin ɗari na duk waɗanda aka tabbatar da cutar da kuma asibitocin cutar ba su da alamun cutar.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada da marasa alamun cutar a cikin rahoton ta na yau da kullun daga ranar 1 ga Afrilu; daga cikin mutane 166 da aka samu a wannan ranar, 130 (78%) sun ce ba su da alamun cutar a lokacin gwajin.
Ƙwari da kuma leɓunanmu suna iya ɗauke da ƙwayoyin cuta sosai.
Sa'ad da kake magana da ƙarfi, ana fitar da ɗigon ruwa fiye da yadda ake yi sa'ad da kake magana da ƙarfi.
Wani bincike da aka yi a ƙasar Singapore ya nuna cewa idan mutum ya yi tari a fili, ɗigon zai iya kaiwa nisan kafa 15 (mita 4.5).
Ba a yawan watsa kwayar cutar ta hanyar iska, amma Cibiyar Kimiyya ta kasa ta yi hasashen cewa za a iya watsa kwayoyin cutar ta hanyar bioaerosol, kuma gwajin iska da aka yi da masu karɓar iska a cikin hanyoyin da ke wajen ɗakunan mutane ya nuna cewa akwai RNA na kwayar cutar.
Wasu hanyoyin magani kamar su intubation da CPR na iya haifar da yayyafa kayan numfashi kuma hakan yana haifar da yaduwar kwayar cutar a cikin iska.
Akwai kuma fargabar cewa kwayar cutar na iya yaduwa ta hanyar ƙazanta, duk da haka, ana ɗaukar wannan haɗarin da ƙanƙanta. Kwayar cutar tana da haɗari sosai lokacin da mutane ke nuna alamun cutar; ana iya yada kwayar cutar kafin bayyanar alamun cutar, amma wannan haɗarin ba shi da yawa.
Ma'aikatan Cibiyar Kula da Cututtuka ta Turai (ECDC) sun ce ba a san yadda cutar ke yaduwa ba, amma an san cewa mutum ɗaya da ke da cutar yakan kamu da mutane 2,3 kuma yana iya rayuwa a kan ƙasa na sa'o'i da yawa zuwa kwanaki.
Musamman, an gano cewa kwayar cutar tana iya rayuwa a kan kwali na kwana ɗaya, a kan filastik (polypropylene) da bakin karfe (AISI 304)  har zuwa kwana uku, kuma a kan 99% na jan ƙarfe  har zuwa awanni 4.
Amma, yawan zafin jiki da kuma yanayin ƙasa suna bambanta.
Sabulu da kuma kayan wanki da aka yi amfani da su da kyau suna da amfani sosai wajen hana kamuwa da cutar. Sabulu yana lalata kitsen da ke kāre ƙwayoyin cuta kuma yana kawar da su daga fata da kuma wasu wurare.
Sauran magunguna kamar su benzalkonium chloride da chlorhexidine gluconate (wani maganin kashe kwayoyin cuta na tiyata) ba su da tasiri sosai a kan wannan kwayar cutar.
A cikin marasa lafiya biyar cikin shida, gwajin farko ya nuna yawan kwayar cutar a cikin jini, kuma a cikin mai haƙuri na shida, an gano mafi yawan kwayar cutar a rana ta biyu na gwajin.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin alamun sabon kwayar cutar SARS-CoV-2 suna cikin kwayar cutar corona da ke da alaƙa da juna.
Bayan jikin mutum, ana kashe kwayar cutar ta sabulu na gida wanda ke buɗe murfinta na kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuka  shine sashin da ya fi fuskantar tasirin COVID-19, saboda kwayar cutar tana shiga cikin ƙwayoyin halitta ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar na huhu na nau'in II.
Kwayar cutar tana haɗuwa da ACE2 kuma tana shiga cikin tantanin halitta ta hanyar amfani da glikoprotein na musamman  shipa (asphalomer).
A cikin mutane 12 cikin 100 da suka kamu da cutar da aka kwantar a asibiti a birnin Wuhan, an gano cewa suna da ciwon zuciya mai tsanani, wanda ya fi yawa a cikin masu ciwon zuciya mai tsanani.
Yawan cututtukan zuciya yana da yawa saboda amsawar kumburi da kuma lalacewar tsarin rigakafi da ake gani yayin ci gaban cutar, amma lalacewar myocardial mai tsanani na iya kasancewa ta hanyar kasancewar masu karɓar ACE2 a cikin zuciya.
Abubuwan da ke karɓar ACE2 suna cikin zuciya da yawa domin suna cikin aikin wannan sashin.
An lura da yawan jini (31%) da kuma jijiyoyin jini (25%) a cikin marasa lafiya da ke cikin OIT tare da COVID-19, kuma yana iya nuna mummunan hangen nesa. Binciken gawa na marasa lafiya da suka mutu daga COVID-19 ya nuna lalacewar alveolar (DAD) da kuma ƙwayoyin cuta masu ƙwayoyin cuta a cikin huhu.
Duk da cewa SARS-COV-2 yana da ƙarancin ƙwayoyin ƙwayoyin cuta na ACE2-mai bayyanawa, marasa lafiya da ke fama da cutar COVID-19 suna da alamun ƙonewa.
Musamman, an gano cewa kwayoyin T-cell na GM-CSF masu cutarwa suna da alaƙa da daukar sabbin ƙwayoyin ƙwayoyin ƙwayoyin cuta masu ƙonewa waɗanda ke samar da IL-6, da kuma mummunan cututtukan huhu a cikin marasa lafiya tare da COVID-19.
An kuma gano wasu ƙwayoyin cuta a lokacin da aka yi wa jaririn autopsy.
Ƙari ga haka, Hukumar Lafiya ta Duniya ta wallafa wasu littattafan gwaji don wannan cuta.
A lokacin da za a yi gwajin, ana yin amfani da maganin polymerase chain reaction (PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samo daga hanci, amma ana iya amfani da samfurin hanci ko kumfa.
Sakamakon gwajin yakan kasance cikin sa'o'i da yawa zuwa kwanaki biyu.
Za a iya yin gwajin jini, amma ana bukatar a yi gwajin jini sau biyu a mako biyu, kuma sakamakon ba shi da muhimmanci.
Masana kimiyya na kasar Sin sun gano wani nau'in kwayar cutar coronavirus kuma sun wallafa jerin kwayoyin halittun sa domin masana kimiyya a dakunan gwaje-gwaje a duniya su iya yin gwajin polymerase chain reaction (PCR) da kansu don gano cutar.
A ranar 4 ga Afrilu, 2020, an fara gwajin rigakafin da zai iya gano cutar a yanzu, da kuma yiwuwar kamuwa da cutar a baya, amma ba a yi amfani da su ba tukuna.
Kwarewar kasar Sin game da nazarin sakamakon gwajin ya nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin dari.
A ranar 21 ga Maris, 2020, Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da gwajin farko don gano cutar a wuri, ta ba da izinin amfani da shi a ƙarshen wannan watan.
Hanyoyin haɗin gwiwar subpleural masu yawa a cikin nau'in gilashin matte  tare da rarrabawa na gefe, asymmetrical da posterior  sune alamun bayyanar cututtuka da aka gano a farkon lokacin cutar.
Subpleural rinjaye, wata alama ce ta dutsen dutse (ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin
Ba a san komai game da cutar COVID-19 da kuma yanayin da ke tattare da ita ba.
Babban sakamakon binciken cututtuka da ake yi a lokacin budewa:
Ƙarin gani: pleurisy, pericarditis, ƙwanƙwasawa da kumburi na huhu
Akwai nau'i huɗu na cutar sankarar bargo:
nau'i mai sauƙi na ciwon huhu: ƙonewa na huhu, hyperplasia na ciwon huhu, manyan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
mummunar cututtukan huhu: lalacewar alveolar (DAD) tare da ɓarna na alveolar.
DAD yana haifar da ciwon numfashi mai tsanani (ADHD) da kuma mummunan hypoxemia.
ciwon huhu mai warkewa: tsari na exudate a cikin alveolar cavities da kuma ciwon fibrosis na huhu.
Jini: yaduwar jini a cikin jijiyoyin jini (DVS-syndrome); amsawar leukoerythroblastic
Matakan kariya don rage yiwuwar kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wuraren da mutane suke, wanke hannuwanku da sabulu da ruwa sau da yawa na akalla dakika 20, kiyaye ƙa'idodin tsabtace numfashi, da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
Cibiyar Kula da Cututtuka ta Amirka ta ce idan kana tari ko atishawa, ka rufe bakinka da hancinka da tawul, ko kuma idan ba ka da tawul, ka rufe bakinka da hancinka da na hannu.
Bayan tari ko hancin, ana bukatar a yi wa hannuwanku tsabta.
Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, musamman don iyakance yaduwar kamuwa da cutar daga mutanen da ba su da alamun cutar. Dabarun nisantar zamantakewar jama'a suna nufin rage hulɗar marasa lafiya da manyan ƙungiyoyin mutane; a cikin waɗannan matakan an rufe makarantu da kamfanoni, an iyakance motsi na jama'a kuma an soke manyan taron jama'a.
Shawarwarin nisantawa sun kuma nuna cewa mutane su kasance aƙalla ƙafa 6 (1.8 m) daga juna.
Babu wasu magunguna da aka tabbatar suna da tasiri a kan COVID-19. Tun da yake ba a sa ran kammala aikin rigakafin ba kafin 2021, yawancin matakan da ake ɗauka don hana yaduwar COVID-19 sun ta'allaka ne da rage yawan annobar, wanda aka sani da "faduwa".
Cibiyar CDC ta kuma ba da shawarar wanke hannuwanka da sabulu da ruwa aƙalla sau 20 a kai a kai, musamman bayan ka je bayan gida ko kuma idan hannayenka sun ƙazantu sosai, kafin ka ci abinci da kuma bayan ka hũra, tari ko hancinka.
CDC ta kuma ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta da ke dauke da barasa (ƙarancin barasa  60%) don maganin hannu, amma kawai a lokuta da sabulu da ruwa ba su samuwa.
Ana amfani da ethanol ko isopropanol a cikin waɗannan abubuwan da ke da tasirin ƙwayoyin cuta.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin barasa kuma ba shi da kyau don maganin cututtuka na hannu.
Ana ƙara glycerol a matsayin mai ƙoshin ruwa.
Ana ba marasa lafiya magani mai taimako, wanda zai iya haɗa da maganin jini, taimakon oxygen, da kuma taimakon wasu gabobin da suka ji rauni.
Cibiyar Kula da Cututtuka ta CDC ta ba da shawarar cewa duk wanda ya yi zaton yana da cutar ya sa takunkumin rufe fuska.
An yi amfani da maganin ƙwayar cuta na waje don magance rashin ƙarfi, amma har yanzu ana nazarin amfaninta.
Don ƙarfafa rigakafin jiki, ana ba da shawarar bin ƙa'idodin tsabtace jiki, salon rayuwa mai kyau da kuma abinci mai gina jiki.
Za a iya ba da magungunan tallafi ga marasa lafiya da ke da alamun rashin lafiya a farkon lokacin cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta Kasa ta China sun wallafa shawarwari kan kula da marasa lafiya da ke cikin asibiti da COVID-19.
A Amirka, likitocin jinya da likitocin cututtukan huhu sun tattara shawarwarin magani daga cibiyoyi daban-daban a cikin kayan aikin kyauta  IBCC.
A watan Afrilun 2020, babu wani magani na musamman don COVID-19.
Don magance cututtuka a matsayin magungunan farko, wasu likitoci sun ba da shawarar yin amfani da acetaminophen a kan ibuprofen.
Idan ana yin wasu ayyuka da za su iya haifar da zubar da jini, kamar intubation ko bushe hannu, dole ne a ɗauki matakan kariya don rage haɗarin kamuwa da cutar, musamman a wuraren kiwon lafiya.
Ma'aikatan kiwon lafiya da ke kula da mutanen da ke da COVID-19 CDC ta ba da shawarar sanya su cikin keɓewar iska-raɓa (AIIR)  ƙarin matakin ban da matakan kariya na yau da kullun game da hulɗa da iska. CDC ta buga shawarwari game da amfani da kayan kariya na mutum (PAS) yayin annobar.
Ana ba da shawarar amfani da kayan kariya na mutum: rigar kariya, respirator ko abin rufe fuska, kayan kariya na ido da safar hannu. Daga cikin kayan da aka lissafa a sama, ya fi dacewa a yi amfani da respirators maimakon masks na likita.
An amince da masu numfashi na N95 don amfani a cikin masana'antu, amma FDA ta ba da izinin amfani da waɗannan masu numfashi a ƙarƙashin izinin Amfani da Gaggawa (EUA).
An tsara su don kare kariya daga ƙwayoyin iska, irin su ƙura, amma idan ba a yi amfani da su ba bisa ga umarnin ba, ba a tabbatar da inganci a cikin kariya daga takamaiman wakili na halitta.
Idan ba a samun abin rufe fuska na likita, CDC ta ba da shawarar amfani da fuskokin fuska masu kariya ko kuma a cikin matsanancin yanayi, yin abin rufe fuska a gida.
A yawancin lokuta, cutar COVID-19 ba ta da tsanani sosai da za ta bukaci yin amfani da iska mai sauƙi ko kuma wasu hanyoyin yin hakan, amma akwai wasu lokuta da ake bukatar yin hakan.
Wani nau'in tallafi na numfashi don marasa lafiya da ke cikin asibiti tare da rashin ƙarfi na numfashi da ke da alaƙa da COVID-19 a halin yanzu ana yin nazari sosai, tare da wasu shaidu don guje wa intubation ta hanyar amfani da bututun oxygen na hanci tare da iska mai ƙarfi ko matsin lamba mai kyau a cikin hanyoyin numfashi.
Ba a san ko waɗannan hanyoyin biyu suna da amfani kamar yadda maganin hana ɗaukar ciki yake yi wa marasa lafiya da ke cikin mawuyacin hali ba.
Wasu likitoci suna zaɓar yin amfani da iska mai iska mai iska idan akwai, saboda wannan hanyar tana iyakance yaduwar ƙwayoyin cuta a cikin iska idan aka kwatanta da hanci mai zurfi.
A ƙasashe da yawa masu tasowa, babu isassun gadajen asibiti a kan kowane mutum, kuma albarkatun tsarin kiwon lafiya sun yi ƙarancin sarrafawa don magance ƙaruwar yawan masu kamuwa da cutar COVID-19 a cikin mawuyacin hali da ke buƙatar asibiti.
Wani bincike da aka yi a ƙasar Sin ya nuna cewa kashi biyar cikin ɗari na marasa lafiya da ke asibiti suna cikin cibiyar jinya, kashi biyu cikin uku suna bukatar taimakon iska, kuma kashi ɗaya cikin huɗu sun mutu.
A China, kusan kashi 30 cikin ɗari na mutanen da aka kwantar da su a asibiti da cutar COVID-19 suna zuwa asibitin jinya.
Matsayin samar da iska mai ƙarfi yana da wuya yayin da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana bukatar maganin hana shan iska da kuma maganin hana shan iska don a samu isashen iskar oxygen zuwa cikin huhu kuma a rage yawan iska da ke cikin huhu, wanda zai iya haifar da ciwon huhu.
A kan tsofaffin samfurin masu motsa jiki, ba za a iya samun babban PDCV ba.
An fara binciken hanyoyin magance cutar a watan Janairun 2020, kuma a yanzu haka, akwai wasu magunguna da ke cikin gwaji.
Abin da ya fi dacewa shi ne maganin Remdesivir.
Za a iya ci gaba da samar da sababbin magunguna har zuwa 2021, amma an riga an amince da wasu magunguna da ake gwadawa don wasu dalilai ko kuma suna cikin ƙarshen gwaji.
Za a iya gwada maganin rigakafin cutar a kan marasa lafiya da ke fama da ciwo mai tsanani.
Masu aikin sa kai da Hukumar Lafiya ta Duniya ta ba da shawarar suna shiga cikin gwajin inganci da amincin hanyoyin magance cutar. FDA ta ba da izinin amfani da jini na ɗan lokaci don amfani da magani na gwaji a lokuta da rayuwar mutum ke cikin haɗari ko kuma na nan take.
Ba a yi amfani da shi ba a cikin gwaji na asibiti, wanda dole ne a gudanar da shi don tabbatar da lafiyar magani da tasiri.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar hannu da aka tsara don magance cutar.
Don shiga, masu amfani suna buƙatar shigar da sunansu da lambar shaidar su.
Aikace-aikacen na iya gano  kusanci  ta hanyar bayanan sa ido kuma don haka ya ƙayyade yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan an gano wata barazana, app din ba kawai yana ba da shawarar keɓe kai ba amma kuma yana aika sanarwar ga hukumomin kiwon lafiya na gida. Nazarin manyan bayanai da aka tattara daga wayoyin hannu, fasahar gano fuska, bin wayar hannu da hankali na wucin gadi  ana amfani da waɗannan kayan don bin mutanen da ke da cutar da kuma waɗanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro izinin saka idanu kan bayanan wayar salula na mutanen da ake zargin sun kamu da cutar coronavirus.
An dauki matakan tabbatar da killacewa da kariya ga mutanen da za su iya saduwa da mutanen da ke dauke da cutar.
Hakanan a cikin Maris na 2020, don bincike da hana yaduwar kwayar cutar Deutsche Telekom ta ba da bayanan haɗin gwiwa game da wurin da masu amfani da wayar salula suke ga hukumomin tarayya na Jamus da Cibiyar Robert Koch.
An gabatar da fasahar gane fuska a Rasha don gano masu keta dokar.
Jami'in kula da lafiyar yankin Italiya, Giulio Galera ya ce masu amfani da wayoyin salula sun ce kashi 40 cikin dari na mutane suna ci gaba da tafiya a kasar.
Gwamnatin Jamus ta gudanar da wasan kwaikwayo na tsawon sa'o'i 48 a ranar karshen mako, inda mutane fiye da 42,000 suka halarci.
Shugabar Estonia Kersty Kaljulaid ta kuma yi kira da a nemi hanyoyin samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane suna iya yin sanyin gwiwa don keɓewa, ƙuntatawa na tafiya, sakamakon rashin lafiyar, ko kuma tsoron kamuwa da cutar.
BBC ta kawo maganar Rory O'Connor: "Ƙara yawan zaman kaɗaici, kadaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki  yanayi ne mai kyau don cutar da lafiyar mutum da lafiyar mutum".
Cutar za ta iya zama mai sauƙi tare da ƙananan alamun bayyanar cututtuka ko babu alamun bayyanar cututtuka kamar cututtukan cututtukan numfashi na sama, kamar sanyi.
Masu fama da cutar suna murmurewa cikin makonni biyu, amma masu fama da cutar suna iya yin mako uku zuwa shida.
Mata masu ciki na iya samun haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanan da aka samu game da wasu ƙwayoyin cuta irin su SARS da MERS, kodayake babu irin wannan bayanan game da COVID-19. A wasu mutane COVID-19 na iya shafar huhu kuma yana haifar da cutar huhu a matsayin matsala.
A cikin mutane da ke fama da cutar COVID-19, cutar za ta iya saurin ci gaba zuwa ciwon numfashi mai tsanani (ARDS), wanda ke haifar da rashin numfashi, harin ƙwayoyin cuta ko rashin aiki.
Matsalolin COVID-19 sun haɗa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An bayyana rashin daidaito na jini, musamman ƙara lokacin prothrombin, a cikin kashi 6% na marasa lafiya da aka kwantar a asibiti tare da COVID-19, yayin da lalacewar aikin koda ke faruwa a cikin kashi 4% na wannan rukunin.
Kimanin kashi 20 zuwa 30 cikin dari na marasa lafiya da COVID-19 suna da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Bisa ga wannan rahoton, matsakaicin lokacin da ya wuce tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, biyar daga cikinsu a asibiti.
Amma, matsakaicin lokacin da ya rage tsakanin asibiti da mutuwa a cikin marasa lafiya da aka kai sashen jinya mai tsanani ya kai kwana bakwai.
Binciken da aka yi a kan waɗanda suka kamu da cutar a farkon lokacin, ya nuna cewa lokaci tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 14, kuma tsawon lokacin ya kai kwanaki shida zuwa 41.
A cewar wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar, mace-macen maza sun kai kashi 2.8 cikin dari, yayin da mata suka kai kashi 1.7 cikin dari.
Binciken cututtukan cututtuka na numfashi na numfashi ya nuna lalacewar alveolar tare da ƙwayoyin fibromycoid a cikin huhu biyu.
An lura da canjin kwayar cutar a cikin ƙwayoyin huhu.
Fuka-fukansa suna kama da ciwon numfashi mai tsanani .
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Kiwon Lafiya ta kasar Sin ta bayar, cututtukan zuciya sun kasance saboda yawan yawan troponin ko kuma ciwon zuciya.
A cewar bayanan da Amurka ta bayar a watan Maris, kashi 89% na marasa lafiya da aka kwantar a asibiti suna da wasu matsalolin kiwon lafiya. Samun albarkatun kiwon lafiya da yanayin tattalin arziki da zamantakewar al'umma a yankin na iya shafar mutuwar.
Ƙididdigar mutuwar ta bambanta dangane da yanayin saboda irin wannan bambancin yanki da kuma matsalolin da ke tattare da hanyoyin.
Idan ba a yi amfani da ƙididdigar ƙwayoyin cuta ba, zai iya sa mutum ya mutu.
Amma, mutuwar da ake yi a yau daga cututtuka da aka samu a dā yana iya nuna cewa ba a san yawan mutanen da suke mutuwa a yau ba.
Masu shan taba suna da yawan kamuwa da cututtukan COVID-19 sau 1.4 kuma irin waɗannan marasa lafiya sun fi buƙatar kulawa mai tsanani ko mutuwa sau 2.4 idan aka kwatanta da waɗanda ba sa shan taba. An nuna damuwa game da tasirin cutar a cikin dogon lokaci.
Wani asibiti a Hong Kong ya gano cewa wasu marasa lafiya da suka warke daga wannan cuta suna da ciwon huhu da ya ragu da kashi 20 zuwa 30 cikin ɗari, kuma gwajin da aka yi musu ya nuna cewa suna da ciwo.
Bayan ya warke, hakan zai iya sa ya soma ciwon ciwon daji.
Har zuwa watan Maris na 2020, ba a san ko marasa lafiya da suka warke daga cutar suna da tsayayyar rigakafi ba.
Bisa ga yadda sauran cututtukan korona ke gudana, ana ganin hakan zai yiwu, amma an kuma bayar da rahoton cewa an yi gwajin cutar bayan an warke daga COVID-19.
Ana ganin cewa waɗannan cututtukan sun nuna cewa cutar ta ci gaba da ƙaruwa, ba sake kamuwa da cutar ba.
Ana ganin cewa kwayar cutar ta halitta ce, ta samo asali ne daga dabbobi kuma cuta ce mai saurin yaduwa.
Ba a san ainihin asalin kwayar cutar ba, amma a watan Disamba na 2019, kusan dukkanin yaduwar cutar ta kasance ta hanyar watsawa daga mutum zuwa mutum.
Binciken farko na mutane 41 da aka tabbatar da cutar COVID-19, wanda aka buga a cikin Janairu 2020 a cikin The Lancet, ya nuna ranar 1 ga Disamba 2019 a matsayin ranar farko da aka fara samun cutar.
A cewar bayanan da Hukumar Lafiya ta Duniya ta wallafa, wannan ranar  8 ga Disamba, 2019.
Ana amfani da hanyoyi da yawa wajen sanin yawan mutuwar.
Dukkanin lambobi sun bambanta dangane da yanki da lokacin yaduwar cutar, kuma ana iya yin tasiri da yawan gwajin, ingancin tsarin kiwon lafiya, tsarin magani da aka yi amfani da shi, lokacin da cutar ta fara, da kuma ma'aunin yawan jama'a kamar shekaru, jinsi da yanayin lafiyar jama'a.
A ƙarshen 2019, WHO ta ba da lambar gaggawa ta ICD-10 ga cutar: U07.1  don mutuwar da aka tabbatar da cutar SARS-CoV-2 da U07.2  don mutuwar da aka tabbatar da cutar COVID-19 ba tare da tabbacin cutar SARS-CoV-2 ba.
A cewar kididdigar Jami'ar Johns Hopkins, a ranar 17 ga Afrilu, 2020, yawan mutuwar duniya da kamuwa da cutar ya kai kashi 6.9% (153 822/2 240 191).
Wannan adadi ya bambanta daga yanki zuwa yanki. Wasu wasu hanyoyin sun haɗa da ƙayyade ƙimar mutuwar cututtuka (CFR), wanda ke nuna yawan adadin marasa lafiya da aka gano da suka mutu daga cutar, da kuma ƙayyade ƙimar mutuwar cututtuka (IFR), wanda ke nuna yawan adadin marasa lafiya da suka kamu da cutar (duka masu cutar da marasa lafiya) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da alaƙa da wani lokaci kuma suna nuna ƙididdigar wani ɓangaren jama'a daga lokacin kamuwa da cutar har zuwa ƙarshen cutar.
Ko da yake ba dukan waɗanda suka kamu da cutar ba ne suke samun ƙwayoyin rigakafi, amma idan akwai ƙwayoyin rigakafi, za ka san yawan mutanen da suka kamu da cutar.
A tsakiyar barkewar cutar a Italiya, Castillone d'Adda, wani karamin kauye mai yawan mutane 4,600, mutane 80 (1.7%) sun mutu.
A garin Gangelt, cutar ta yadu a lokacin bikin Carnival tsakanin matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 za a iya rarraba su a matsayin haka ba.
Ƙari ga haka, ba a cika tsarin kiwon lafiya na ƙasar Jamus da aiki ba.
A ƙasar Netherlands, kashi uku cikin ɗari na mutanen da aka ba da jini suna da ƙwayoyin rigakafi.
COVID-19  shine sanadin mutuwar mutane 69 (0,004% na yawan jama'a).
Sakamakon annobar da kuma yawan mace-mace sun bambanta tsakanin maza da mata.
Bincike da aka yi a ƙasar Sin da Italiya ya nuna cewa maza ne suke mutuwa fiye da mata.
Ƙungiyar da ke da haɗari sosai  maza ne da suka haura shekara 50; kawai bayan shekara 90 ne rata tsakanin maza da mata ke raguwa.
A ƙasar Sin, mace-macen da ke mutuwa a lokacin suna da kashi 2.8 cikin ɗari a tsakanin maza da kuma kashi 1.7 cikin ɗari a tsakanin mata.
Ba a san ainihin dalilin wannan bambancin ba, amma wataƙila akwai wasu abubuwa da suka shafi hali da kuma al'ada.
Bambancin jinsi, shan taba sigari a tsakanin mata, cututtuka masu haɗari a cikin maza (misali hauhawar jini, wanda ke faruwa a cikin maza a lokacin da suka fi ƙuruciya fiye da mata) na iya zama sanadin mutuwar maza.
A Turai, maza ne suka kai kashi 57 cikin ɗari na waɗanda suka kamu da cutar, kuma maza ne suka kai kashi 72 cikin ɗari na waɗanda suka mutu sanadiyyar COVID-19.
A watan Afrilu na 2020, gwamnatin Amurka ba ta gudanar da ƙididdigar jinsi game da COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura, da CVD suna da bambancin jinsi.
Mata ne suka fi yawa a aikin kiwon lafiya, musamman ma ma'aikatan jinya, kuma suna iya kamuwa da cutar.
A ranar 11 ga Fabrairun 2020, Hukumar Lafiya ta Duniya ta sanar da sunan cutar  COVID-19.
Shugaban WHO, Mr Tedros Adhanom Ghebreyesus ya bayyana cewa: CO na nufin corona, VI virus, D disease, kuma 19  shekarar da aka fara gano barkewar cutar: 31 ga Disamba, 2019.
An zaɓi wannan sunan ne don kauce wa yin magana game da takamaiman wurin da ake ciki (misali China), nau'in dabbobi ko rukunin mutane, kamar yadda shawarwarin duniya game da suna ke buƙata don hana ƙyama. Kwayar cutar da ke haifar da COVID-19 ana kiranta mai tsanani mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
A cikin saƙonnin jama'a, WHO tana amfani da ƙarin kalmomin Covid-19 da Covid-19.
Ana kiran cutar da kwayar cutar da coronavirus.
A lokacin barkewar cutar a Wuhan, China, an kira cutar da cutar coronavirus da Wuhanky coronavirus.
A watan Janairun 2020, bisa ga shawarwarin 2015 game da amfani da wuraren wurare a cikin sunayen cututtuka da ƙwayoyin cuta, WHO ta ba da shawarar amfani da kalmomin Cutar numfashi mai tsanani 2019-nCov da 2019-nCoV a matsayin sunayen ɗan lokaci na ƙwayoyin cuta da cututtuka.
A ranar 11 ga Fabrairun 2020, an buga sunayen hukuma  COVID-19 da SARS-CoV-2.
Saboda ƙuntataccen sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayan aikin likita kamar tampons don ɗaukar hanci da kuma sassan na'urorin IVF.
A wani lokaci, asibiti a ƙasar Italiya yana bukatar bawul ɗin iska, amma mai sayar da kayayyaki bai iya kawo shi ba, sai aka sake gina wani asibiti a wurin kuma aka buga bawul 100 a cikin dare ɗaya.
Tun bayan barkewar cutar COVID-19, ra'ayoyin rikici, rashin gaskiya da bayanan karya game da asalin cutar, girmanta, rigakafinta, magani da sauran fannoni sun bazu cikin sauri a Intanet.
Wataƙila mutane za su iya yaɗa cutar ga wasu dabbobi.
Sakamakon binciken bai tabbatar da yaduwar cutar a cikin aladu, ducks da kaji ba.
A yanzu haka babu wani allurar rigakafin cutar ko magani da aka amince da shi.
A halin yanzu, ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu suna gudanar da bincike na duniya daban-daban kan alluran rigakafi da magunguna na COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta soma wani shiri mai suna SOLIDARITY Trial don a gwada maganin da ake amfani da shi a wasu wurare guda huɗu da ake ganin sun fi amfani.
Har yanzu babu riga-kafin da aka gama, amma ƙungiyoyi da yawa suna aiki tuƙuru don samar da maganin.
Dukansu SARS-CoV da SARS-CoV-2 suna shiga cikin ƙwayoyin mutum ta hanyar mai karɓar ACE2, don haka ana amfani da sakamakon binciken da aka yi a baya akan SARS-CoV a cikin ci gaban kimiyya.
Akwai hanyoyi uku na yin allurar.
Na farko, masu bincike suna son su yi allurar rigakafi mai ɗauke da ƙwayoyin cuta.
Amfani da irin wannan kwayar cutar, ko dai a cikin yanayin rashin aiki ko kuma a cikin yanayin mutuwa, yana nufin haifar da saurin rigakafin jikin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu, samar da allurar rigakafi mai ƙananan ƙwayoyi, tana nufin samar da allurar rigakafi da ke ƙara ƙarfin tsarin garkuwar jiki ga wasu ƙananan ƙwayoyin cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken yana nufin lalata furotin mai kama da S wanda ke taimaka wa kwayar cutar shiga cikin mai karɓar enzyme ACE2.
Hanya ta uku ita ce yin allurar rigakafi da ke ɗauke da sinadarin nucleic acid (DNA ko RNA-vaccine, sabuwar hanyar yin allurar rigakafi).
Dole ne a gwada alluran rigakafin gwaji da aka tsara ta kowane ɗayan waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, gwajin farko na allurar rigakafin ya fara a Seattle akan masu sa kai huɗu.
Allurar rigakafin ta ƙunshi kwafin kwayar halitta mara lahani wanda aka kwafe daga kwayar cutar da ke haifar da cutar. An nuna ƙarfafawar rigakafin a matsayin ɗaya daga cikin matsalolin da za a iya samu a cikin samar da alluran rigakafin SARS-COV-2, amma wannan zato yana da rikici.
A watan Afrilun 2020, an gudanar da gwaji sama da 300.
An gwada magungunan da aka amince da su don maganin zazzabin cizon sauro a cikin gwaji bakwai, hudu daga cikinsu sun shafi hydroxychloroquine ko chloroquine.
Gyaran magungunan rigakafin cutar ya zama babban ɓangare na binciken China; a ƙarshen Afrilu, an gudanar da gwaje-gwaje tara na mataki na III akan remdesivir a ƙasashe da yawa.
A watan Afrilu na 2020, an gudanar da bita mai ƙarfi game da ci gaban asibiti na alluran rigakafi da magungunan da ake son yi don maganin COVID-19. Don wannan dalili, wasu magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir, da lopinavir / ritonavir a hade tare da interferon beta, ana yin nazari.
A watan Maris na 2020, akwai bayanan farko game da tasirin amfani da remdesivir.
An sami ci gaba a cikin marasa lafiya waɗanda suka karɓi remdesivir a matsayin banda.
An riga an fara gwajin gwaji na uku a Amurka, China da Italiya. An yi amfani da chlorokhin, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, a China a watan Fabrairun 2020, kuma akwai sakamakon farko.
Duk da haka, akwai bukatar a yi nazari sosai.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chlorine.
Cibiyar nazarin ƙwayoyin cuta ta Wuhan ta ba da shawarar a yi amfani da gram ɗaya a rana, amma ta ce idan aka ninka yawan maganin, zai iya zama haɗari kuma zai iya kashe mutum.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine a cikin ƙwarewar likitocin da ke kula da marasa lafiya da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar yawan ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar yin cikakken bincike a cikin in vivo, yana nuna hana SARS-CoV-2 a ƙananan taro. Bincike ya nuna cewa don shiga SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2 ana buƙatar sulhunta furotin ƙaya tare da serine transmembrane protease 2 (TMPRSS2).
Nazarin amfani da chlorokhin da hydroxychloroquine tare da azithromycin ko ba tare da shi ba yana da manyan iyakoki waɗanda ke hana ƙungiyar likitoci amfani da waɗannan hanyoyin ba tare da ƙarin bincike ba. Ozeltamavir ba ya hana SARS-CoV-2 a cikin vitro, kuma rawar da yake takawa wajen magance COVID-19 ba a bayyana ba.
Ana iya samun cutar hypercytokinemia a matsayin matsala a ƙarshen mawuyacin COVID-19.
Akwai tabbacin cewa hydroxychloroquine na iya haifar da cutar hypercytocinemia. A sakamakon wani karamin bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta gudanar, an hada tocilizumab a cikin shawarar maganin cutar coronavirus.
Wannan magani ya shiga cikin gwajin gwaji na biyu wanda ba a yi ba a Italiya, bayan an sami sakamako mai kyau a cikin marasa lafiya da ke fama da cutar.
Idan aka haɗa da gwajin jini don gano ferritin don gano hadari na cytokine, an tsara shi don magance abubuwan da ake tsammanin sun haifar da mutuwa a wasu marasa lafiya.
A cikin 2017, FDA ta amince da mai karɓar mai karɓar interleukin-6 bisa ga binciken binciken baya don magance cutar ƙwayar cuta ta ƙwayar cuta ta hanyar wata hanyar, maganin T-cell CAR.
A yau, babu wata hujja da aka yi amfani da ita ta hanyar sarrafawa da kuma sarrafawa cewa tocilizumab yana da tasiri a maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A halin yanzu ana ganin bayar da rigakafin rigakafin da aka tsabtace da kuma ƙididdigar rigakafin da tsarin garkuwar jiki na marasa lafiya da suka warke daga COVID-19 ga mutanen da suke buƙatar su a matsayin hanyar rigakafin da ba ta da rigakafi.
An gwada wannan dabarar wajen kula da marasa lafiyar SARS, amma sakamakon bai yi tasiri ba.
Kashe kwayar cutar  sakamako ne da ake tsammani wanda ke ba da maganin rigakafi na iya ba da kariya daga SARS-CoV-2.
Duk da haka, ana iya amfani da wasu hanyoyin, kamar su antibody-dependent cytotoxicity da / ko phagocytosis.
Ana kuma yin wasu hanyoyin maganin rigakafi, kamar su rigakafin da aka yi da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Za a iya ƙara yin amfani da jini mai ƙoshin lafiya, wanda ya ƙunshi jini mai ruwa na marasa lafiya da suka warke kuma yana ɗauke da ƙwayoyin cuta da ke hana cutar.
Cutar coronavirus, ƙungiyar cututtuka masu kama da juna
Li Wenliang, likita a babban asibitin Wuhan, wanda daga baya ya kamu da cutar kuma ya mutu daga COVID-19 bayan ya ba da rahoton yaduwar cutar.
